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       Psychological reactance theory posits that when something threatens or eliminates 
people’s freedom of behaviour, they experience psychological reactance, a motivational state 
that drives autonomy restoration. Section one reports a quantitative systematic literature 
review examining the relationship between psychological reactance and healthcare 
engagement. Six databases were searched (MEDLINE, CINAHL, PsycINFO, Academic 
Search Ultimate, SocINDEX, Embase) and fifteen studies met requirements for inclusion. 
Three studies investigated long-term physical health conditions, two investigated antibiotic 
adherence and ten studies investigated mental health conditions. Psychological reactance was 
significantly associated with: Adherence in nine studies; attendance in two studies; drop-out 
in two studies; and treatment satisfaction in one study. Nonsignificant associations between 
psychological reactance and engagement were reported in six studies. Further research is 
needed before strong conclusions can be drawn regarding the role of reactance within 
engagement. Nonetheless, the findings suggest that reactance is an important factor to 
consider. 
  Section two reports an empirical study investigating the role of psychological factors 
in engagement with mental health services for people with experiences of psychosis. Factors 
investigated were: Perceptions of autonomy, control beliefs, psychological reactance and 
expressed emotion. Participants (N=113) completed an online survey comprising of self-
report measures of these variables and engagement. Expressed emotion was not significantly 
associated with engagement. In a regression model, autonomy, psychological reactance and 
control beliefs significantly accounted for 46.2% of the variance in engagement; although at 
the final step, autonomy was the only significant predictor, accounting for 28.2% of the 
variance in engagement alone. This study demonstrated the utility of measuring perceptions 
of autonomy in relation to service engagement in psychosis. Findings highlight the 
importance of considering psychological variables in predicting therapeutic engagement.  
Section three includes a discussion of issues surrounding the conceptualisation and 
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Non-engagement with healthcare is a prevalent, persistent and costly problem for health 
services. One potentially important factor determining engagement is psychological 
reactance. This is a motivational state that develops when a person perceives there to be a 
threat to their personal freedom. Reactance functions to reinstate an individual’s perceptions 
of autonomy, often through restoring the behaviour that is being threatened. People vary in 
their trait propensity to experience reactance. This systematic review aimed to synthesise data 
on the relationship between psychological reactance and engagement variables in healthcare.  
Methods: Six databases were searched (MEDLINE, CINAHL, PsycINFO, Academic Search 
Ultimate, SocINDEX, Embase) for relevant literature from their inception until 20/05/2020 to 
identify studies investigating psychological reactance and engagement (adherence, 
attendance, drop-out, therapeutic engagement). A total of 2047 records were retrieved; 15 
studies were retained for inclusion.  
Thirteen studies employed a cross-sectional design; one was a quasi-experimental design and 
one was a longitudinal study. Three studies investigated long-term physical health conditions; 
two investigated antibiotic adherence; ten studies investigated mental health conditions. 
Psychological reactance was significantly associated with: adherence in nine studies; 
attendance in two studies; drop-out in two studies; and treatment satisfaction in one study. 
Non-significant associations between psychological reactance and engagement variables were 
reported in six studies. Salient additional relevant variables related to reactance and 
engagement were identified, including: social support, control and autonomy support; 
perceived coercion; working alliance; perceived provider collaboration; and Theory of 
Planned Behaviour variables (control beliefs, self-efficacy, attitudes and intentions).  
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This review showed significant associations between psychological reactance and 
engagement variables (adherence, attendance, drop-out, treatment satisfaction) across 
physical and mental health conditions. Further research is needed before strong conclusions 
can be drawn regarding the role of reactance within engagement. Nonetheless, the findings 
suggest that reactance is an important factor to consider. 
 
Keywords: psychological reactance; adherence; engagement; attendance; patient; physical 
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Introduction 
Engagement in Healthcare 
Non-engagement with treatment is a prevalent, persistent and costly problem for 
health services (Cutler et al., 2018), with estimates of ~50% non-adherence to long-term 
therapy for chronic illnesses (Sabaté & Sabaté, 2003). The issue of non-engagement is 
ubiquitous in health care, occurring across physical and mental health, adult and paediatric 
healthcare, and acute and chronic illnesses (Kardas et al., 2013; Martin et al., 2005). Non-
engagement can compromise patient care in many ways, and has been associated with poorer 
health and wellbeing outcomes (Aznar-Lou et al., 2017; Doyle et al., 2014; Ho et al., 2016; 
Kretchy et al., 2018; Martin et al., 2005; Walsh et al., 2019).   
Healthcare engagement is complex, encompassing concepts of adherence, attendance, 
drop-out/premature termination of treatment and therapeutic engagement. Adherence is 
defined as ‘‘the extent to which a person’s behaviour - taking medication, following a diet 
and/or executing lifestyle changes, corresponds with agreed recommendations from a 
healthcare provider’’ (World Health Organisation, 2003). Research has therefore investigated 
adherence to: medication, treatments/interventions and physician/healthcare provider 
recommendations (Ahmed & Aslani, 2014; Becker et al., 2018; Dixon et al., 2016; Vermeire 
et al., 2001). Therapeutic engagement differs from engagement in the literal sense of 
adherence or attendance/drop-out from interventions (Tetley et al., 2011). Bright et al. (2015) 
define therapeutic engagement as a “co-constructed process and state. It incorporates a 
process of gradually connecting with each other and/or a therapeutic program, which enables 
the individual to become an active, committed and invested collaborator in healthcare”, with 
O’Brien et al. (2009) suggesting therapeutic engagement includes “the acceptance of a need 
for help, the formation of a therapeutic alliance with professionals, satisfaction with the help 
already received, and a mutual acceptance and working towards shared goals".  
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Due to its complexity, measuring engagement can be difficult. Objective measures of 
engagement are generally accurate, but can be impractical to include within research, with 
self-report measures often being more time and cost efficient (Lam & Fresco, 2015). A 
number of validated self-report measures for adherence exist (Lam & Fresco, 2015; Stirratt et 
al., 2015), and these have been shown to correlate well with objective measures in both 
physical and mental healthcare (Monnette et al., 2018). Measures of therapeutic engagement 
have also been developed and validated, and these often contain items relating to appointment 
attendance (Graffigna et al., 2015; O'Brien et al., 2009; Tait et al., 2002; Xu, 2018). 
However, there appear to be no existing subjective measures designed to solely measure 
appointment attendance or treatment utilisation.  
Despite the complexity of measuring healthcare engagement, the importance of this 
issue has prompted extensive research into its causes, correlates and predictors (Martin et al., 
2005). This research has examined a wide range of determinants of non-engagement (see 
Kardas et al. [2013] for a review). The Theory of Planned Behaviour (TPB; Ajzen, 1985) has 
been widely used to underpin much health engagement research. The TPB posits that 
engagement is determined by the strength of a person’s intention to engage. Intentions, in 
turn, are predicted by attitude, subjective norms and perceived behavioural control. Attitude 
refers to a person’s evaluation of how beneficial engaging will be; subjective norms are 
people’s perceptions of social approval for engaging; and perceived behavioural control 
concerns self-efficacy – a person’s perception of their control over and ability to engage in 
health-related behaviour (Montaño & Kasprzyk, 2015). Indeed, attitudes, subjective norms 
and perceived behavioural control have predictive value for health-related intentions and 
behaviour, with perceived behavioural control being the strongest TPB predictor of adherence 
in chronic illness (McEachan et al., 2011; Rich et al., 2015). In a meta-analysis, Rich et al. 
(2015) found TPB variables accounted for 33% and 9% of the variance in intentions and 
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behaviour in treatment engagement in chronic illness, respectively. Much research has 
investigated and identified other psychological factors predictive of engagement (Marrero et 
al., 2020), often in an attempt to explain the “intention-behaviour gap” (Liddelow, Mullan, & 
Boyes, 2020; Liddelow, Mullan, & Novoradovskaya, 2020; Papies, 2017; Vasiljevic et al., 
2016). One such potentially important factor is psychological reactance.  
Psychological Reactance 
Psychological reactance theory (Brehm, 1966) proposes that freedom of behaviour is 
an important, beneficial and pervasive aspect of people’s lives. When this freedom is 
threatened, individuals become motivated to restore their freedom and sense of autonomy; 
this motivational state is termed psychological reactance (Rosenberg & Siegel, 2018). The 
motivational state of psychological reactance has been conceptualised as (and measured via) 
negative cognitions and emotional affect (anger), and results in behavioural and cognitive 
efforts to re-establish autonomy (Dillard & Shen, 2005). Behaviourally, people may attempt 
to engage in the behaviour being threatened or a similar/related behaviour. Cognitively, 
people may derogate the source of threat, upgrade the restricted freedom or downgrade the 
imposed option’s favourableness (Miron & Brehm, 2006; Reynolds-Tylus, 2019; Shen & 
Dillard, 2005). Various factors are thought to influence the amount of psychological 
reactance elicited, including the importance of the threatened freedom and the perceived 
magnitude of the threat (Miron & Brehm, 2006; Steindl et al., 2015). Additionally, based on 
the assumption that people vary in the strength of their need for autonomy, researchers have 
shown the amount of state reactance experienced is influenced by trait reactance proneness; 
that is, a person’s likelihood of perceiving stimuli as freedom threatening (Brehm & Brehm, 
1981; Dillard & Shen, 2005; Miller et al., 2006; Quick et al., 2011; Quick & Stephenson, 
2008; Rains, 2013; Rosenberg & Siegel, 2018; Shen & Dillard, 2005). Trait psychological 
reactance is most commonly measured via the Hong Psychological Reactance Scale (HPRS; 
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Hong & Page, 1989) or the Therapeutic Reactance Scale (TRS; Dowd, Milne & Wise, 1991); 
both are self-report measures and have been employed widely in social psychology research 
(Rosenberg & Siegel, 2018)2. State psychological reactance, in turn, has been shown to 
predict attitudes, motivations, behavioural intentions and behaviours across a variety of 
contexts (Quick et al., 2013; Rosenberg & Siegel, 2018; Steindl et al., 2015). Within such 
research, trait reactance has been positively associated with intentions to engage in 
“unhealthy” behaviours, such as tobacco use and risky sexual behaviour (Miller et al., 2006; 
Miller & Quick, 2010) 
Much research has investigated factors impacting the perception of health 
communication campaigns/messages as freedom threatening. Results have consistently 
shown that controlling messages are perceived as a threat to freedom/autonomy, and evoke 
state reactance and reduced intention to change behaviour across a variety of health contexts, 
including: alcohol consumption, drug use, sunscreen usage, tobacco use and vaccination.  In 
contrast, autonomy-supportive, choice-enhancing messages have been shown to diminish 
reactance arousal (Reynolds-Tylus, 2019; Reynolds-Tylus et al., 2020). In the current context 
of COVID-19, researchers are considering the importance of government communication 
strategies that minimise reactance (Bhanot, 2020; Dagnall et al., 2020; Sibony, 2020; 
Stapleton, 2020). In a Finnish sample, Soveri et al. (2020) found that higher trait reactance 
was significantly associated with lower intent to engage in health protective behaviour during 
COVID-19. Moreover, in a US sample, Díaz and Cova (2020) found that trait reactance 




2 Table 3 contains further information on these scales.  
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Psychological Reactance and Healthcare Engagement 
There is evidence of the impact of autonomy on healthcare engagement; patient 
perceptions of autonomy and autonomy-support, including experiences of shared decision 
making, have been shown to be important predictors of better engagement across various 
health conditions/settings (Arrieta-Valero, 2019; Fiorillo et al., 2020; Graffigna et al., 2017; 
Kennedy et al., 2004; Koponen et al., 2017; Nafradi et al., 2017; Ng et al., 2014; Russell & 
Bray, 2010; Sandman et al., 2012; Umeukeje et al., 2016). In contrast, experiences of control 
and coercion have been shown to predict less engagement (Caruso et al., 2019; Goethals et 
al., 2017; Jaeger et al., 2013; Tessier et al., 2017). It is noteworthy that coercive and 
controlling behaviour from healthcare providers may occur in response to (expected) non-
engagement, with some studies finding coercion increases medication adherence (Wade et al., 
2017). This is an issue particularly relevant to mental healthcare, where issues of control, 
coercion and power asymmetry are widely recognised; with recognition that coercion (often 
via compulsory treatment) may improve medication adherence but reduce therapeutic 
engagement (Hotzy & Jaeger, 2016; James & Quirk, 2017), and that non-coercive strategies 
are always best practice (Danzer & Rieger, 2016).  
Such findings indicate the potential importance of psychological reactance to 
healthcare engagement. Various aspects of healthcare provision could be deemed by patients 
as threatening to freedom of behaviour, and more so by individuals high in trait reactance. 
This may be further influenced by whether the patient experiences healthcare provision as 
being provided in an autonomy-supportive (collaborative) or autonomy-restrictive 
(controlling) way. Healthcare provision being perceived as threatening freedom could evoke 
state psychological reactance and lead to reduced engagement. In a social care context, 
Mirick (2014) found trait reactance was negatively associated with engagement in child 
welfare services. Moreover, in a meta-analysis, Beutler et al. (2018) found that psychotherapy 
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clients higher in trait reactance had better therapy outcomes when the therapist assumed a 
nondirective stance, rather than a directive and authoritative one. In a qualitative study, 
Grinter (2012) found clients experiencing psychosis responded to reported difficulties with 
constraints of medication prescribing and diagnostic labelling by rejecting clinician advice 
and/or refusing treatment. Grinter (2012) explained these responses as acts of reactance that 
aimed to reinstate autonomy. Two qualitative studies found adolescents living with HIV felt 
psychological reactance was an important barrier to antiretroviral medication adherence 
(Fields et al., 2017; Lowenthal et al., 2014) 
To date, no systematic review has been conducted regarding the relationship between 
psychological reactance and healthcare engagement. This review aimed to systematically 
synthesise all available data, to inform current understandings of the role of psychological 
reactance in healthcare engagement.  
Method 
      This systematic review was conducted in accordance with the guidelines and criteria for 
systematic reviews laid out by the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses statement (Stewart et al., 2015). 
Initial Search 
      Initial scoping searches were completed using Google Scholar and PSYCInfo to 
determine the suitability of the review topic and to identify any previous literature reviews in 
this subject area. There are no existing systematic literature reviews published in English 
pertaining to the relationship(s) between psychological reactance and engagement variables.  
Inclusion and Exclusion Criteria 
      Inclusion criteria, established prior to conducting the systematic search (Stewart et al., 
2015), included: (1) The study must be quantitative; (2) The study must have been published 
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in an English language, peer-reviewed journal any time up until 20th May 2020; (3) The study 
sample must consist of participants receiving, having had received or intending to receive 
healthcare for a physical or mental health condition, or paediatric caregivers thereof; (4) 
Studies must measure psychological reactance and state the measure used; (5) Studies must 
measure patient adherence, attendance, drop-out and/or engagement with/from healthcare 
treatment(s)/intervention(s), or intentions of such behaviour thereof; (6) Analyses must 
include investigation(s) of the relationship(s) between the psychological reactance and 
adherence, attendance, engagement and/or drop-out measure(s).  
      Studies were excluded if they met any of the following criteria: (1) Studies investigating 
treatment/intervention outcomes (including changes in health behaviours e.g. substance 
use/eating), without measuring adherence, attendance, engagement and/or drop-out3 (2) 
Studies investigating reactance only in the context of health communication 
messages/campaigns; (3) Unpublished articles, conference papers, theses, dissertations, 
systematic reviews or non-empirical papers.  
Search Strategy 
    Six bibliographic databases (MEDLINE, CINAHL, PsycINFO, Academic Search Ultimate, 
SocINDEX and Embase) were searched independently for relevant published literature from 
their inception until 25/05/2020, using Boolean operators to increase specificity. Searches 
were devised in collaboration with an information specialist. Full search terms are shown in 
Table 1. Additionally, each database was searched for database-specific 
subject/keyword/MeSH titles. Where possible, searches were also limited using database 
limiters “in English” and “in peer-reviewed journal”4. Next, duplicates were removed and the 
 
3 From hereon, these separate variables will be referred to as “engagement variables” for brevity and ease of 
reading. 
4 See Appendix B for full information regarding search syntax used for each database. 
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titles and/or abstracts of remaining papers were read. Finally, the reference lists of all 
included papers were manually searched to identify any further papers that fulfilled inclusion 
criteria.  
[TABLE 1 ABOUT HERE] 
Data Extraction 
 Data from the included articles were extracted using a standardised form. The 
information extracted included: The author(s) and year of publication; where the study was 
conducted; study aims; study design; participant demographics and characteristics; 
psychological reactance measure(s), including Cronbach’s alpha (if reported); engagement 
variable(s) investigated, including measure(s) used; any additional variables that were 
measured and included in statistical analyses relating to psychological reactance, and 
measure(s) utilised; statistical test(s) used; results; and study outcomes. 
 Information regarding additional variables measured (beyond psychological reactance 
and engagement variables) was extracted to increase the depth of the results obtained from 
this review and to demonstrate the theoretical nature of included studies. 
Quality Assessment 
      Each study was subject to a quality assessment as described by Kmet et al. (2004). This 
tool was chosen as it is suitable for use with a range of study designs and includes an 
extensive manual for quality scoring with definitions and instructions. A scoping search of 
Google Scholar highlighted that the tool has been used extensively (cited 984 times) and in 
many systematic reviews pertaining to physical and mental health (a “search within results” 
search of “physical health” or “mental health” yielded 136 results).  
      The tool outlines 14 items that the quality can be assessed against (Appendix C). These 
include appropriateness of study design, internal validity, the extent to which conduct and 
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analyses biases/errors were minimised, the reporting of results, and the extent to which the 
results supported the study’s conclusions. Items are scored depending on the degree to which 
the specific criteria were met (“yes” = 2, “partial” = 1, “no” = 0). Items not applicable to a 
study design are excluded. A summary score is calculated by summing the total score 
obtained across relevant items and dividing by the total possible score. This was converted 
into a percentage for ease of reference. No cut-off scores for quality categorisation are 
suggested by the authors, but higher scores indicate a higher quality of research. No papers 
were excluded based on quality, but the quality appraisal process, and subsequent ratings, 
was/were used to weigh the evidence from papers in drawing conclusions and to see patterns 
of strength and weakness across included studies. Studies were scored independently by the 
author. To improve the reliability of quality appraisal, a subsample (n = 5) were 
independently rated by a colleague. Respective scores were compared and discussed. There 
were two minor discrepancies. These were discussed, and in reference to the manual and with 
further consideration of the papers, these discrepancies were resolved and scores were agreed 
between both raters.    
Results 
            See Figure 1 for an overview of the systematic screening process. The search yielded 
a total number of 2047 records. Following removal of duplicates, 1555 articles were 
retrieved. Of these, 1486 were excluded based upon title and abstract and 69 papers were 
deemed potentially relevant, the full-text versions then being read. Of these, 15 fulfilled the 
inclusion criteria. No further papers were found through reference list searching. 
[FIGURE 1 NEAR HERE] 
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Study Characteristics 
Table 2 summarises the main characteristics of the 15 studies (incorporating the data 
extracted from each study, as described above). Studies were published between 1999 and 2019 
and assessed a total of 3672 participants.  
Thirteen of the studies were cross-sectional, one employed a quasi-experimental design 
(Fogarty & Youngs, 2000), and one employed a longitudinal design (Orbell & Hagger, 2006). 
Three of the studies used the same sample (De las Cuevas et al., 2017; De las Cuevas & Peñate, 
2015; De las Cuevas et al., 2016), and these studies are included within the same row in Table 
2. From here on, for brevity, De las Cuevas et al. (2017) is the reference used to denote these 
three studies throughout the results section.  
Six studies were conducted in the United States of America (Caruso et al., 2019; 
Fogarty & Youngs, 2000; Madsen et al., 2009; McNiel et al., 2013; Seibel & Dowd, 1999; 
Smith, Kim, & M'Ikanatha, 2018); five in Tenerife, Spain (De las Cuevas & de Leon, 2019; De 
las Cuevas et al., 2017; De las Cuevas, Peñate, & Sanz, 2014); two in the United Kingdom 
(Moore et al., 2000; Orbell & Hagger, 2006); one in Canada (Kealy et al., 2018); and one in 
Germany (Ungar et al., 2016).  
[TABLE 2 NEAR HERE] 
Participants 
 Sample sizes ranged from 42 (Moore et al., 2000) to 966 (De las Cuevas et al., 2017) 
with a mean of 244.8 participants. Mean age of participants ranged from 14.3 (Caruso et al., 
2019) to 56.1 years (De las Cuevas, Peñate, & Sanz, 2014). Twelve studies utilised an adult 
patient sample, one utilised a paediatric patient sample (Caruso et al., 2019), and one sample 
consisted of parents/guardians of children (whom were responsible for making children’s 
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medical decisions; Smith, Kim, & M'Ikanatha, 2018). The percentage of female participants 
ranged from 16% (Madsen et al., 2009) to 100% (Orbell & Hagger, 2006). 
Three studies investigated participants with long-term physical health conditions: 
Chronic paediatric headache (Caruso et al., 2019); colposcopy clinic patients requiring up to 
three follow up appointments over a 15-month period (Orbell & Hagger, 2006); and cancer 
outpatients (Ungar et al., 2016). Two studies investigated acute health conditions: Bacterial 
infection (Fogarty & Youngs, 2000) and paediatric caregivers’ intentions to comply with 
antibiotic recommendations (Smith, Kim, & M'Ikanatha, 2018). Ten studies investigated 
mental health conditions, with eight studies utilising samples of psychiatric outpatients: Two 
samples consisting of patients with depressive disorder diagnoses (De las Cuevas, Peñate, & 
Sanz, 2014; Madsen et al., 2009); three with wide ranging psychiatric diagnoses (De las 
Cuevas & de Leon, 2019; De las Cuevas et al., 2017; McNiel et al., 2013); and one with 
schizophrenia spectrum diagnoses (Moore et al., 2000). One sample consisted of patients 
enrolled in a group therapy program for personality difficulties (Kealy et al., 2018), and one 
sample consisted of psychotherapy clients (Seibel & Dowd, 1999).  
Quality Appraisal 
Table 3 shows each study’s scores on each item of the quality assessment tool (Kmet 
et al., 2004). Quality percentage scores ranged from 70% (Seibel & Dowd, 1999) to 100% 
(De las Cuevas & de Leon, 2019; De las Cuevas et al., 2017; De las Cuevas, Peñate, & Sanz, 
2014; Kealy et al., 2018; Orbell & Hagger, 2006; Smith, Kim, & M'Ikanatha, 2018), with a 
mean percentage score of 94%. Six studies scored less than 2 on item-8 (outcome measures 
well defined and robust to misclassification/measurement bias; means of assessment 
reported); this was largely because studies did not use validated measures for engagement 
variable(s) and did not report on reliability/validity for the measures employed (Caruso et al., 
2019; Fogarty & Youngs, 2000; Madsen et al., 2009; McNiel et al., 2013; Moore et al., 2000; 
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Seibel & Dowd, 1999). Four studies were marked ‘partial-1’ for item-9 (sample size 
appropriate), due to (as per the manual’s guidance) large standard error sizes accompanying 
statistically significant findings, absence of variance estimates or power analyses within 
seemingly “small” samples (Caruso et al., 2019; Moore et al., 2000; Seibel & Dowd, 1999; 
Ungar et al., 2016). Three studies scored imperfectly on item-11 regarding estimates of 
variance being reported in the main results (Moore et al., 2000; Seibel & Dowd, 1999; Ungar 
et al., 2016). Two studies scored ‘partial-1’ for item-13 regarding the results being reported in 
sufficient detail (Fogarty & Youngs, 2000; Seibel & Dowd, 1999). Overall, the quality 
appraisal tool did not reveal any systematic methodological issues across the studies, and 
generally the quality of included studies could be considered high.  
[TABLE 3 ABOUT HERE] 
Psychological Reactance Measures 
 Table 4 summarises the psychological reactance measures employed. Seven studies 
utilised the HPRS (Hong & Page, 1989). Caruso et al. (2019) added “regarding my treatment 
plan” at the end of each item and reported a Cronbach’s alpha of 0.915. Smith, Kim and 
M'Ikanatha (2018) calculated a mean score using five items from the “resisting influence” 
and “reactance to recommendations” subscales reported by Shen and Dillard (2005), with a 
reported Cronbach’s alpha of 0.76. In two of Des las Cuevas et al.’s samples, the HPRS was 
utilised based on a two-factor solution of affective and cognitive psychological reactance, 
with reported Cronbach’s alphas of 0.76 and 0.62, respectively (De las Cuevas et al., 2017; 
De las Cuevas, Peñate, & Sanz, 2014); this was based on an earlier validation study of the 
HPRS in psychiatric patients (De las Cuevas, Peñate, Betancort, et al., 2014). Madsen et al. 
(2009) calculated HPRS total scores and Hong and Page’s (1989) four subscale scores, but 
 
5 Note: The authors report using a 16-item HPRS, but this doesn’t exist – it is therefore assumed the authors 
incorrectly reported ‘16’ rather than ‘14’ 
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did not report a reliability estimate. Moore et al. (2000) reported a HPRS Cronbach’s alpha of 
0.86. Thus, the reliability estimates, where provided, indicate that the internal consistency of 
the HPRS in included studies was generally acceptable (Tavakol & Dennick, 2011). In a 
study designed to validate the Patient Health Belief Questionnaire (De las Cuevas & de Leon, 
2019), psychological reactance was measured using a subscale consisting of three items (8, 
11, 13) from the original HPRS, with a reported corrected Cronbach’s alpha of 0.18.  
 Four studies utilised the TRS (Dowd et al., 1991); none of these reported on reliability 
estimates (Fogarty & Youngs, 2000; Kealy et al., 2018; McNiel et al., 2013; Seibel & Dowd, 
1999). Seibel and Dowd (1999) reported on TRS-Total score and TRS-behavioural/verbal 
subscales separately, whilst other studies reported only on TRS-Total scores. Seibel and 
Dowd (1999) also utilised the Questionnaire for the Measurement of Psychological 
Reactance (QMPR, Merz, 1983). Orbell and Hagger (2006) conceptualised reactance as a 
form of volitional control (Kuhl, 2000), and utilised the Volitional Components Inventory 
reactance subscale (Kuhl & Fuhrmann, 1998), with a reported Cronbach’s alpha of 0.73.  
 Two studies attempted to measure state psychological reactance. Ungar et al. (2016) 
measured state reactance using four items developed for a previous intervention study on the 
impact of reactance on perceptions of health communication messages (Ungar et al., 2015), 
with a reported Cronbach’s alpha of 0.71. Fogarty and Youngs (2000) attempted to elicit state 
psychological reactance by manipulating physician tone and choice conditions in a 2x2 study 
design, and attempted to measure the occurrence of state reactance via adherence outcomes. 
[TABLE 4 ABOUT HERE] 
Engagement Variables  
 Adherence was the engagement variable studied the most, being investigated in 
thirteen studies (ten samples). Nine studies investigated psychiatric medication adherence. Of 
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these, six studies utilised previously validated self-report measures of medication adherence 
(De las Cuevas & de Leon, 2019; De las Cuevas et al., 2017; De las Cuevas, Peñate, & Sanz, 
2014; Madsen et al., 2009), whilst Moore et al. (2000) and McNiel et al. (2013) used rating 
scales designed for their studies. Seibel and Dowd (1999) did not report on how medication 
adherence was measured.  
 Caruso et al. (2019) measured treatment adherence in paediatric headache (to 
medication, physical therapy, psychological treatment and lifestyle recommendations) using a 
neurologist-rated form developed for their study. Fogarty and Youngs (2000) measured 
antibiotic medication adherence using author-designed self-report methods, as well as 
adherence to physician requests via measuring whether participants followed instructions to 
return a medical questionnaire. Smith, Kim and M'Ikanatha (2018) measured paediatric 
caregivers’ intentions to adhere to physician’s antibiotic stewardship recommendations using 
a measure developed for a previous study. Ungar et al. (2016) measured cancer patients’ 
adherence to exercise recommendations using a validated measure.  
 Attendance, treatment completion, treatment satisfaction and/or therapy 
disengagement were measured in four studies. Orbell and Hagger (2006) objectively 
measured attendance at follow-up colposcopy clinic appointments; Kealy et al. (2018) 
objectively measured program attendance and treatment completion in group psychotherapy 
for personality dysfunction; McNiel et al. (2013) measured psychiatric patients’ self-reported 
appointment attendance using an author-designed rating scale, and treatment satisfaction with 
a previously validated scale; and Seibel and Dowd (1999) reported psychotherapy clients’ 
previous disengagement according to patient records.  
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Additional Variables  
 Other factors that were measured in relation to psychological reactance and 
engagement variables were: maternal autonomy support, structure and controllingness 
(Caruso et al., 2019); TPB variables (Orbell & Hagger, 2006); social support and social 
control (Ungar et al., 2016); health locus of control and self-efficacy (De las Cuevas & de 
Leon, 2019; De las Cuevas et al., 2017; De las Cuevas, Peñate, & Sanz, 2014); perceptions of 
group therapy processes (Kealy et al., 2018); perceived provider collaboration (Madsen et al., 
2009); and working alliance and perceived coercion (McNiel et al., 2013).  
Study Results 
Physical health, Reactance and Engagement Variables  
 Fogarty and Youngs (2000) found no significant relationship between antibiotic 
medication adherence or adherence to physician request and trait or state reactance using 
correlations or ANOVAs. The authors do not report the correlation coefficients but argue this 
is due to sample size. In a structural equation model (SEM) they found a significant negative 
relationship between trait reactance and adherence. In a larger sample (N=606), Smith, Kim 
and M'Ikanatha (2018) found that paediatric caregivers with stronger trait psychological 
reactance were significantly more likely to belong to a profile of non-adherence and engage 
in “non-compliance behaviours”. 
Caruso et al. (2019) found that, in chronic paediatric headache, psychological 
reactance was not significantly correlated with physician reported treatment adherence. 
However, they did find that higher levels of maternal autonomy support and structure, and 
lower levels of maternal controllingness, significantly predicted lower psychological 
reactance in children and better treatment adherence. Here, psychological reactance and 
adherence were both outcome variables (i.e. moderating effects were not investigated). 
Similarly, Ungar et al. (2016) found that whilst psychological reactance was not significantly 
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correlated with adherence to exercise recommendations in cancer patients, perceived and 
relative reported social control, and relative reported social support were significantly 
correlated with psychological reactance. It is noteworthy that both these studies utilised small 
samples of 58 and 56, respectively. In a much larger sample (N=660), Orbell and Hagger 
(2006) found that psychological reactance was significantly negatively correlated with 
attendance at colposcopy clinic appointments. Moreover, they found that psychological 
reactance augments the prediction of attendance from TPB variables, with 10% of the 
variance in attendance explained by these variables. There was a significant interaction 
between reactance and intention, with people higher in reactance being more likely to behave 
in accordance with their own intentions to attend/not attend appointments than people low in 
reactance.  
Mental health, Reactance and Engagement Variables 
 Psychological reactance was found to be significantly associated with psychiatric 
medication adherence in six studies (four samples); as psychological reactance increased, 
adherence decreased (De las Cuevas & de Leon, 2019; De las Cuevas et al., 2017; De las 
Cuevas, Peñate, & Sanz, 2014; Moore et al., 2000). Moore et al. (2000) also measured 
perceived threat to freedom from treatment provision, and found that people who scored 
higher in this and higher in psychological reactance were most likely to have been non-
adherent in the past. They report psychological reactance didn’t predict current adherence, 
with the best predictor of current adherence being past adherence. De las Cuevas et al. (2017) 
found significant interactions between health locus of control (HLOC) and psychological 
reactance; for pure internal believers, pure external believers and dual-control believers, there 
is better adherence in patients who are less reactant. However, this was not true for no-control 
believers. De las Cuevas and de Leon (2019) found that, together, low psychological 
reactance, low internal-HLOC and low negative attitudes towards medication have a high 
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predictive efficiency of psychiatric medication adherence (predicted 82% adequate adherence 
in Chi Squared Automatic Interaction Detector Analysis).  
Madsen et al. (2009) found that psychological reactance was not significantly 
associated with medication adherence in depression. However, regression analyses showed 
that only the interaction between perceived provider collaboration and psychological 
reactance significantly predicted adherence, accounting for 18.3% of the variance. Among 
more reactant participants, greater collaboration predicted better adherence, whereas less 
collaboration predicted better adherence among less reactant participants. When the HPRS 
subscales were entered separately into the model, only the conformity subscale and provider 
collaboration interaction significantly predicted adherence (12.9% variance), with the authors 
suggesting reactance regarding conformity may moderate the relationship between 
collaboration and adherence. McNiel et al. (2013) and Seibel and Dowd (1999) reported that 
psychological reactance was not significantly associated with medication adherence.  
Kealy et al. (2018) found that psychological reactance was significantly associated 
with reduced attendance and premature termination (both by administrative-discharge 
[Cramér's V = .15] and self-discharge [Cramér's V = .16]) from a group therapy program for 
personality dysfunction (symptom distress nor severity of difficulties were associated with 
attendance or termination); however, it is noteworthy that these effect sizes were relatively 
small. They also found psychological reactance significantly contributed to perceptions of 
both avoidant and conflictual group climate. McNiel et al. (2013) found no association 
between reactance and appointment attendance in psychiatric outpatients. However, they did 
find a significant association between psychological reactance and treatment being perceived 
as beneficial. They reported that, together, better working alliance, lower reactance and less 
perceived coercion significantly explained 24.8% of the variance in treatment satisfaction. 
Treatment satisfaction was the only variable measured related to the concept of therapeutic 
SYSTEMATIC LITERATURE REVIEW   1-21                                                                                                                                                                                                                                       
 
engagement, as described by O'Brien et al. (2009). It is noteworthy that McNiel et al.’s 
(2013) non-significant findings regarding adherence and attendance were obtained via non-
validated rating scales, whereas significant findings regarding treatment satisfaction were 
obtained via a previously validated measure. Seibel and Dowd (1999) reported that 
participants higher in TRS-behavioural reactance were significantly more likely to have 
terminated therapy prematurely, but reported no association between TRS-verbal reactance or 
the QMPR.   
Discussion 
 
This review aimed to synthesise findings from all studies examining relationships 
between psychological reactance and engagement variables (adherence, attendance, drop-out 
and/or engagement) across physical and mental healthcare. A systematic search identified 15 
studies, utilising 12 samples, for inclusion. Psychological reactance was significantly 
associated with: adherence in nine studies; attendance in two studies; drop-out in two studies; 
and treatment satisfaction in one study. Non-significant associations between psychological 
reactance and engagement variables were reported in six studies.  
Overall, the quality of the included studies was considered high (mean 94%). 
However, the quality appraisal indicated that there were potentially issues with some studies’ 
statistical analyses being powered insufficiently due to small sample sizes (Caruso et al., 
2019; Moore et al., 2000; Seibel & Dowd, 1999; Ungar et al., 2016). Moreover, use of non-
validated scales in the measurement of engagement variables may have potentially impacted 
findings in some studies (Caruso et al., 2019; Fogarty & Youngs, 2000; Madsen et al., 2009; 
McNiel et al., 2013; Moore et al., 2000; Seibel & Dowd, 1999).  
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Measurement of Psychological Reactance 
Psychological reactance was generally measured via (adaptations) of the HPRS (Caruso 
et al., 2019; De las Cuevas & de Leon, 2019; De las Cuevas et al., 2017; De las Cuevas, 
Peñate, & Sanz, 2014; Madsen et al., 2009; Moore et al., 2000; Smith, Kim, & M'Ikanatha, 
2018) and the TRS (Fogarty & Youngs, 2000; Kealy et al., 2018; McNiel et al., 2013; Seibel 
& Dowd, 1999). This review’s findings highlight that where the TRS was used, total scores 
were reported, which has been deemed unsuitable (Buboltz Jr et al., 2002). Future researchers 
considering employing the TRS should be mindful of the caution to not use it in its original 
form due to it being found to be psychometrically unstable (Buboltz Jr et al., 2002; Inman et 
al., 2019). The HPRS was generally reported via total score. De las Cuevas et al. (2014; 
2017) reported on the affective and cognitive components they previously demonstrated in a 
sample of psychiatric patients (De las Cuevas, Peñate, Betancort, et al., 2014). Thus, the 
HPRS was generally used appropriately. Future researchers should be mindful of the recent 
research finding a bifactor model is the best fit for the HPRS, but advising calculating total 
scores is appropriate (Yost & Finney, 2018), and avoid using the originally described four 
factor solution (Hong & Page, 1989). Further research on the factor structure of the HPRS in 
samples of psychiatric patients would be beneficial to replicate De las Cuevas, Peñate, 
Betnacort et al.’s (2014) findings. 
Measurement of Engagement Variables 
Out of nine measures of medication adherence, only four were validated measures (De las 
Cuevas & de Leon, 2019; De las Cuevas et al., 2017; De las Cuevas, Peñate, & Sanz, 2014; 
Madsen et al., 2009); with four studies employing self-report measures designed for their 
study or a previous study (Fogarty & Youngs, 2000; McNiel et al., 2013; Moore et al., 2000; 
Smith, Kim, & M'Ikanatha, 2018). Two studies measured adherence to treatment more 
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generally (Caruso et al., 2019; Ungar et al., 2016). Attendance, treatment completion and 
therapy disengagement were measured objectively in three studies (Kealy et al., 2018; Orbell 
& Hagger, 2006; Seibel & Dowd, 1999), with one study utilising a self-report measure of 
attendance (McNiel et al., 2013). The studies included demonstrate a lack of consistency in 
the measurement of engagement, especially with regards to adherence; constraints with time 
and resources, as well as consideration of patient burden, can contribute to short, unvalidated 
rating scales being employed (Basu et al., 2019). However, there are short, well-established 
measures of adherence available – such as the Morisky Medication Adherence Scale 
(Morisky et al., 2008). Employing validated measures ensures consistency in the validity of 
findings across populations and studies; and this should be considered in future research 
(Basu et al., 2019; Tan et al., 2014). 
Psychological Reactance and Engagement 
 The findings from this review tentatively suggest psychological reactance is 
significantly negatively associated with psychiatric medication adherence. In nine studies 
(seven samples), psychological reactance was significantly correlated with medication 
adherence in six studies (De las Cuevas & de Leon, 2019; De las Cuevas et al., 2017; De las 
Cuevas, Peñate, & Sanz, 2014; Moore et al., 2000). Two studies found no association with 
psychiatric medication adherence (McNiel et al., 2013; Seibel & Dowd, 1999); it is possible 
these non-significant results were influenced by the measures used. Madsen et al. (2009) 
found no direct association between reactance and adherence, but found that only the 
interaction between provider collaboration and HPRS significantly predicted adherence, 
highlighting perceived provider collaboration as a potentially important factor relating to 
reactance and adherence.  
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 Fogarty and Youngs (2000) reported non-significant correlations between reactance 
and antibiotic adherence; but reported finding a significant SEM model. Smith, Kim and 
M'Ikanatha (2018) found paediatric caregivers higher in reactance were significantly more 
likely to belong to a profile of non-compliance relating to intentions to engage in antibiotic 
adherence. Two studies found no association between reactance and treatment adherence in 
cancer patients and paediatric chronic headache; although both these studies utilised 
relatively small samples (Caruso et al., 2019; Ungar et al., 2016). Whilst this evidence for 
reactance in physical health medication/intervention adherence is inconclusive, and was 
investigated only in the above four studies, the significant findings in Smith, Kim and 
M'Ikanatha (2018) suggest this is an area warranting further consideration.  
 Psychological reactance was significantly associated (in the expected direction) with 
objectively measured: Attendance and treatment completion in group therapy – where 
symptom severity was not (Kealy et al., 2018); appointment attendance to colposcopy clinics 
(Orbell & Hagger, 2006): and premature termination in psychotherapy (Seibel & Dowd, 
1999). In McNiel et al. (2013), reactance was not correlated with self-reported appointment 
attendance but results did show better working alliance, lower reactance and less perceived 
coercion significantly explained 24.8% of the variance in treatment satisfaction. These results 
tentatively suggest that when objective measures are employed, psychological reactance is 
significantly associated with lower attendance and premature termination of therapy.  
Psychological Reactance Theory 
When considering this review’s findings, it is important to consider how trait 
psychological reactance is conceptualised within psychological reactance theory literature. 
Trait psychological reactance is a person’s likelihood of experiencing stimuli as a threat to 
freedom and therefore state reactance, resulting in behavioural and cognitive efforts to restore 
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freedom/autonomy (Quick et al., 2011; Rosenberg & Siegel, 2018). Only one of the included 
studies (Fogarty & Youngs, 2000) considered all core components of the psychological 
reactance model. Ungar et al. (2016) was the only study to measure state reactance via self-
report; they did not measure trait reactance. Perhaps freedom threat and state reactance 
components of the theory were generally not explicitly attended to within included studies as 
researchers were interested in the direct relationship between trait reactance and engagement. 
However, it is important to consider that, according to psychological reactance theory, trait 
reactance does not impact freedom restoration outcomes without the prior occurrence of a 
perceived threat to freedom and state reactance. It is noteworthy that whilst the impact of trait 
reactance on outcomes requires the occurrence of state reactance, state reactance’s impact on 
outcomes is not dependent upon trait reactance. Indeed, reactance was originally proposed to 
be a state phenomenon only (Brehm, 1966), and there is a debate over the validity of trait 
reactance as a construct, with queries over whether trait reactance is a stable trait, and 
whether the HPRS and TRS measures reflect the construct of reactance (Rosenberg & Siegel, 
2018; Shoham et al., 2004). Silvia (2006) argues that evidence for the validity of trait 
reactance is indirect, as researchers do not measure its relationship to state reactance. This 
view is rarely considered in trait reactance research within clinical/health psychology. 
However, this review has highlighted trait reactance as a potentially significant factor in 
healthcare engagement, and Orbell and Hagger (2006) showed that trait reactance predicted 
behavioural patterns up to 15 months later, suggesting trait reactance is strongly dispositional. 
Moreover, recent research has confirmed the psychometric properties, and supported the use 
of, the HPRS (Yost & Finney, 2018). Perhaps future research could consider all/more 
components of the psychological reactance model in study designs, especially state reactance, 
to provide further evidence for trait reactance as a construct and its important role in health-
related behaviour.  
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Only two studies within this review considered the “freedom threat” component of 
psychological reactance theory. Fogarty and Youngs (2000) conceptualised physician tone 
and choice conditions as ways of creating freedom threat, but in their discussion noted design 
flaws contributed to these conditions not being successful in producing freedom threat. 
Moore et al. (2000) measured threat to freedom from treatment provision, and found a 
significant interaction between trait reactance and threat to freedom in predicting adherence. 
Thus, within included studies where a significant relationship between trait reactance and 
engagement was found, it remains unclear what aspects of healthcare provision participants 
were perceiving as a threat to freedom. In a relevant study published since this review’s 
search was conducted, Lowenthal et al. (2020) measured medication-specific state reactance 
and its association with adherence in adolescents living with HIV. The reactance measure 
was designed for their study, and adherence and attendance were measured objectively, as 
well as participants’ autonomy over medication taking (with lower medication autonomy 
conceptualised as a threat to freedom). Higher state reactance was significantly positively 
correlated with treatment failure; medication autonomy did not modify this association. Thus, 
in this sample, it is noteworthy that it was perhaps something other than the act of taking 
medication threatening freedom. Other research has suggested that, for adolescents living 
with HIV, it is the illness itself that restricts freedom, rather than the treatment for the illness 
(Brown et al., 2016). 
It is important to understand what is being perceived as a threat to freedom, and not 
assume reduced engagement is related to certain aspects of treatment provision, i.e., reduced 
medication adherence is not necessarily the result of medication being perceived as a threat to 
freedom. As reactance theory describes, freedom may be restored behaviourally not only via 
engaging in the behaviour being threatened, but also in a similar/related behaviour (Brehm & 
Brehm, 1981). This leads to consideration of context in reactance’s role in healthcare 
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engagement; there are many factors which might influence people perceiving their freedom is 
threatened in long-term illnesses. This is in contrast to acute physical health conditions; as 
noted by Fogarty and Youngs (2000), restricted choice and collaboration in treatment 
received for bacterial infection is perhaps unlikely to be perceived as a valued freedom to be 
limited.  
Other factors may also be relevant to the context of reactance in healthcare 
engagement; trait reactance is higher in younger and older people (relative to middle aged 
people), men, and Black, Asian and Minority Ethnic individuals (Woller et al., 2007). 
Moreover, Moore et al. (2000) suggest that threat perceived by treatment provision may 
decrease over time, possibly with age or length of time involved with mental health services. 
Madsen et al. (2009) found no significant relationships among collaboration, reactance, and 
adherence beyond the first 3 weeks of treatment. They suggest reasons provided for 
antidepressant non-adherence vary over the course of treatment; relationship dynamics may 
affect adherence immediately following treatment initiation, whereas patients’ beliefs about 
treatment and depression might be more robust predictors later (Demyttenaere et al., 2001). 
Whilst there is no conclusive evidence regarding the impact of reactance on adherence at 
different time points, this is an interesting point to consider and one which could have useful 
clinical implications. Overall, the freedom threat component of reactance, considered in the 
context of the health condition/setting and individual factors, is important to understanding 
patient experiences and for the clinical implications of reactance in healthcare engagement 
research. 
Autonomy Supportive Variables 
Health communication research has shown that autonomy-supportive messages 
diminish reactance arousal, whereas controlling, persuasive messages increase perceived 
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freedom threat and evoke state reactance (Reynolds-Tylus, 2019; Reynolds-Tylus et al., 
2020). In healthcare engagement, research has shown that patient perceptions of autonomy 
and autonomy-support are important predictors of better engagement across various health 
conditions/settings (Arrieta-Valero, 2019). In two included studies within this review, social 
control and autonomy support in parents of chronic paediatric headache patients, and 
perceived social support and social control in cancer patients, were significantly related to 
higher reactance and less adherence separately, where a direct relationship between reactance 
and engagement was not found (Caruso et al., 2019; Ungar et al., 2016). McNiel et al. (2013) 
showed perceived coercion, working alliance and reactance were all significantly associated 
with treatment satisfaction. Notably, interactions between these variables were not 
investigated in these studies. Madsen et al. (2009) did not find a direct relationship between 
reactance and medication adherence but did find only the interaction between trait reactance 
and provider collaboration significantly predicted psychiatric medication adherence. Among 
more reactant participants, greater collaboration predicted better adherence, whereas less 
collaboration predicted better adherence among less reactant participants. Trait reactance may 
interact with autonomy-supportive (collaboration, shared decision making, working alliance) 
variables; i.e. autonomy-supportive healthcare provision may reduce perceived freedom 
threat in high trait reactant individuals, and therefore reduce non-engagement behaviours. 
However, this is a tentative theoretical suggestion; future research examining such 
interactions, with consideration of the clinical implications of these, would be useful in 
furthering understanding of reactance’s role in engagement.   
Theory of Planned Behaviour (Ajzen, 1985) 
Smith, Kim and M’Ikanatha (2018) showed that trait reactance was significantly 
associated with intentions to comply with antibiotic recommendations. Furthermore, Orbell 
and Hagger (2006) researched reactance’s role in attendance in the context of TPB variables, 
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based on the suggestion that attention to volitional processes might augment the explanation 
of behaviour provided by the TPB (Ajzen, 1985; Kuhl, 2000). They found that psychological 
reactance augments the prediction of attendance from TPB variables via the interaction 
between intention and reactance. They found people least likely to keep their appointments 
possess both weaker intentions and higher reactance. These findings demonstrate how 
psychological reactance adds to the well-established model of the TPB in predicting health-
related behaviour.  
A previous systematic review found perceived behavioural control to be the strongest 
predictor of adherence in chronic illness (Rich, 2015). Based on TPB, De las Cuevas et al.’s 
(2017) research, utilising a large sample, has shown that there are significant interactions 
between HLOC and psychological reactance; for pure-internal believers, pure-external 
believers and dual-control believers, there is better adherence in patients who are less 
reactant. However, this was not true for no-control believers, with the authors suggesting this 
type of HLOC is a sufficient variable to explain adherence by which reactance loses its 
interaction role. This further adds to an understanding of reactance in healthcare; trait 
reactance and the evocation of state reactance is perhaps less important to engagement if 
people feel they have no control over the behaviour, as restoration of freedom through non-
adherence won’t be felt to be possible. This is perhaps important in situations where coercive 
or compulsory treatment is employed in psychiatric healthcare. In such situations where 
behavioural restoration of freedom via non-engagement does not feel possible, patients may 
instead only have cognitive means to restore freedom (derogating the source of threat, 
upgrading the restricted freedom or downgrading the imposed option’s favourableness), with 
a potential result of better medication adherence but reduced therapeutic engagement (Hotzy 
& Jaeger, 2016; James & Quirk, 2017). 
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Clinical Implications 
 Whilst there is more research needed to confirm the exact nature of reactance’s role 
within healthcare engagement, so far research indicates that reactance is an important issue 
for clinicians to consider. Potentially, clinicians could discuss the nature of reactance with 
patients (as has been done in qualitative studies [Lowenthal et al., 2014]) and collaboratively 
decide how treatments/interventions can be delivered in a way that feels most beneficial for 
the patient. Generally, provider collaboration, working alliance and autonomy-support are 
important factors in patient satisfaction and outcomes (Nafradi et al., 2017). However, some 
research suggests lower reactant individuals prefer more direction in treatment delivery 
(Beutler et al., 2018). Clinicians may therefore benefit from responding flexibly within the 
therapeutic relationship, i.e. encouraging autonomy/freedom of choice in those prone to 
reactance, whereas others, low in reactance, may prefer more direction, and engagement will 
improve as a result. Such an approach has indeed been shown to improve outcomes in 
therapeutic alcohol treatment (Karno et al., 2009; Karno et al., 2010). 
Strengths and Limitations 
 A key strength of this review is it has been the first to synthesise data on the 
relationship between psychological reactance and engagement variables in healthcare. 
Moreover, the review was inclusive, not limiting health issues or engagement variables 
included, and considering additional relevant factors that were investigated in the included 
studies. This has facilitated an understanding of the current state of evidence regarding 
reactance and engagement research, how reactance and engagement variables are measured, 
as well as the theoretical nature of studies investigating reactance and engagement. 
Hopefully, this review forms a base to inform future research into reactance and engagement 
across health conditions. Another strength of the review is the rigorous methodology 
followed (Stewart et al., 2015) despite heterogeneity of the studies included. Additionally, the 
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thorough search strategy identified all relevant papers, with no further papers being identified 
via reference list searching.  
 Limitations of this review are reflective of limitations in the quality of some of the 
studies included. As mentioned above, four studies were potentially insufficiently powered, 
and six studies scored imperfectly in quality appraisal regarding outcome measures being 
robust to measurement error. The lack of utilisation of valid measures reflect that some 
studies were conducted ~two decades ago, before now validated measures were developed 
(e.g. Morisky et al., 2008). Additionally, the heterogeneity of included studies re: health 
conditions/settings/measures contributes to difficulty in drawing firm conclusions.  
Conclusion 
 There are significant associations between psychological reactance and engagement 
variables (adherence, attendance, drop-out, treatment satisfaction) across physical and mental 
health conditions. Some studies reported non-significant findings. Whilst this is potentially 
due to some methodological issues within the studies, further research is needed before strong 
conclusions can be drawn regarding the role of reactance within engagement. Nonetheless, 
overall, the results of this review suggest that reactance is an important factor to consider, 
particularly in combination with sense of autonomy or restrictions of freedom of choice. 
Future research would be valuable to further understanding of the relationship between 
reactance and engagement and its clinical implications, incorporating consideration of: all 
reactance components (notably, freedom threat and state reactance); the context of health 
conditions/settings and individual factors in reactance’s impact on engagement; the role 
autonomy-supportive variables have in the relationship between trait reactance and perceived 
freedom threat; and TPB variables. 
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Titles and abstracts screened  
n = 1555 
Records excluded 
n = 1486 
Records identified through database searching 
(n = 2047) 
Collated from:PsycINFO = 135; MEDLINE = 500; Embase = 
813; Academic Search Ultimate = 340; CINAHL = 230; 
SocINDEX = 29 
Records after duplicates removed  
(n = 1555) 
Full-text articles assessed for 
eligibility 
n = 69 
Full-text articles excluded, with 
reasons 
n = 54 
Non-clinical sample = 7 
Did not measure psychological 
reactance = 16 
Did not measure 
adherence/engagement/drop-out = 22 
Was not journal article (conference 
abstract/unpublished theses) = 9 
 
Total number of studies 
included in systematic 
literature review 
n = 15 (12 samples) 
Studies included from 
database searches 
n = 15 
Studies included from 
reference list search 
n = 0 
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String Search Terms 
 
String 1 "mental health" or “physical health” or "healthcare" or "health care" or "health-care" or "patient*" 
or "nursing" or "condition*" or "diagnos*" or "chronic" or "illness*" or "disease*" or 
"syndrome*" or “depress*” or “anxi*” or “psychiatr*” or "severe mental" 
 
String 2 AND "psych* reactance" or "reactan* 
 
String 3 AND “Adher*” or “complian*” or “concordan*” or “nonadher*” or “noncomplian*” or 
“persisten*” or “treatment us*” or “attend*” or “non-attend*” or “engag*” or “disengag*” or 
“reject* ADJ2 therapy” or “reject* ADJ2 treatment” or “DNA” or “did not attend” or “drop out” 
or “drop-out” or “service use” or “retention” or “attrition” or “premature termination” or 
"treatment ADJ2 refus*" or "therapy ADJ2 refus*" 
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Analysis Findings / Comments 
Caruso et al. 


























Trait PR - 
Adapted 






















developed for the 
study 











N = 58 
10-17years age 






PR was not significantly correlated with 
physician reported adherence (r = -.26+). 
Simultaneous regression analyses with 
adherence & PR as outcome variables 
showed that higher maternal autonomy 
support & higher maternal structure were 
both associated with lower PR (β=−0.46, 
t[53]=−3.11** & β=−0.58, t[53]=−4.75*, 
respectively) & greater treatment adherence 
(β=0.35, t[53]=2.78**) & lifestyle 
adherence (β=0.28, t[53]=2.30*). Higher 
controllingness was associated with higher 
PR (β=0.60, t[53]=4.23***) & lower 
ratings of lifestyle adherence (β=−0.28, 
t[53]=−2.04*). 
 
PR & adherence were 
not significantly 
correlated (p < .10). 
 
Higher levels of parental 
autonomy support, 
lower levels of parental 
controllingness, & 
higher levels of structure 
around the children’s 
treatment predicted 
lower  











Trait PR- TRS 








 /  






There were no significant interactions or 
main effects for “state reactance” IVs (tone 
& choice) on any adherence DVs.  
As TRS scores increased, postcard 
compliance declined (r = -.32). TRS scores 
No relationship between 
adherence & “state PR” 
induced via tone & 
choice conditions. 
 
6 Where the term “compliance” is used throughout this table, it is to replicate the named variable measured within the research study. However, throughout the main text, the 
variables termed “compliance” here are referred to as adherence. This is reflective of shifts in widely used and accepted terminology (Tilson, 2004). 
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Design /  










































tone & choice 
conditions.   
 
 
was filled, no. of 
times per day 
medication was 
taken, no. of days 
medication was 
taken, whether any 
pills were skipped & 













N = 101 
M age = 35 
years  
62% Female 
56% never met 
physician 
before, 21% had 
met physician ≤ 
3 times 
correlated negatively with adherence: how 
soon prescription was filled (r = -.51); no. 
of days medication was taken (r = -.35); 
whether doses were skipped (r = -.37); & 
whether all medication was taken (r = -.47). 
Significance levels of correlations not 
reported.  
SEM showed a strong, inverse relationship 
between TRS scores & adherence. All paths 
were significant* & all goodness of fit 
statistics indicated a good fit between 
proposed model & the actual data (x2[8, N= 
101] = 10.19, p = .025; RMR = .032; GFI 
= .97; & AGFI = .92). 
The most reactant participants provided the 
least consistent data (r = -.28**). 
 
Authors report study 
finds evidence for an 
inverse correlational 
relationship between 
trait-PR & treatment 
adherence & compliance 
with physician requests, 
but significance levels 
not clear.  
Most reactant 
participants provided the 
least consistent data.   / 
Authors suggest design 
flaws contribute to non-
significant findings i.e. 
whether having no 
“choice” in antibiotic 
treatment is a valued 















could add to 
predictive 
value to theory 
of planned 








Attendance at up to 
3 colposcopy clinic 
follow-up 
appointments over 
15month period / 
No. of appointments 












PR was significantly negatively correlated 
with attendance (r = -.13*). 
When PR was entered into third step of 
regression (following demographics & 
planned behaviour variables), there was a 
significant increment in explained variance 
(β = -.12**, F change = 10.39, R2change 
= .015**). Interaction of PR X Intention 
was entered as final step, finding a 
Women higher in PR 
were less likely to keep 
their appointments.  
 
PR augments the 
prediction of attendance 
from TPB variables & 
demonstrates that main 
effects of intention & 
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Design /  











































behavioural control /  
Likert scales 










N = 660 
M age = 33.92 
(±10.28) years  
98% White 
British 
significant increment in explained variance 
(β=.12**, F change = 9.79, R2 change 
= .014**). The final equation was 
significant (F(8, 651) = 8.56, R2 = .095**). 
Slopes were computed for the regression of 
attendance on intention at low & high PR. 
Unstandardized regression coefficients for 
intention were significantly different from 
zero for low PR (β = .0535, t = 5.1509**) 
& high PR (β = .1314, t = 4.5677**). The 
predictive validity of intention is greater at 
high levels than low levels of PR.  
Hierarchical discriminant analysis showed 
that demographic variables, TPB variables 
& PR (entered at third step) were able to 
significantly discriminate between 
“scheduled”, “delayed” & “ceased” 
attenders (2 difference [2] = 10.76**). 
Discriminant function two (canonical r 
= .16, 2(6) = 17.05**) clearly 
discriminated delayed attenders from 
ceased attenders & had a strong positive 
correlation with PR (r = .51, F(2, 657) = 
5.31**), with delayed attenders having 
lower PR than ceased attenders.  
 
reactance on attendance 
are qualified by the 
interaction of intention 
X reactance. TPB 
variables and PR 
explained 10% variance 
in attendance.  
The predictive validity 
of intention is greater at 
high levels of PR, thus 
people high in PR were 
more likely to behave in 
accordance with their 
own intentions to 
attend/not attend 
appointments than were 
people low in PR. 
PR distinguished 
delayed attenders, who 
responded to repeat 
appointments issued by 
the clinic, from the 
ceased attenders, who 















for at least one 
Used LCA to test whether PR predicted 
odds of membership in a profile of 
noncompliance relative to compliance. 
Pediatric caregivers with 
stronger trait PR were 
more likely to engage in 
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Design /  























































alpha = .76. 
stewardship actions 
related to their 
children / 
Eight items adapted 
from Smith et al. 
(2015) to assess 





ages of 6months 
to 12years.  
 
N = 606 
M age = 35.60 










Caregivers with higher PR were more likely 
to belong to one of three profiles of 
noncompliance: “stockers” (OR = 1.45, β = 
0.37, SE = 0.13), “persuaders” (OR = 1.37, 
β = 0.31, SE = 0.11), “dissenters” (OR = 
1.34, β = 0.29, SE = 0.11) than compliance 
profile (“stewards” – reference class) (LL2 
= 9.78*).  
Overlapping CIs (not specified) for the ORs 
suggest that while reactant caregivers are 
more likely to engage in noncompliance, 
they are equally likely to restore their 
freedom through storing unused antibiotics, 
persuading providers to change their minds, 
or engaging in every act of noncompliance. 
“Stockers” & “Persuaders” show some 




caregivers were just as 
likely to restore their 
freedom by storing 
unused antibiotics, 
persuading providers to 
change their minds, or 
engaging in every act of 
noncompliance.  
However, two profiles 
of noncompliance did 
show some level of 
compliance with 
vaccinations, indicating 
that PR does not rule out 
compliance.  



























study on fruit 
& vegetable 
intake (Ungar 








(Sarkin et al., 1997). 
 
Social Support & 
Social Control for 







N = 56 
27-75years age 




PR was not significantly correlated with 
exercise (r = .05, p = -.08). 
Men reported significantly more PR (p 
= .001). 
Perceived social control & relative-reported 
social control were both significantly 
correlated with PR (r = .375, p = .004 & r 
= .407, p = .002, respectively). Perceived 
social support was not significantly 
correlated with PR, but relative reported 
PR was not significantly 




significantly more PR. 
Social control 
(perceived & relative 
reported) & relative-
reported social support 
were significantly 
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Design /  




















   social support was significantly correlated 
with PR (r = .303, p = .023). 
correlated with PR. 
Perceived social support 
was not significantly 


















































version of Morisky 
scale  
(Morisky et al., 
1986; Val et al., 
1992) 
 













N = 119 
30-82years age 










Cognitive PR & affective PR both 
significantly positively correlated with 
medication adherence scores (r = .25** & r 
= .32**, respectively) – showing that as PR 
increases, medication adherence decreases. 
Cognitive PR significantly positively 
correlated with Chance HLOC (r = .36**). 
Neither HLOC nor self-efficacy were 
significantly correlated with adherence.   
ANOVA showed cognitive & affective PR 
subscales attained significant differences 
between adherent & non-adherent patients 
(F = 7.48, p = .007 & F = 9.57, p = .002, 
respectively [df not reported]). 
 




scored higher for both 
affective & cognitive PR 
subscales, indicating 
more PR in patients who 












using the same 













N = 966 
18-87 years age 
PR was significantly negatively correlated 
with adherence -both affective PR (r = 
-.20***) & cognitive PR (r = -.20***). 




correlated with affective 
& cognitive dimensions 
of PR. 
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Design /  
















Analysis Findings / Comments 
De las 




















to validate the 
MMAS-8 
scale (2015) & 
investigate the 
predictive 

























































drugs M = 2.9 
(±1.4) 
ANOVAs were performed to assess the 
relationship of HLOC with PR. There were 
significant differences between HLOC 
orientation groups (pure internal, pure 
external, dual-control believer & no-control 
believer) & patients’ levels of cognitive & 
affective PR (F = 4.227, p = .006 & F = 
7.471, p = .000, respectively).  
Analysed whether HLOC moderates the 
association of PR with adherence. There 
were significant differences in adherence 
between high & low affective & cognitive 
PR & pure internal (affective F = 3.942, p 
= .048; cognitive F = 5.484, p = .020), pure 
external (affective F = 18.856, p = .000; 
cognitive F = 6.822, p = .010) & dual-
control believers (affective F = 4.971, p 
= .027; cognitive F = 7.994, p = .005). No 
significant interactions were found for the 
no-control believer group. 
Sociodemographic, clinical & control 
(HLOC, PR & self-efficacy) variables were 
examined through SEM to test patterns of 
relationships in predicting adherence, with 
measurement invariance re: drug attitudes 
& diagnoses tested – neither were 
significant (p > .05). The SEM showed 
adherence is influenced by cognitive PR (-
0.14), the doctor’s subscale of HLOC (0.26) 
There were interactions 
between HLOC & PR; 
for pure internal 
believers, pure external 
believers & dual-control 
believers, there is better 
adherence in patients 
who are less reactant. 
However, this was not 







SEM demonstrated that 
adherence was 
associated: 1) negatively 
with cognitive PR 
(adherence decreased as 
cognitive PR increased), 
2) positively with 
patients’ trust in their 
psychiatrists (doctors’ 
HLOC subscale), 3) 
negatively with patients’ 
belief that they are in 
control of their mental 





Location /  
Design /  
















Analysis Findings / Comments 
& internal-HLOC (-0.15). Age was also 
weakly associated with adherence (0.14). 
Self-efficacy was indirectly related to 
adherence through its direct relationship 
with the internal HLOC (0.22). The 
significance of these relationships in SEM 
not reported. The model fit was significant 
(χ2[163] = 303.696, p < .001, GFI = .99, 
AGFI = .99, NFI = .92, RMSEA = .03). 
 
health & that their 
mental health depends 
on their own actions 
(internal HLOC 
subscale), & 4) 
positively (although 










(2019) /  
 
Psychiatric 



















PR & HLOC 












alpha of PR 
subscale = 
0.39, rij = 0.18 
Medication 
adherence / Spanish 
version of 
Sidorkiewicz tool 
(De las Cuevas et al., 
2018; Sidorkiewicz 











N = 588 
30-82years age 











Adherence dichotomised as “adequate” and 
“inadequate”. In a univariate logistic 
regression, PR was significantly associated 
with adequate adherence (OR = 0.945 [95% 
CI = 0.914–0.978], significance level not 
specified). PR was dichotomised using 
median scores (low/high PR), & univariate 
logistic regression analysis showed low-PR 
was significantly associated with adequate 
adherence (OR = 1.44 [95% CI= 1.12–
1.85], significance level not specified). 
CHAID was used to predict adherence. The 
first predictor was negative attitudes 
towards medication, with low-PR (X2 (1) = 
6.110, Adjusted p = 0.13), I-HLOC & D-
HLOC appearing after. High-PR and low 
PR was significantly 
associated with 
adherence in five 
independent analyses – 








PR, Internal & Doctor 
HLOC & negative 
attitudes towards 
medications together 
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Design /  






















negative attitudes towards medication 
predicted 67% adequate adherence; Low 
negative aspects of medication, low PR & 
high I-HLOC predicted 69% adequate 
adherence; Low negative aspects of 
medication, low PR and low I-HLOC 
predicted 82% adequate adherence. The 
effectiveness of this tree was high: total 
predictive efficiency was 66.1% and 
sensitivity was 100%. 
have a high predictive 










Kealy et al. 





























































N = 138 
M age = 37 
(±10) years 
No association between gender & PR. 
PR was significantly negatively associated 
with weeks attended (rho = -.23, p = .007). 
However, neither symptom distress nor 
severity of personality dysfunction were 
associated with weeks attended.  
A significant difference was found for type 
of discharge & PR (X2 = 12.79, p = .002). 
No significant differences were found for 
general symptom or PD severity & type of 
discharge. 
Pairwise comparisons showed that PR 
tended to be greater among patients in the 
self-discharge category than among patients 
who achieved therapeutic discharge (X2 [2] 
= 7.26, p = .02, V = .16). Patients who were 
administratively discharged also tended to 
have higher PR to those who 
PR was significantly 
associated with reduced 





symptom distress nor 
severity of personality 
dysfunction were 
associated with 
attendance or discharge 
type. However, these 
effect sizes were 
relatively small.  
 
PR, within the context 
of overall personality 
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Design /  
















Analysis Findings / Comments 
Perceptions of 
group therapy 


















criteria for a 







therapeutically discharged (X2 [2] = 6.31, p 
= .04, V = .15). Though significant, the 
effect sizes of these differences were 
relatively small. 
Mediation analyses using bootstrapping 
found a significant indirect effect of 
personality dysfunction on perceptions of 
both Avoidance (unstandardized indirect 
effect = 0.61, 95% CI = 0.17 - .132*; R2 
= .076, F[3, 113] = .576, p = .03) & 
Conflict (unstandardized indirect effect = 
0.67, 95% CI = 0.22 - .138*; R2 = .066, F[3, 
113] = 2.680, p = .05), via the mediating 
effect of PR. These findings were 
significant (indicated by an absence of zero 
within 95% CIs) after controlling for 
general symptom distress. No significant 
relationship was observed with regard to 





to perceptions of both 
avoidant and conflictual 
group climate, i.e. to 
view the group as 
excessively dependent 
on the direction of 
therapists, and as 
harbouring tension and 
conflict. However, PR 
was not significantly 
associated with the 
engagement subscale of 
the Group Climate 
Questionnaire. 
Madsen et 













Trait PR – 
HPRS 


















PR was not associated with drop-out. 
Multiple regression analysis showed that at 
3-weeks postbaseline, only the interaction 
between HPRS & PAQ-collaboration 
significantly predicted adherence (β = .002, 
F[1, 42] = 9.38, p = .004, R2= .183). PR 
alone was not significantly associated with 
PR was not significantly 
associated with 
adherence. 
However, the interaction 
between provider 
collaboration & PR was 
significant & accounted 
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Design /  
















Analysis Findings / Comments 
of provider 
collaboration 















(Maddox et al., 
1994). 
Administered at 3, 6, 
9 & 12 weeks after 







designed for this 
study. 







N = 50 
21.7-71 years 
age 
M = 41.3 
(±12.6) 
16% Female 











adherence scores. Increase in HPRS score 
was associated with an increase in the 
positive slope of PAQ-collaboration. 
Conversely, decrease in HPRS score 
strengthened a negative relationship 
between PAQ-collaboration and 3-week 
adherence. No variables predicted 
adherence beyond 3-week post-baseline.  
The four HPRS subscale scores, the PAQ-
collaboration score, the four interactions, & 
BDI-II were entered simultaneously into a 
regression model predicting 3-week 
adherence. Only the HPRS conformity 
subscale X PAQ-collaboration interaction 
significantly predicted 3-week adherence, 
accounting for 12.9% of the variance, F(1, 
36) = 5.35*, showing that increases in 
conformity increased the strength of a 
positive relationship between collaboration 
& adherence, whereas decreases in 
conformity strengthened a negative 
relationship. 
for 18.3% of the 
variance in 3-week 
adherence. Among more 
reactant patients, greater 
collaboration predicted 
better adherence, 
whereas among patients 
lower in PR, less 
collaboration predicted 
better adherence. No 
relationships were 
observed beyond 3 
weeks. 
 
HPRS conformity factor 
may be a particularly 





































Logistic regression analyses showed that 
PR was not significantly associated with 
medication adherence or appointment 
attendance. Multiple regression analysis 
showed that when controlling for clinical & 
demographic characteristics as well as the 
experience of leverage, higher treatment 
PR was not significantly 
associated with 
medication adherence or 
appointment attendance.  
However, PR was 
significantly associated 
with treatment 
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a group of 




scales designed for 









N = 198 














satisfaction (perception that treatment was 
beneficial) was associated with a better 
working alliance, lower PR (β = -.020, t 
=-.280**), & less perceived coercion; 
(F(13, 168) = 5.58, p = .001, R2Ajusted 
= .248).   
 
satisfaction (perceptions 
that treatment was 
beneficial). Together, 
better working alliance, 
lower PR & less 
perceived coercion 
significantly explained 
24.8% of the variance in 
treatment satisfaction.  































9months) & past 
(from initial 
diagnosis to 9months 




adherence /  
Two self-report 
Likert scales 








(N = 39) or 
schizoaffective 
disorder (N = 3). 
  
N = 42 
36% Female 
19-63 years age 
M = 39 (±11) 
Current compliance was not significantly 
associated with PR or perceived threat to 
freedom from treatment provision. Past 
compliance was the best predictor of 
current compliance (β(1)= -2.84; p = .008), 
with drug attitudes also making a 
significant contribution (β(1)=-0.17; p 
= .01). 
Participants who had been non-compliant in 
the past scored higher on PR (U = 66.0, p 
= .04) & were more likely to feel that their 
personal freedom was being threatened by 
treatment provision (U = 86.5, p = .0016). 
Past compliance was significantly 
Individuals who scored 
higher in trait PR & who 
perceived treatment 
provision to be a threat 
to their freedom of 
choice were the most 
likely to have been non-
compliant in the past.  
PR only predicted past 
compliance, not current 
compliance. Authors 
suggest the degree to 
which treatment is 
perceived as a threat to 
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Design /  





















(Barrowclough et al., 
1999) 
Perceived threat to 
personal freedom 
from treatment 
provision / Author 
designed Likert scale 
Drug Attitudes / 
Drug Attitude 
Inventory (Hogan et 
al., 1983) 
 
M no. of 
admissions = 
5.6 (±4.1) 
M duration of 
illness = 14.3 
years (±10.1) 
negatively correlated with PR (r = -.56, p 
= .001) & perceived threat to freedom from 
treatment provision (r = -.56, p = .001).  
Logistic regression showed that PR made 
the most significant contribution 
(β(1)=0.17; p = .002) to non-compliance, 
with age also making a significant 
contribution (β(1)=-0.08, p = .02). The 
interaction between PR X treatment being 
perceived as a threat to freedom 
significantly further contributed to 
compliance (β(1)=0.005; p = .002).  
 
freedom may reduce 
over time.  
It is not clear what other 
variables were entered 
into regression model, 
but results suggest PR & 
threat to freedom from 
treatment better 
predicted compliance 
than drug attitudes, 
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Study aimed to 
investigate the 
relationship 




























History of premature 
termination 
according to records 
Psychotherapy 





N = 90 
66% Female 
21-60 years age 




duration M = 
15.9months 
(±18.1) 
PR was not significantly correlated with 
medication compliance (number of 
participants prescribed medication not 
specified).  
 
Premature terminators were significantly 
more reactant on the TRS-Total (t = -1.97*) 
& the TRS-Behavioral (t=-1.97*). There 
were no significant differences associated 
with premature termination for the TRS-
Verbal or the QMPR. 
PR was not significantly 
correlated with 
medication compliance, 
although neither the 
number of participants 
prescribed medication 
nor method of 
measuring compliance 
are described.  
 
As measured by the 
TRS, participants higher 
in behavioural PR were 
significantly more likely 
to have terminated 
therapy prematurely. 





Location /  
Design /  

























However, verbal PR had 
no association with 
disengagement. The 






Note: BDI-II = Beck Depression Inventory (Beck et al., 1996); DSM-IV = The Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition (American Psychiatric Association, 2000); GPSES = General Perceived Self-Efficacy Scale (Schwarzer & Jerusalem, 1995); HPRS = 
Hong Psychological Reactance Scale (Hong & Page, 1989); MHLC-C = Form C of Multidimensional Health Locus of Control Scale (Wallston et 
al., 1994); MHSIPCS-TSM = Mental Health Statistics Improvement Program Consumer Survey–Treatment Satisfaction Module (Teague et al., 
1997); MMAS-8 = Spanish validated version of Morisky Medication Adherence Scale -8 item version (Morisky et al., 2008); MPCS = MacArthur 
Perceived Coercion Scale (Gardner et al., 1993); no. = number; OCD = Obsessive Compulsive Disorder; re: = regarding; PR = Psychological 
Reactance; PSCQ = Parents as Social Context Questionnaire (Skinner et al., 2005); QMPR = Questionnaire for the Measurement of Psychological 
Reactance (Merz, 1983); SIPES = Spousal Involvement in Patient Exercise Scale (Khan et al., 2013); TRS = Therapeutic Reactance Scale (Dowd 
et al., 1991); USA = United States of America; WAI-Client Version = Working Alliance Inventory (Horvath & Greenberg, 1989) 
Analysis abbreviations: AGFI = Adjusted Goodness of Fit Index; CHAID = Chi-squared Automatic Interaction Detector Analysis; CI = Confidence 
Interval; df = degrees of freedom; DV = Dependent Variable; GFI = Goodness of Fit Index; IV = Independent Variable; LCA = Latent Class 
Analysis; M = Mean; NFI = Normed Fit Index; OR = Odds Ratio; rij = Cronbach correction (see Rogers, Schmitt & Mullins [2002]); RMR = Root 
Mean Square Residual; RMSE = Root Mean Square Error of Approximation; SE = Standard Error; SEM = Structural Equation Modelling; (±) = 
Standard Deviation; + = reported as significant at p <.10 level; * = reported as significant at p <.05 level; ** = reported as significant at p <.01 
level; *** = reported as significant at p < .001 level. 
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Table 3: Quality appraisal of studies using the standard quality assessment criteria for evaluating primary research papers from a variety of 











































































































































































































































































































































































































































































































































































































































Caruso et al. (2019) 2 2 2 2 N/A N/A N/A 1 1 2 2 N/A 2 2 18/20 
90% 
Fogarty and 
Youngs Jr (2000) 
2 2 2 2 N/A N/A 2 1 2 2 2 N/A 1 2 20/22  
90% 
Orbell and Hagger 
(2006) 
2 2 2 2 N/A N/A N/A 2 2 2 2 N/A 2 2 20/20  
100% 
Smith, Kim and 
M’Ikanatha (2018) 
2 2 2 2 N/A N/A N/A 2 2 2 2 N/A 2 2 20/20  
100% 
Ungar et al. (2016) 2 2 2 2 N/A N/A N/A 2 1 2 1 N/A 2 2 18/20 
90% 












































































































































































































































































































































































































































































































































































































































De las Cuevas et al. 
(2014) 
2 2 2 2 N/A N/A N/A 2 2 2 2 N/A 2 2 20/20 
100% 
De las Cuevas and 
Peñate (2015)a 
 
2 2 2 2 N/A N/A N/A 2 2 2 2 N/A 2 2 20/20  
100% 
De las Cuevas et al. 
(2016)a 
2 2 2 2 N/A N/A N/A 2 2 2 2 N/A 2 2 20/20 
100% 
De las Cuevas et al. 
(2017)a 
2 2 2 2 N/A N/A N/A 2 2 2 2 N/A 2 2 20/20 
100% 
De las Cuevas and 
de Leon (2019) 
2 2 2 2 N/A N/A N/A 2 2 2 2 N/A 2 2 20/20 
100% 
Kealy et al. (2018) 2 2 2 2 N/A N/A N/A 2 2 2 2 N/A 2 2 20/20 
100% 
Madsen et al. 
(2009) 
2 2 2 2 N/A N/A N/A 1 2 2 2 N/A 2 2 19/20 
95% 












































































































































































































































































































































































































































































































































































































































McNiel et al. 
(2013) 
2 2 2 2 N/A N/A N/A 1 2 2 2 N/A 2 2 19/20 
95% 
Moore et al. (2000) 2 2 2 2 N/A N/A N/A 1 1 2 1 N/A 2 2 17/20 
85% 
Seibel and Dowd 
(1999) 
2 2 2 2 N/A N/A N/A 0 1 2 0 N/A 1 2 14/20 
70% 
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(Hong & Page, 1989) 
Trait Self-report 
 
5-point Likert scale 
(strongly disagree – 
strongly agree)  
 
14 items 
“I become angry when my 
freedom of choice is restricted”; 
“I consider advice from others to 
be an intrusion”;  
“Regulations trigger a sense of 
resistance in me”. 
 
The HPRS was originally reported to have 
four factors by Hong and Page (1989), but 
researchers commonly report a total score. 
Yost and Finney (2018) found calculating a 
total score is appropriate, but a bifactor model 
is the best fit for the HPRS.  
 
Caruso et al. (2019); De las 
Cuevas, Peñate and Sanz (2014); 
De Las Cuevas and De Leon 
(2017); De las Cuevas and de 
Leon (2019); Madsen et al. 
(2009); Moore et al. (2000); 





(Dowd et al., 1991) 
Trait Self-report 
 
5-point Likert scale 
(strongly disagree – 




“If I am told what to do, I often do 
the opposite”;  
“I am sometimes afraid to 
disagree with others”;  
“I usually go along with others’ 
advice”. 
Dowd et al. (1991) reported a two factor 
solution – Behavioural and Verbal reactance. 
Total TRS scores are often reported. 
Validation studies have found four factor 
solution most appropriate and cautioned 
against using total scores, or Verbal or 
Behavioural subscale scores (Buboltz Jr et al., 
2002; Inman et al., 2019). 
 
Fogarty and Youngs Jr (2000); 
Kealy et al. (2018); McNiel et al. 
(2013); Seibel and Dowd (1999). 







6-point Likert scale 





“I seldom behave according to 
others’ standards”; 
“The thought of being dependent 
on others is very unpleasant to 
me”; 
“When I get advice, I take it more 
as a demand” 
Seibel and Dowd (1999) reported QMPR total 
scores.  
The QMPR was originally written in German. 
The English version has never been found to 
be psychometrically stable and hence no 
recommended scoring method was ever 
reported in translation/validation studies 
(Donnell et al., 2001; Hong & Ostini, 1989; 
Tucker & Byers, 1987). 
 
Seibel and Dowd (1999) 












subscale (Kuhl & 
Fuhrmann, 1998) 
Trait  Self-report 
 





When I take on something 
difficult or unpleasant, I am the 
type of person who… “refuses to 
satisfy others’ demands”; “avoids 
being forced to meet others’ 
expectations”; “becomes angry 
when others’ rules restrict my 
freedom” 
 
Reported to be unidimensional (Kuhl, 2000; 
Kuhl & Fuhrmann, 1998) and total scores 
were calculated by Orbell and Hagger (2006).  
Orbell and Hagger (2006) 
Author designed scale 
measuring reactions 
to the behaviour of 
relatives & asking for 
cognitions that have 
been described as 
typical indicators of 
reactance 




7-point Likert scale 
(does not apply at all 
– applies completely) 
 
4 items 
“Through my relative’s behavior 
concerning my exercise during the 
last month, I felt very restricted in 
my personal freedom”. (only one 
example item given in paper). 
Ungar et al. (2016) reported total scores.  Ungar et al. (2016) 






choice (choice vs no 
choice) conditions 
(Fogarty & Youngs, 
2000) 
 
State Attempted to measure 
occurrence of state 
reactance via impact 





N/A N/A Fogarty and Youngs Jr (2000) 
 
  




Appendix A: Social Science and Medicine Author Guidelines 
DESCRIPTION 
Social Science & Medicine provides an international and interdisciplinary forum for the 
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The reference style used by the journal will be applied to the accepted article by Elsevier at 
the proof stage. Note that missing data will be highlighted at proof stage for the author to 
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Formatting Requirements 
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your paper to meet these criteria please see the attached guidelines. The journal requires that 
your manuscript is submitted with double spacing applied. There are no other strict 
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Divide the article into clearly defined sections. 
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Provide the full postal address of each affiliation, including the country name and, if 
available, the e-mail address of each author. 
Corresponding author. Clearly indicate who will handle correspondence at all stages of 
refereeing and publication, also post-publication. Ensure that telephone and fax numbers 
(with country and area code) are provided in addition to the e-mail address and the complete 
postal address. Contact details must be kept up to date by the corresponding author. 
Present/permanent address. If an author has moved since the work described in the article was 
done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated 
as a footnote to that author's name. The address at which the author actually did the work 
must be retained as the main, affiliation address. Superscript Arabic numerals are used for 
such footnotes. 
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text, references, appendix, figure captions, tables and figures. Author details, keywords and 
acknowledgements are entered separately during the online submission process, as is the 
abstract, though this is to be included in the manuscript as well. During submission authors are 
asked to provide a word count; this is to include ALL text, including that in tables, figures, 
references etc. 
Title 
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Highlights are optional yet highly encouraged for this journal, as they increase the 
discoverability of your article via search engines. They consist of a short collection of bullet 
points that capture the novel results of your research as well as new methods that were used 
during the study (if any).  
Highlights should be submitted in a separate editable file in the online submission system. 
Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 
characters, including spaces, per bullet point). 
Abstract 
An abstract of up to 300 words must be included in the submitted manuscript. An abstract is 
often presented separately from the article, so it must be able to stand alone. It should state 
briefly and clearly the purpose and setting of the research, the principal findings and major 
conclusions, and the paper's contribution to knowledge. For empirical papers the 
country/countries/locations of the study should be clearly stated, as should the methods and 
nature of the sample, the dates, and a summary of the findings/conclusion. Please note that 
excessive statistical details should be avoided, abbreviations/acronyms used only if essential 
or firmly established, and that the abstract should not be structured into subsections. Any 
references cited in the abstract must be given in full at the end of the abstract. 
Keywords 
Up to 8 keywords are entered separately into the online editorial system during submission, 
and should accurately reflect the content of the article. Again abbreviations/acronyms should be 
used only if essential or firmly established. For empirical papers the 
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Authors of empirical papers are expected to provide full details of the research methods used, 
including study location(s), sampling procedures, the date(s) when data were collected, 
research instruments, and techniques of data analysis. Specific guidance on the reporting of 
qualitative studies are provided here. 
Systematic reviews and meta-analyses must be reported according to PRISMA guidelines. 
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Please submit tables as editable text and not as images. Tables can be placed either next to the 
relevant text in the article, or on separate page(s) at the end. Number tables consecutively in 
accordance with their appearance in the text and place any table notes below the table body. 
Be sparing in the use of tables and ensure that the data presented in them do not duplicate 
results described elsewhere in the article. Please avoid using vertical rules and shading in 
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but may be mentioned in the text. If these references are included in the reference list they 
should follow the standard reference style of the journal (see below) and should include a 
substitution of the publication date with either "Unpublished results" or "Personal 




SYSTEMATIC LITERATURE REVIEW  1-75                                                                                                                                                                                                                                       
 
 
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a source 
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which citations and bibliographies will be automatically formatted in the journal's style. If no 
template is yet available for this journal, please follow the format of the sample references 
and citations as shown in this Guide. If you use reference management software, please 
ensure that you remove all field codes before submitting the electronic manuscript. More 
information on how to remove field codes from different reference management software. 
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any style or format as long as the style is consistent. Where applicable, author(s) name(s), 
journal title/ book title, chapter title/article title, year of publication, volume number/book 
chapter and the article number or pagination must be present. Use of DOI is highly encouraged. 
The reference style used by the journal will be applied to the accepted article by Elsevier at the 
proof stage. Note that missing data will be highlighted at proof stage for the author to correct. 
If you do wish to format the references yourself they should be arranged according to the 
following examples: 
Reference style 
Text: All citations in the text should refer to: 
Single author: the author's name (without initials, unless there is ambiguity) and the year of 
publication; 
Two authors: both authors' names and the year of publication; 
Three or more authors: first author's name followed by 'et al.' and the year of publication. 
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Examples: 'as demonstrated (Allan, 2000a, 2000b, 1999; Allan and Jones, 1999)…. Or, as 
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MEDLINE Complete  
 
500 results 
(MH "Mental Health") OR (MH "Health+") OR (MH "Day Care, Medical") OR (MH "Patient Care Team") OR (MH "Health Services 
Research") OR (MH "Psychiatric Nursing") OR (MH "Psychiatric Rehabilitation") OR (MH "Social Work, Psychiatric") OR (MH 
"Involuntary Treatment, Psychiatric") OR (MH "Emergency Services, Psychiatric") OR (MH "Mental Disorders") OR (MH "Mentally 
Ill Persons") OR 
TI ( "mental health" or “physical health” or "healthcare" or "health care" or "health-care" or "patient*" or "nursing" or "condition*" or 
"diagnos*" or "chronic" or "illness*" or "disease*" or "syndrome*" or “depress*” or “anxi*” or “psychiatr*” or "severe mental" ) OR 
AB ( "mental health" or “physical health” or "healthcare" or "health care" or "health-care" or "patient*" or "nursing" or "condition*" or 
"diagnos*" or "chronic" or "illness*" or "disease*" or "syndrome*" or “depress*” or “anxi*” or “psychiatr*” or "severe mental" ) AND 
TI ( "psych* reactance" or "reactan*" ) OR AB ( "psych* reactance" or "reactan*" ) AND 
(MH "Compliance") OR (MH "Patient Compliance") OR (MH "Treatment Adherence and Compliance+") OR (MH "Medication 
Adherence") OR (MH "Guideline Adherence") OR (MH "Patient Participation") OR (MH "Treatment Refusal+") OR TI ( “Adher*” or 
“complian*” or “concordan*” or “nonadher*” or “noncomplian*” or “persisten*” or “treatment us*” or “attend*” or “non-attend*” or 
“engag*” or “disengag*” or “reject* ADJ2 therapy” or “reject* ADJ2 treatment” or “DNA” or “did not attend” or “drop out” or “drop-
out” or “service use” or “retention” or “attrition” or “premature termination” or "treatment ADJ2 refus*" or "therapy ADJ2 refus*" ) OR 
AB ( “Adher*” or “complian*” or “concordan*” or “nonadher*” or “noncomplian*” or “persisten*” or “treatment us*” or “attend*” or 
“non-attend*” or “engag*” or “disengag*” or “reject* ADJ2 therapy” or “reject* ADJ2 treatment” or “DNA” or “did not attend” or 
“drop out” or “drop-out” or “service use” or “retention” or “attrition” or “premature termination” or "treatment ADJ2 refus*" or 
"therapy ADJ2 refus*" 
 




((((DE "Mental Health" OR DE "Mental Status") AND (DE "Physical Health" OR DE "Physical Health Assessment" OR DE "Health 
Screening" OR DE "Pain Measurement" OR DE "Physical Illness (Attitudes Toward)" OR DE "AIDS (Attitudes Toward)")) OR (DE 
"Health Care Psychology" OR DE "Health Belief Model" OR DE "Medical Psychology")) OR (DE "Medical Diagnosis" OR DE 
"Autopsy" OR DE "Biopsy" OR DE "Cardiography" OR DE "Dexamethasone Suppression Test" OR DE "Echoencephalography" OR 
DE "Electro Oculography" OR DE "Electroencephalography" OR DE "Electromyography" OR DE "Electronystagmography" OR DE 
"Electroplethysmography" OR DE "Electroretinography" OR DE "Encephalography" OR DE "HIV Testing" OR DE 
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"Magnetoencephalography" OR DE "Ophthalmologic Examination" OR DE "Plethysmography" OR DE "Pneumoencephalography" 
OR DE "Prenatal Diagnosis" OR DE "Rheoencephalography" OR DE "Roentgenography" OR DE "Spectroscopy" OR DE 
"Tomography" OR DE "Urinalysis")) OR (DE "Medical Psychology") OR TI ( "mental health" or “physical health” or "healthcare" or 
"health care" or "health-care" or "patient*" or "nursing" or "condition*" or "diagnos*" or "chronic" or "illness*" or "disease*" or 
"syndrome*" or “depress*” or “anxi*” or “psychiatr*” or "severe mental") OR AB ( "mental health" or “physical health” or 
"healthcare" or "health care" or "health-care" or "patient*" or "nursing" or "condition*" or "diagnos*" or "chronic" or "illness*" or 
"disease*" or "syndrome*" or “depress*” or “anxi*” or “psychiatr*” or "severe mental" ) AND 
(DE "Psychological Reactance") OR (DE "Psychotherapeutic Resistance") OR TI ( "psych* reactance" or "reactan*" ) OR AB ( 
"psych* reactance" or "reactan*" ) AND 
(((((DE "Treatment Refusal") OR (DE "Treatment Termination")) OR (DE "Compliance" OR DE "Treatment Compliance")) AND (DE 
"Treatment Compliance" OR DE "Treatment Dropouts")) OR (DE "Treatment Dropouts")) AND (DE "Client Participation" OR DE 
"Treatment Barriers") OR  
TI ( “Adher*” or “complian*” or “concordan*” or “nonadher*” or “noncomplian*” or “persisten*” or “treatment us*” or “attend*” or 
“non-attend*” or “engag*” or “disengag*” or “reject* ADJ2 therapy” or “reject* ADJ2 treatment” or “DNA” or “did not attend” or 
“drop out” or “drop-out” or “service use” or “retention” or “attrition” or “premature termination” or "treatment ADJ2 refus*" or 
"therapy ADJ2 refus*") OR AB ( “Adher*” or “complian*” or “concordan*” or “nonadher*” or “noncomplian*” or “persisten*” or 
“treatment us*” or “attend*” or “non-attend*” or “engag*” or “disengag*” or “reject* ADJ2 therapy” or “reject* ADJ2 treatment” or 
“DNA” or “did not attend” or “drop out” or “drop-out” or “service use” or “retention” or “attrition” or “premature termination” or 








(MH "Mental Health") OR (MH "Mental Health Services+") OR (MH "Community Mental Health Services+") OR (MH "Medical 
Practice+") OR (MH "Medical Care") OR (MH "Health+") OR (MH "Psychiatry+") OR (MH "Child Psychiatry") OR (MH "Forensic 
Psychiatry") OR (MH "Telepsychiatry") OR (MH "Geriatric Psychiatry") OR (MH "Adolescent Psychiatry") OR (MH "Psychiatric 
Service") OR (MH "Psychiatric Patients") OR TI ( "mental health" or “physical health” or "healthcare" or "health care" or "health-care" 
or "patient*" or "nursing" or "condition*" or "diagnos*" or "chronic" or "illness*" or "disease*" or "syndrome*" or “depress*” or 
“anxi*” or “psychiatr*” or "severe mental" ) OR AB ( "mental health" or “physical health” or "healthcare" or "health care" or "health-
care" or "patient*" or "nursing" or "condition*" or "diagnos*" or "chronic" or "illness*" or "disease*" or "syndrome*" or “depress*” or 
“anxi*” or “psychiatr*” or "severe mental" ) AND 
(MH "Psychotherapeutic Processes+") OR  
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People who experience psychosis have a high rate of disengagement from mental health 
services. This has led to investigations of correlates of service (dis)engagement, in an effort 
to further understanding of how engagement can be increased. This study aimed to 
investigate the predictive value of potentially important psychological variables in therapeutic 
engagement in this group. Perceptions of autonomy, control beliefs, psychological reactance 
and expressed emotion were predicted to be associated with engagement levels.  
Participants (N=113) completed an online survey comprising of measures of the above 
variables and demographic questions. Those included were 18 years+ of age, experiencing 
psychosis and currently or previously a service user of mental health services. 
An exploratory factor analysis showed the author-devised autonomy scale was 
unidimensional, and accounted for 58.67% of the variance in overall scale score. Participants 
who reported one previous hospital admission had significantly lower engagement scores 
compared with participants who reported no previous admissions. There were no other 
significant relationships between sociodemographic variables and engagement. Expressed 
emotion was not significantly associated with engagement. In a regression model, autonomy, 
psychological reactance and control beliefs significantly accounted for 46.2% of the variance 
in engagement; although at the final step, autonomy was the only significant predictor, 
accounting for 28.2% of the variance in engagement alone.  
This study demonstrated the utility of measuring perceptions of autonomy in relation to 
service engagement in psychosis. Findings highlight the importance of considering 
psychological variables in predicting therapeutic engagement, something future research 
should continue to do.  
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Introduction 
The prevalence of clinical levels of psychosis is high, with meta-analyses finding 
annual incidence of psychotic disorders being 32 cases per 100,000 people in the UK 
(Kirkbride et al., 2012), and 26.6 per 100,000 people based on multinational samples 
(Jongsma et al., 2019), with both reviews finding higher rates in men and Black and Minority 
Ethnic (BAME) groups. Whilst each individual’s experiences of psychosis are unique, 
psychosis is typically characterised by experiences of hallucinations, delusions, changes in 
mood and/or cognitive and interpersonal difficulties (British Psychological Society, 2017). 
Psychosis often causes individuals, and their families, significant distress and is associated 
with poorer health outcomes and reductions in global functioning (Hjorthøj et al., 2017; 
Kelleher et al., 2015). People experiencing psychosis benefit from long-term, recovery-
oriented support from multi-disciplinary services to achieve improvements in mental health 
and quality of life (Csillag et al., 2016). Therapeutic benefits associated with mental health 
services are influenced by the degree to which participants engage with the service (Mitchell 
& Selmes, 2007). Disengagement rates from mental health services by people experiencing 
psychosis are high, at around one in three for Early Intervention for Psychosis services (EIS; 
Doyle et al., 2014). A recent study found disengagement rates in First Episode Psychosis 
(FEP) of 56.3% (Brown et al., 2019). This presents an important clinical challenge for 
researchers and services to consider (Mascayano et al., 2020).  
There are inherent challenges in measuring and researching such (dis)engagement, 
due to it being a complex and multifaceted concept (Reynolds, Brown, Tindall, et al., 2019; 
Tindall et al., 2018). A recent review found that across psychosis studies, there is little 
consensus between researchers in how (dis)engagement is conceptualised, operationalised 
and measured, and that researchers tend to measure engagement categorically (i.e. non-
attendance at appointments; Reynolds, Brown, Tindall et al., 2019). However, measuring 
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(dis)engagement categorically implies engagement is a binary outcome, rather than a 
dynamic, relational process that changes in relation to stage of treatment and service user 
needs (Lal & Malla, 2015).  
 “Therapeutic engagement” is conceptualised differently from engagement in the 
literal sense of adherence/attendance (Tetley et al., 2011). O’Brien et al. (2009) suggest 
therapeutic engagement includes “the acceptance of a need for help, the formation of a 
therapeutic alliance with professionals, satisfaction with the help already received, and a 
mutual acceptance and working towards shared goals". The Singh O’Brien Level of 
Engagement Scale (SOLES; O’Brien et al., 2009) is a self-report scale designed to measure 
therapeutic engagement with services for people experiencing psychosis. Items were 
developed representing concepts related to engagement: attendance, satisfaction, therapeutic 
alliance, insight and adherence. The SOLES has good predictive validity in terms of 
longitudinal disengagement, cross-sectional disengagement and attendance at appointments 
(O'Brien et al., 2009).  
Facilitating engagement is a key priority within EIS; this is based on the rationale that 
the initial stages of support received when experiencing psychosis are crucial in terms of 
longer-term outcomes (Aceituno et al., 2019; Correll et al., 2018). Studies of (dis)engagement 
with EIS have largely focused on sociodemographic and clinical variables. Substance use, 
low baseline severity of illness, insight, past forensic history, unemployment, duration of 
untreated psychosis, lack of family support, medication non-adherence, symptomatology and 
socioeconomic status have been found to be associated with non-engagement (Doyle et al., 
2014; Mascayano et al., 2020; Reid & Murray, 2018; Reynolds, Brown, Geros, et al., 2019), 
with equivocal evidence for associations with BAME status (Casey et al., 2016; Kline & 
Thomas, 2018; Solmi et al., 2018; Wang, 2007).  
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Whilst the issue of engagement with EIS is undoubtedly important, the literature’s 
predominant focus upon EIS and prevention (Fusar-Poli et al., 2012) seems to have been at 
the cost of sufficient attention being paid to this issue in longer-term psychosis. There seem 
to be no existing studies investigating the prevalence rates of disengagement from mental 
health services for individuals with established psychosis/schizophrenia-spectrum diagnoses; 
although it has been recognised that secondary care services experience difficulties in 
engaging this group (Bouras et al., 2018; Edwards et al., 2016; Kreyenbuhl et al., 2009). 
Whilst research into FEP tends to focus upon attendance/drop-out, research into established 
psychosis typically focuses on medication adherence (Chaudhari et al., 2017; Czobor et al., 
2015; Goff et al., 2011) – with less overall focus on therapeutic engagement. Regardless of 
the stage of illness, there remains an assumption that mental health service input improves 
outcomes for individuals. Understanding factors that impact therapeutic engagement (not just 
attendance/adherence) at all stages of illness is, therefore, important (Kline & Thomas, 2018).  
Psychological factors should be considered, but have been largely absent from 
reviews. Psychological variables have the potential to be amenable to intervention, thus 
leading to the identification of treatment targets to enhance engagement. Interestingly, 
quantitative research investigating psychological factors tends to include participants 
experiencing established psychosis as well as individuals in earlier stages (Reid & Murray, 
2018). Studies have investigated associations between engagement and recovery style (Tait et 
al., 2003); beliefs and attributions about illness (Casey et al., 2016; Shah et al., 2009; 
Williams & Steer, 2011); stigma and discrimination (Clement et al., 2015; Hack et al., 2020; 
Tsang et al., 2010); attachment (MacBeth et al., 2011); psychosocial functioning (Rossi et al., 
2017); quality of life and self-esteem (Staring et al., 2009); therapeutic alliance (Farrelly et 
al., 2014); and experiences of childhood abuse (Lecomte et al., 2008; Spidel et al., 2010). 
Qualitative research into engagement with EIS has also highlighted the importance of 
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psychological factors; with an emphasis on the importance of shared goals, client autonomy 
and therapeutic relationships (Cowan et al., 2020; Loughlin et al., 2020; Tindall et al., 2020; 
Tindall et al., 2018). These findings highlight the potential utility of further investigating 
psychological factors in relation to service engagement in psychosis.  
Autonomy 
 Self-determination theory posits that autonomy, defined as the ability to act out of 
personal choice (rather than control), is a basic psychological need of all people (Ryan & 
Deci, 2002). Discussions of autonomy in healthcare generally focus on patients’ decisional 
autonomy (freedom to deliberate and choose a course of action/treatment from among a range 
of options), and experiences of autonomy-support (the extent to which individuals feel 
empowered and supported to make informed choices based on their own values and 
preferences; Arrieta-Valero, 2019; Hagger & Protogerou, 2020). Indeed, there is evidence 
that patient perceptions of autonomy and autonomy-support predict increased adherence 
across various health conditions/settings (Kennedy et al., 2004; Koponen et al., 2017; Nafradi 
et al., 2017; Ng et al., 2014; Russell & Bray, 2010; Sandman et al., 2012; Umeukeje et al., 
2016).  
These are interrelated concepts; clients’ decisional autonomy is dependent, at least in 
part, upon the autonomy-support provided by services/professionals. Within psychosis 
literature, client autonomy and autonomy-support are generally considered in the context of 
treatment-related empowerment, via implementing shared decision making and reducing 
experiences of coercion and compulsory treatment. Treatment-related empowerment is 
associated with increased service user satisfaction, medication adherence and quality of life, 
and reduced hospitalisations (Ahmed et al., 2016; Baker et al., 2019; Delman et al., 2015; 
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Elwyn et al., 2012; Fiorillo et al., 2020; Holttum, 2020; Stovell, Morrison, et al., 2016; 
Stovell, Wearden, et al., 2016).  
Despite attention to treatment-related empowerment, there has been relatively little 
focus on client perceptions of autonomy and autonomy-support in psychosis (Gleeson et al., 
2020). Individuals with FEP experience low levels of perceived autonomy, and report loss of 
autonomy as one of the main difficulties associated with experiencing psychosis (Breitborde 
et al., 2012; Breitborde et al., 2019; Jordan et al., 2018). Moreover, a recent study was the 
first to measure autonomy-support in FEP, and showed autonomy-support is associated with 
increased quality of life and potentially reduced depression (Browne et al., 2017). These 
findings, alongside research evidencing the impact of increased autonomy-support on 
healthcare adherence, suggest research into the relationship between client perceptions of 
autonomy and therapeutic engagement in psychosis would be valuable. 
Control beliefs 
Control beliefs are another related construct which may play an important role in 
predicting engagement in psychosis. Locus of control beliefs have been extensively studied in 
healthcare, with findings often being that external control beliefs (where individuals believe 
they have little or no control over their life/health) are predictive of less adherence compared 
with internal control beliefs (where individuals believe they can control factors which 
influence their life and health; Nafradi et al., 2017). These findings have been replicated in 
psychiatric samples, with recognition that individuals experiencing psychosis tend to possess 
more external than internal control beliefs (De las Cuevas et al., 2017; De las Cuevas et al., 
2016; Hutcheson et al., 2014; Jaeger et al., 2014). Control beliefs do not seem to have yet 
been investigated in the context of therapeutic engagement. Understanding whether control 
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beliefs predict therapeutic engagement for people who experience psychosis would also be 
valuable in furthering understanding of engagement.  
Psychological Reactance 
 Psychological reactance theory (Brehm, 1966) proposes that freedom of behaviour is 
an important and pervasive aspect of people’s lives. When this freedom is threatened, 
individuals become motivated to restore their sense of autonomy; this motivational state is 
termed psychological reactance (Rosenberg & Siegel, 2018). Psychological reactance results 
in behavioural and cognitive efforts to re-establish autonomy (Dillard & Shen, 2005). 
Behaviourally, people may attempt to engage in the behaviour being threatened or a 
similar/related behaviour. Cognitively, people may derogate the source of threat, upgrade the 
restricted freedom or downgrade the imposed option’s favourableness (Miron & Brehm, 
2006; Reynolds-Tylus, 2019; Shen & Dillard, 2005). Based on the assumption that people 
vary in the strength of their need for autonomy, researchers have shown the amount of state 
reactance experienced is influenced by trait reactance proneness; that is, a person’s likelihood 
of perceiving stimuli as freedom/autonomy threatening (Brehm & Brehm, 1981; Dillard & 
Shen, 2005; Miller et al., 2006; Quick et al., 2011; Quick & Stephenson, 2008; Rains, 2013; 
Rosenberg & Siegel, 2018; Shen & Dillard, 2005).  
 Several studies have shown trait psychological reactance predicts medication 
adherence and appointment attendance in psychiatric patient samples (Section One). 
Moreover, Wilson and Deane (2012) showed that need for autonomy was a strong barrier to 
seeking mental healthcare in FEP. Various aspects of mental healthcare provision could be 
deemed as threatening to freedom of behaviour/autonomy, and even more so by individuals 
high in trait reactance – leading to reduced therapeutic engagement (Grinter, 2012). This may 
be further influenced by whether clients experience healthcare provision as autonomy-
EMPIRICAL PAPER  2-10 
 
supportive (collaborative) or autonomy-restrictive (controlling). Perceived autonomy may 
moderate the relationship between trait reactance and engagement, so that higher perceived 
autonomy increases engagement for participants higher in trait psychological reactance. 
Indeed, it has been shown in psychotherapy clients that those high in trait reactance had better 
therapy outcomes when the therapist assumed a nondirective, autonomy-supportive stance, 
rather than a directive and authoritative one (Beutler et al., 2018). 
 Expressed Emotion 
Patterns of family interactions are another area of potential importance related to 
engagement. Expressed Emotion (EE) is a construct comprised of emotional over 
involvement, criticism, hostility and warmth. High-EE (criticism and emotional over 
involvement) relatives of people experiencing psychosis act in more controlling ways in 
comparison to low-EE relatives (Hooley & Campbell, 2002; Peterson & Docherty, 2004; 
Vasconcelos e Sa et al., 2013; Wuerker et al., 2002). Such experiences likely lead to a 
reduction in perceived autonomy (Aguilera et al., 2010), although there are no studies 
investigating this relationship.  
High levels of EE predict poorer service user outcomes, including more frequent 
relapse and hospital admissions (Cechnicki et al., 2013; Domínguez-Martínez et al., 2014; 
O'Driscoll et al., 2019). In a recent study, da Silva et al. (2020) did not find a relationship 
between high-EE and medication adherence in FEP, but suggested this warrants further 
consideration in the context of therapeutic engagement. However, Sellwood et al. (2003) did 
find that high-EE was associated with reduced medication adherence in psychosis. Moreover, 
high-EE is associated with high levels of carer burden (Marom et al., 2005; Patel et al., 
2014), and a recent study found an association between high levels of carer burden and 
reduced EIS engagement (Reid & Murray, 2018). Family interventions, targeted at EE, have 
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also been shown to increase medication adherence in psychosis (Pharoah et al., 2010). It 
therefore seems that the relationship between EE and therapeutic engagement, in the context 
of perceived autonomy in relation to mental healthcare, is worthwhile investigating further.  
Aims 
Using the SOLES (O’Brien et al., 2009), this study aimed to investigate factors that 
predict therapeutic engagement with mental health services for people who self-report 
experiencing psychosis.  
First, in an effort to utilise demographic data and identify potential covariates, this 
study aimed to investigate whether demographic variables were associated with engagement. 
Next, we sought to investigate the relationships between perceived autonomy, control beliefs, 
psychological reactance, EE and engagement. It was hypothesised that autonomy, 
psychological reactance, control beliefs and EE would be significantly correlated with 
engagement, and that together these variables would predict a significant amount of the 
variance in engagement in a regression model.  
Finally, it was hypothesised that perceived autonomy would significantly moderate 




Participants were recruited between 27th May and 9th September 2020. Eligibility 
criteria were participants who self-reported: being ≥18 years of age; experiencing psychosis; 
and are, or had previously been, mental health service users. No exclusions were placed on 
location. 
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Procedure 
The study received ethical approval from Lancaster University’s Faculty of Health 
and Medicine Research Ethics Committee. Feedback on design was obtained from experts by 
experience from Lancaster University’s Public Involvement Network via a focus group. 
Additionally, an EIS’s Participation Consultant provided feedback. This was used to refine 
the accessibility of the information/survey, to understand the potential time burden of 
participating, and to re-word some of the demographic and autonomy questions. Suggested 
changes were included in the final design.  
Participants responded to an anonymous online survey which was advertised on social 
media platforms (Facebook, Twitter, Instagram and Reddit). Key stakeholders were also 
asked to circulate the study advertisement; these included mental health charities, student 
research websites, academic researchers and public champions for people with lived 
experience of psychosis.  
Prior to beginning the survey, participants completed a consent form and indicated 
that they had read the participant information sheet fully. They were informed that the 
purpose of the study was to investigate factors that influence whether people experiencing 
psychosis decide/feel able to engage with services. Next, participants were asked to confirm 
their eligibility. Here, and within the study advertisement and information sheet, psychosis 
was described as “psychosis might be seeing or hearing things (voices) that other people 
cannot, or having strong beliefs that others think are very unusual. Experiencing psychosis is 
sometimes linked with diagnoses like “schizophrenia”, “schizoaffective disorder” or 
“delusional disorder”, but not necessarily”. Examples of mental health teams were given. 
Following survey completion, participants were given the option to enter a prize draw for an 
opportunity to win one of five £30 Amazon vouchers. This information was gathered 
EMPIRICAL PAPER  2-13 
 
separately to maintain participants’ anonymity. Within the information and debrief sheets, 
participants were directed to supportive resources for if they felt any distress2.  
Demographic Questions  
Respondents entered sociodemographic information relating to a range of variables 
(Table 1). For the questions regarding diagnoses and type(s) of mental health service, 
participants could select more than one option or specify a different answer in an ‘other’ 
category – this was to acknowledge that participants may identify as having/experiencing 
multiple mental health diagnoses/difficulties, as well as having had experience of multiple 
mental health services. 
Measures 
SOLES (O’Brien et al., 2009). The SOLES is a 16-item self-report measure of 
engagement with services for people experiencing psychosis. Example items include “I have 
benefited from mental health services”, “I attend appointments with my care coordinator/key 
worker”, “I feel listened to by health professionals”, “I need to take my psychiatric 
medication”, “I always take my medication”. For questions that included the term 
‘keyworker’, ‘/care coordinator’ was added, to reflect a term many UK secondary care 
service users may be more familiar with. Participants were asked to rate their agreement with 
statements on a 10-point scale (0 = not at all – 10 = entirely). Participants who were not 
currently service users were asked to answer based on how they felt when they were 
previously a service user.   
The SOLES is scored by calculating the mean of all non-missing items. Item 13 is 
reverse scored. The authors report that three items can be missed if a person does not have a 
keyworker. In this study, participants were instructed to leave any questions that were not 
 
2 Full details of the study procedure and ethical approval are included in Section 4. 
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relevant to them blank, because additional questions were also potentially irrelevant for some 
participants (e.g. questions regarding medication or hospital admissions). Higher scores 
indicate better engagement. O’Brien et al.’s (2009) analysis revealed that the scale had good 
internal consistency (α=.843). An additional supplementary question was asked on whether 
the participant feels there have been times in the past they have disengaged from mental 
health services. 
Autonomy. At the time of study design, a scoping search of the literature did not 
identify measures of perceptions of autonomy related to mental health. Throughout physical 
healthcare literature, autonomy-support is often measured via the Health Care Climate 
Questionnaire (Williams et al., 1996), which asks about perceptions of autonomy-support 
provided by a patients’ key physician. For this study, it was important to have questions 
designed around both decisional autonomy and autonomy-support, in relation to others and 
mental health services more generally (rather than one key physician). After reviewing both 
autonomy and psychosis literature, the authors generated seven items to measure this. These 
were taken to experts by experience to receive feedback on the concept being measured and 
wording of items. Item six was changed in response to service user feedback.  
Participants were asked to rate the extent to which they agreed with each statement (1 
= not at all – 4 = all of the time). Participants who were not currently service users were 
asked to answer based on how they felt when they were previously a service user. Items are 
shown in Table 2. Items 3, 4 and 5 are reverse scored. Total scores are calculated, with higher 
scores reflecting greater perceived autonomy.  
 Mastery Scale – short version. This is a five item self-report scale which measures 
individual’s control beliefs; the extent to which individuals view themselves as being in 
control over things that happen in their lives (Clench-Aas et al., 2017; Pearlin & Schooler, 
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1978). Individuals answer on a five-point scale their agreement with the statements that: they 
have little control over things that happen to them; are unable to solve problems they have; 
cannot change important things in their life; feel helpless when dealing with problems in life; 
and sometimes feel they are being pushed around in life. The total scores are summed with 
higher scores indicating higher sense of mastery.  
The Mastery scale short version has been shown to be internally consistent (α=.84) 
(Clench-Aas et al., 2017; Gadalla, 2009). The mastery scale has previously been used in 
psychosis research (Eklund et al., 2012; Hsiung et al., 2010).  
Hong Psychological Reactance Scale (HPRS). The HPRS is a 14-item scale measuring 
trait psychological reactance proneness (Hong & Page, 1989). Individuals rate their 
agreement with each item (1=strongly disagree – 5=strongly agree). Items include: “I 
consider advice from others to be an intrusion”, “The thought of being dependent on others 
aggravates me”, and “When something is prohibited, I usually think ‘that is exactly what I 
am going to do’”. Total item scores are summed, with higher scores indicating higher 
reactance proneness. The appropriateness of utilising total HPRS score as an overall index of 
trait reactance has been verified (Brown & Finney, 2011; Brown et al., 2011; Moreira et al., 
2020; Waris et al., 2020; Yost & Finney, 2018). Yost and Finney (2018) describe HPRS 
reliability via explained common variance (ECV), reporting that ECV is between 63-69%, 
higher than the 50% ‘acceptable’ standard (Brown & Finney, 2011; Brown et al., 2011).  
Brief Dyadic Scale of Expressed Emotion (BDSEE). This is a 14-item scale measuring 
patients’ perceptions of EE (Medina-Pradas et al., 2011). It is composed of three subscales: 
perceived criticism, perceived emotional over involvement and perceived warmth, which 
accounted for 73.1% of the variance. Items are scored on a 10-point scale (1=not at all/never 
– 10=very/always). Participants were asked to answer the questions about “the person you 
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are closest to, whom you spend the most time with through the week and whom helps support 
you with your mental health”. Sum scores for each subscale are calculated, with higher scores 
indicating more perceived criticism, emotional over involvement or warmth. The criticism 
factor consists of four items with a Cronbach’s alpha of .90 (e.g. “How critical is this person 
of you?”). The emotional over involvement factor consists of six items with a Cronbach’s 
alpha of .82 (e.g. “This person does not let me do things on my own.”). The warmth factor 
consists of four items with a Cronbach’s alpha of .92 (e.g. “How caring is this person of 
you?”). Medina-Pradas et al. (2011) validated the scale in a sample of people who had 
received eating disorder diagnoses. The scale was originally validated by Keefe et al. (2006 – 
as cited in Medina-Pradas et al., 2011) on a sample of people who had received schizophrenia 
diagnoses. Whilst this study was never published, Medina-Pradas et al. (2011) report 
Cronbach’s alphas from the sample of patients with schizophrenia diagnoses was .67 to .79. 
Medina-Pradas et al. (2011) also investigated the BDSEE’s construct validity via comparison 
with several EE instruments, including with the Camberwell Family Interview (CFI) – the 
gold standard for investigating EE. They found participants’ perceptions and the “objective” 
ratings derived from the CFI were significantly correlated for criticism and emotional over 
involvement, and a positive but non-significant relationship was observed between the 
BDSEE and CFI’s measure of warmth. Thus, their findings suggest the BDSEE’s construct 
validity is good. 
Before participants completed the BDSEE, three accompanying questions were asked 
about who the participant lives with, whom the closest person in their life is, and how much 
time per week the participant spends with this person. 
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Analysis Strategy 
First, descriptive statistics of demographics were examined to understand sample 
characteristics. An exploratory factor analysis (EFA) was conducted to examine the structure 
of the autonomy measure; principal axis factoring with varimax rotation, and extraction 
criteria of eigenvalue > 1 were utilised (Costello & Osborne, 2005).  
Next, the relationships between demographic variables and engagement were 
investigated, using independent samples t-tests, one-way ANOVAs and correlational 
analyses. Due to participants self-reporting as experiencing/being given multiple 
conditions/diagnoses, and as having been involved with multiple services, it was not possible 
to analyse these variables’ relationships with engagement in a way that would provide 
meaningful results. Additionally, for ethnicity and country variables, the non-dominant 
groups (i.e. non-White and non-UK) had too small a sample sizes to allow for meaningful 
analysis. The nature of the relationships between reactance, mastery, autonomy, EE and 
engagement variables was then explored using correlational analysis. Assumptions 
underlying correlational analysis, t-tests and ANOVAs were considered. Scatterplots, 
histograms, boxplots and Q-Q plots for each variable were inspected. There were no 
“extreme” outliers (± 3.29 standard deviations away from the mean), and assumptions of 
linearity and normality were met. For t-tests/ANOVAs, homogeneity of variances was 
assumed, as assessed by Levene’s test for equality of variances (Field, 2018).  
Next, a hierarchical multiple linear regression analysis, using forced entry method, 
was employed to determine the combined predictive value of the independent variables on 
engagement. During design of the study, an a priori power analysis using G*power for a 
multiple regression with seven predictors at an alpha level of 0.05 and a power of 0.80 
predicted requiring a sample size of N = 103 in order to identify a medium effect size (f 2 = 
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0.15). It was hypothesised that each of the key variables (EE [perceived criticism, emotional 
over involvement], autonomy, mastery, psychological reactance) would significantly predict 
engagement in a regression model. Correlational analysis findings did not indicate for any 
demographic variables to be entered into the model as control variables. Moreover, following 
correlational analysis, EE subscales were not included in regression analyses, as it was clear 
these would not add predictive value to the model. Thus, the remaining predictors were 
entered sequentially. HPRS was entered in the first step; followed by mastery in the second 
step; and autonomy in the final step.  
Finally, a moderation analysis was conducted using the Hayes PROCESS Tool 
Version 3.5 (Hayes, 2012) to investigate whether perceived autonomy moderated the 
relationship between psychological reactance and engagement. Predictor variables were 
centred to improve the interpretability of the results by providing meaningful zero points 
(Aiken et al., 1991).  
Prior to conducting the analyses, the assumptions of regression were tested. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 1.533. Assumptions of 
homoscedasticity and linearity were met, as observed via a residual scatterplot between the 
model and engagement. There was no evidence of multicollinearity, as assessed by tolerance 
values of greater than 0.1. No cases had standardised residuals greater than ±3 standard 
deviations from the mean, and the value for Cook’s distance was .310, indicating there were 
no residual outliers in the data. The assumption of normal distribution of residuals was also 
accepted as illustrated by the histogram (Field, 2018). 
Results 
Participant characteristics 
 A total of 113 complete participant responses were recorded. There were some partial 
responses; 117 participants completed only demographics, SOLES, Autonomy, Mastery and 
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HPRS measures; 115 completed only demographics, SOLES, and HPRS; and 119 completed 
only demographics and SOLES. These partial responses were retained to include, where 
possible, within analyses. 
 Participant characteristics are summarised in Table 1. Participants’ mean age was 
31.47 years, ranging from 18-74, and 64.7% of participants were female. The majority of 
participants lived in the United Kingdom (53.8%) or the USA (22.7%). A large proportion of 
participants reported being White (82.4%). Approximately half the sample reported currently 
working or studying (56.2%) and currently being in a relationship (50.4%). Most participants 
lived with their partner/family or parents (63%); 21.8% reported living alone.  
 Participants (N=119) identified as having/experiencing 469 diagnoses/conditions, in 
total: 90 participants selected ‘Psychosis’; 23 selected ‘First Episode Psychosis’; 14 selected 
‘At Risk of Developing Psychosis’; 51 participants selected Schizophrenia Spectrum 
Disorder diagnoses; 63 participants reported experiencing Depression and 67 reported 
experiencing Anxiety; 43 participants selected ‘Post-Traumatic Stress Disorder’. Most 
participants reported being currently involved with a mental health team (70.6%). 
Participants identified as being/having previously been involved with 267 mental health 
services in total: 71 participants selected Community Mental Health Team; 70 selected Crisis 
Team; 35 selected Early Intervention for Psychosis Service. 71.4% of participants reported a 
history of psychiatric hospital admissions. 60.5% of participants reported having previously 
disengaged from services. 
[TABLE 1 ABOUT HERE] 
Autonomy Scale EFA 
The factorability of the items was examined. Cronbach’s alpha was .905, suggesting 
strong internal consistency; analysis showed Cronbach’s alpha would not have improved if 
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any items were deleted. The coherence of the criterion set was further supported by the 
strength of the intercorrelations among the items; all correlation coefficients were between 
.409 and .844, and were all significant (Table 2). The determinant statistic was .011, 
confirming there was no multicollinearity; this was further confirmed by the fact none of the 
correlations were above 0.9. Together these results suggested good factorability (Field, 
2018). The Kaiser-Meyer-Olkin measure of sampling adequacy was very good, at .877, above 
the commonly recommended value of .5 (Field, 2018), and Bartlett’s Test of Sphericity was 
significant (χ2(21) = 511.958, p < .001). Finally, the communalities were all above .3, further 
confirming that each item shared some common variance with other items. Given these 
overall indicators, factor analysis was deemed to be suitable with all seven items. Results of 
the principal axis factoring are shown in Table 2. Examination of the scree plot suggested a 
unidimensional structure. Indeed, a one factor solution was extracted, with an eigenvalue of 
4.486 (other eigenvalues ranged from .145 - .704). This factor accounted for 58.67% of the 
variance. Factor loadings ranged from .604 to .879. The mean Autonomy score was 17.17 
(SD = 5.55), with a range of 21.  
[TABLE 2 ABOUT HERE] 
Scale Reliabilities 
All Cronbach’s alphas were high, indicating strong internal consistencies (Gliem & 
Gliem, 2003): SOLES α = .897; Mastery α = .841; HPRS α = .847; BDSEE Criticism α = 
.773; BDSEE Emotional over involvement α = .820; BDSEE Warmth α = .909.  
Relationships between variables and engagement 
Descriptive statistics and Pearson correlations among variables are included in Table 
3. Age was not significantly correlated with engagement. There was no significant difference 
in SOLES scores between: Male and female participants (t = 1.325, p = .188); participants in 
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a relationship and those who reported being single (t = .731, p = .466); and participants who 
reported currently working and those who reported not currently working (t = -.158, p = 
.874).  
Participants who reported currently being involved with a mental health team had a 
significantly higher SOLES score (M = 7.37, SD =1.89) than participants who were not 
currently service users (M = 5.68, SD =2.04; M Difference = 1.69, 95% CI [0.9-2.48], t(115) 
= 4.245, p < .001). Participants who reported having previously disengaged from mental 
health services (M = 6.49, SD =2.13) had a significantly lower SOLES score than 
participants who reported no previous instances of disengagement (M = 7.96, SD =1.97; M 
Difference = 1.06, 95% CI [0.26-1.87], t(111) = 2.621, p = .01). The number of times 
participants reported having previously disengaged from services was significantly positively 
correlated with the time they spent with the closest person in their life (r = .386, p = .004), 
but not with any other variables. 
A one-way ANOVA showed there were significant differences in SOLES scores 
between participants who reported one, more than one or no previous psychiatric hospital 
admissions (F(3, 115) = 3.109, p = .029, η2 = .02). Tukey post hoc analysis revealed that mean 
SOLES scores were significantly lower in those who reported one previous hospital 
admission (M =7.84, SD= 1.94), compared to participants who reported no previous 
admissions (M = 6.26, SD= 2.09; M Difference = 1.57, 95% CI [0.07 to 3.07], p = .035); the 
differences between no previous admissions and more than one previous admission, and one 
admission and more than one previous admission, were nonsignificant.  
Two further one-way ANOVAs showed that there were no significant differences in 
SOLES scores depending on who the participant lives with (F(6, 112) = .436, p = .853); nor 
whom participant reported being the closest person in their life (F(4, 114) = .591, p = .670).  
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As hypothesised, SOLES score was significantly positively correlated with control 
beliefs (r = .406, p < .001) and autonomy (r = .663, p < .001); and significantly negatively 
correlated with psychological reactance (r = -.219, p = .019). However, contrary to the 
hypotheses, none of the BDSEE subscales were significantly correlated with engagement.  
[TABLE 3 ABOUT HERE] 
Relationships between other variables 
Psychological reactance was significantly negatively correlated with mastery (r = -
.269, p = .004), and significantly positively correlated with BDSEE Critical (r = .222, p = 
.018). However, reactance was not significantly correlated with autonomy or BDSEE warmth 
or emotional over involvement. Autonomy was significantly correlated with mastery (r = 
.494, p < .001). Autonomy was not significantly correlated with any of the BDSEE subscales. 
Mastery was significantly negatively correlated with emotional over involvement (r = -.201, 
p = .033), but not warmth or criticism. Length of time involved with a mental health service 
was significantly negatively correlated with criticism (r = -.245, p = .012); and time spent per 
week with the closest person in participants’ life was significantly positively correlated with 
warmth (r = .281, p = .012).  
Regression and moderation 
Full results of the regression are included in Table 4. At the first step, psychological 
reactance was found to be a significant predictor (β = -.219, p = .019), explaining 4.8% of the 
variance in engagement (F(2, 112) = 5.683, Adjusted R2  = .039). In the second step, the 
addition of mastery significantly accounted for 13.3% additional variance (F(2, 112) = 
12.355, p < .001, Adjusted R2 = .166). Mastery obtained a significant beta value (β = .378, p 
< .001), but psychological reactance was no longer significant. At the final step, the addition 
of autonomy significantly explained an additional 28.2% of the variance in engagement (F(3, 
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111) = 31.819, p < .001, Adjusted R2 = .448). Autonomy obtained a significant positive beta 
value (β = .611, p < .001); at this step, both reactance and mastery were non-significant.  In 
total, the model explained 46.2% of the variance in engagement (p < .001). These findings 
indicate that whilst psychological reactance and mastery independently predict engagement, 
when these are controlled for within regression analysis, autonomy remains the only 
significant predictor; higher perceived autonomy predicts better engagement.  
[TABLE 4 ABOUT HERE] 
Autonomy did not significantly moderate the relationship between psychological 




 This observational, cross-sectional study aimed to further understanding of 
psychological factors associated with therapeutic engagement with mental health services in 
psychosis. It was hypothesised that autonomy, psychological reactance, control beliefs and 
EE would be significantly correlated with engagement, and that together these variables 
would predict a significant amount of the variance in engagement in a regression model. This 
hypothesis was partially met; whilst EE was not significantly correlated with engagement, in 
a regression model, autonomy, psychological reactance and control beliefs significantly 
accounted for 46.2% of the variance in engagement. At the final step, autonomy was the only 
significant predictor, accounting for 28.2% of the variance in engagement. The second 
hypothesis was that perceived autonomy would significantly moderate the relationship 
between psychological reactance and engagement; this hypothesis was rejected. 
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The mean age of participants was 31.47, and the mean length of time participants 
reported being involved with a mental health team was 5.5 years. Only 35 and 23 participants 
reported having been involved with an EIS and identified as experiencing FEP, respectively. 
Community mental health and crisis teams were the services participants most reported 
being/having previously been involved with. These sample characteristics suggest that this 
sample consisted of participants with established psychosis and/or longer-term mental health 
difficulties, rather than primarily FEP as in previous studies (Doyle et al., 2014). 119 
participants reported having/experiencing 469 diagnoses/conditions in total, and as having 
been involved with 267 mental health services in total.  
Participants were given the option of providing multiple answers to these questions, to 
acknowledge that many service users feel their difficulties cannot be explained by one 
diagnosis or “label” (Forgione, 2019; Grinter, 2012), and to reflect that many people 
transition between services at different stages of treatment/illness. Every participant chose 
more than one diagnosis, and 63% of participants identified as being/having been involved 
with multiple mental health services. Whilst data did not allow for further analysis of this in a 
meaningful way, this is important to acknowledge and raises important questions. The 
literature shows that psychiatric service users experience difficulties with diagnosis, finding 
them stigmatising (Forgione, 2019). Moreover, therapeutic relationships between 
professionals and clients with psychosis are important in facilitating recovery (Tindall et al., 
2020). Transitions between services will often mean the loss of these attachments, and 
perhaps make it harder to create new ones (especially in the context of crisis teams, where 
there is often no key worker/care coordinator). Thus, the number of diagnoses clients have 
been given, or the number of times they’ve transitioned between services, could potentially 
have a significant impact on engagement; this does not seem to have been considered 
previously.  
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Here, we did find significantly lower engagement in participants who reported one 
previous psychiatric hospital admission, compared to more than one or no previous 
admissions. Although this was a small effect size, it does suggest experiences of admissions 
impact engagement. This is perhaps unsurprising. First experiences of admission could lead 
to reduced engagement due to individuals losing trust in services/professionals. Moreover, 
people may perceive their freedom/autonomy as being threatened (this would occur more in 
those high in trait reactance), and attempt to reinstate this via non-engagement. Perhaps this 
effect no longer occurs following multiple admissions, as clients might feel less able to not 
engage (perhaps due to compulsory treatment orders and/or worries of readmission). 
Although the SOLES measures therapeutic engagement, it perhaps captures this via questions 
around medication and appointment attendance. This is a tentative suggestion, but one which 
may warrant further investigation in future studies.  
Previous studies’ findings were replicated here, in that there were no associations 
between engagement and age, gender, partnership status, who the participant lives 
with/identifies as being the closest person in their life, or occupational status (Doyle et al., 
2014). Due to 82.4% of the sample identifying as White, it was not possible to examine 
differences in engagement between ethnicities. Given the known mental health disparities 
among BAME populations, and to date inconclusive findings around the impact of ethnicity 
on engagement, this remains an important focus for future research (Casey et al., 2016; Kline 
& Thomas, 2018; Solmi et al., 2018; Vahdaninia et al., 2020; Wang, 2007).  
Significantly higher SOLES scores in participants who reported being currently 
involved with a mental health service, and significantly lower scores in participants who 
identified as having previously disengaged from services, provides some reassurance as to the 
validity of the SOLES. However, the number of times participants reported having previously 
disengaged was not significantly correlated with SOLES. This is a variable that previous 
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studies have found difficult to capture (Reynolds, Brown, Tindall, et al., 2019). Perhaps 
varying engagement is an area qualitative research could explore in depth, to provide further 
insights into factors related to this.  
Independently, increased sense of control over one’s life and higher autonomy, and 
lower trait reactance, predicted better therapeutic engagement. However, EE was not 
significantly associated with engagement. When reactance, control beliefs and autonomy 
were entered into a regression model, the addition of each variable explained a significant 
increment of explained variance in engagement. However, at the final step, when autonomy 
was entered, autonomy remained the only significant predictor. The model explained 46.2% 
of the variance in engagement, with autonomy accounting for 28.2% of this. Moderation 
analysis showed that autonomy did not significantly moderate the reactance and engagement 
relationship. 
This has been the first study to investigate these variables in relation to therapeutic 
engagement in psychosis. All findings therefore contribute to understanding engagement. 
Autonomy was measured using an author-devised scale, as a scoping search of the literature 
did not identify an existing, appropriate measure. The author aimed to devise a short, 
complete and easy to administer scale, capturing the interrelated concepts of decisional 
autonomy and autonomy-support in relation to mental healthcare. The scale captures 
participants’ perceptions of whether they are supported, and therefore feel able, to make their 
own treatment decisions, and whether their views are heard and acknowledged as important 
by others. Whilst pre-EFA tests indicated the data had strong factorability and some papers 
suggest smaller sample sizes can be used in EFAs, others recommend samples >300 
(Kyriazos, 2018). However, results of the EFA showed the autonomy scale had strong 
psychometric properties, with one factor explaining a large amount of the variance (58.67%). 
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Future research into further development of this, or a new, autonomy scale is probably 
important.  
Client autonomy is infrequently given considerable attention to as a concept in its 
own right within mental health literature; it is generally implicitly considered in the context 
of treatment-related empowerment (e.g. shared decision making; Stovell, Morrison, et al., 
2016). Literature in physical healthcare has demonstrated the importance of autonomy-
support to adherence and health-related behaviour (Sandman et al., 2012). A few recent 
studies have shown that individuals with FEP experience low levels of perceived autonomy 
(Breitborde et al., 2012; Breitborde et al., 2019; Jordan et al., 2018), and that autonomy-
support is associated with increased quality of life (Browne et al., 2017). We have now 
shown that perceived autonomy in relation to mental healthcare in psychosis is predictive of 
therapeutic engagement, accounting for 28.2% of the variance alone. This emphasises the 
importance of increased research focus on autonomy, and psychological variables generally, 
in understanding (dis)engagement; and perhaps justifies a move away from predominantly 
focussing on demographic variables.  
Whilst control beliefs and reactance were no longer significant in the final step of the 
regression, their predictive value to engagement remains important. Both these variables have 
been previously found to predict psychiatric medication adherence (De las Cuevas et al., 
2016); this study extends these findings to therapeutic engagement. Mastery (control beliefs) 
and autonomy were significantly correlated, and perhaps mastery was no longer significant in 
the regression due to shared variance with autonomy; whilst different, they are highly related 
concepts. However, reactance and autonomy were not significantly correlated. This was 
expected; we measured trait reactance and state autonomy. Trait psychological reactance is 
based on the assumption that individuals vary in the strength of their needs for autonomy 
(Reynolds-Tylus, 2019). It describes a person’s likelihood of perceiving situations as a threat 
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to their freedom/autonomy, and is assumed to be a relatively stable trait (Rosenberg & Siegel, 
2018). Ungar et al. (2015) argue the role of trait reactance becomes less important when 
situational challenges restrict people’s personal freedom and autonomy, i.e. when state 
autonomy is low, trait reactance is no longer important, as the threat to freedom/autonomy 
has already occurred. Moreover, we found autonomy did not significantly moderate the 
relationship between reactance and engagement. Previous studies have found significant 
interactions between autonomy-supportive variables (e.g. provider collaboration) and trait 
reactance in predicting medication adherence (Section One). Perhaps the fact that we 
attempted to directly measure perceptions of autonomy, rather than a related autonomy-
supportive variable, impacted these findings. We also used an author-devised scale, and 
measured therapeutic engagement rather than medication adherence/attendance. Each of these 
factors may have impacted our findings. Whilst our findings may further highlight the 
importance of considering autonomy as a concept in its own right, future research 
investigating the interaction between reactance and autonomy on therapeutic engagement 
would be useful. 
Mastery and reactance were also significantly correlated with each other, with higher 
trait reactance being associated with lower beliefs of having control over one’s life. Similarly, 
EE-criticism was significantly positively associated with reactance. Perhaps individuals high 
in trait reactance are more likely to perceive others’ behaviour as controlling and criticising, 
and therefore threatening to autonomy. This may increase individuals’ beliefs that their own 
control over their life is reduced. We hypothesised that EE would significantly predict 
engagement; however, EE subscales were not significantly correlated with SOLES, nor with 
autonomy. However, autonomy here was measured in relation to mental health service 
provision, not autonomy generally – so this non-significant correlation may be 
understandable. However, the number of times participants reported having previously 
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disengaged from services was significantly positively correlated with the time they spent with 
the closest person in their life; EE-criticism was significantly negatively correlated with 
length of time participants reported having been involved with a mental health team; and EE-
emotional over involvement was significantly correlated with mastery. These findings may 
suggest that EE plays an important role in factors related to engagement. This supports recent 
findings that EE is not related to adherence in FEP (da Silva et al., 2020).  
Limitations 
This was a cross-sectional study, preventing causal relationships from being inferred. 
Moreover, this was an online sample of participants who self-reported their experiences of 
psychosis and involvement with mental health teams; thus, it is impossible to validate that 
participants were experiencing psychosis or their actual engagement levels. Furthermore, the 
sample were self-selected and may have had a particular interest in (dis)engagement and 
other relevant factors. The sample may therefore not be representative of the mental health 
service user population in general, or of service users who experience psychosis. 
 The study was originally designed to collect data through mental health services in 
the North West of England. This was not possible due to the 2019 novel coronavirus 
(COVID-19). The study design was adapted, and online data collection commenced in May 
2020 – in the midst of a global pandemic and wide-spread restrictions on people’s freedom. 
The overwhelming amount of social media posts relating to COVID-19 seemingly made it 
more difficult to advertise the study widely. Most importantly, people experiencing psychosis 
were likely faced with additional challenges during the time of data collection, likely further 
limiting opportunities for recruitment. Thus, the overall sample size in this study is smaller 
than originally hoped for. Nonetheless, it was adequately powered and significant results 
were obtained. It is also a possibility that collecting data during a global pandemic may have 
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influenced findings; for example, perceptions of autonomy in relation to mental health 
services (at a time when support was likely reduced) may have been different to usual; as 
may have control beliefs.  
There are also demographic limitations. Whilst 53.8% of participants were living in 
the UK, and 22.7% in the USA, the remaining participants either chose not to disclose their 
location, or lived in one of ten other countries. This prevented meaningful analysis of the 
relationship between location and engagement. As abovementioned, 82.4% of the sample 
were White, meaning other ethnicities were significantly underrepresented in the sample, and 
limiting the generalisability of findings across groups.  
Clinical implications and future directions 
Typically, the purpose of research into predictors of engagement in psychosis is to 
increase understanding of ways engagement can be increased. Trait reactance and control 
beliefs are important variables to consider in therapeutic engagement (De las Cuevas & de 
Leon, 2019). Psychological reactance is a social psychology construct that has been available 
in the literature for over fifty years, but is rarely used in clinical practice. Considerations of 
trait reactance and consequent adaptations to care delivery are likely commonly carried out, 
unconsciously, by clinicians. For example, providing a less-directive stance to clients whom 
clearly value autonomy (Beutler et al., 2018; Henderson et al., 2020). Further research into 
both trait reactance and control beliefs, in the context of therapeutic engagement, could 
facilitate these concepts being usefully and easily brought consciously into clinical practice to 
increase provision of person-centred care.  
Shared decision making has been shown to be beneficial, increasing medication 
adherence and treatment satisfaction (Fiorillo et al., 2020; Stovell, Morrison, et al., 2016). 
Here, we have shown the importance of client perceptions of autonomy to therapeutic 
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engagement. This suggests that the process by which shared decision making improves 
adherence and engagement is perhaps via increased perceptions of autonomy. It is important 
for services to evaluate whether they provide support in a way that promotes decisional 
autonomy and autonomy-support, and recognise barriers to this within their service. Focusing 
on reduced autonomy as a barrier to therapeutic engagement facilitates consideration of 
relational and service-level (rather than solely individual) factors that are amenable to 
change. This allows more scope for improvements in care and engagement, and increases 
acknowledgement of the responsibility of services to adapt service provision in order to 
increase engagement.  
This study has highlighted the utility of investigating psychological factors in 
engagement across all stages of illness, and encourages a future research focus on 
psychological variables. Finally, this study has measured therapeutic engagement from the 
service user perspective; one of only a few studies to do so in quantitative psychosis 
engagement research (Casey et al., 2016; Perry et al., 2019). Qualitative research has 
consistently highlighted the importance of therapeutic engagement (Tindall et al., 2018). A 
continued focus in future quantitative research on the concept of therapeutic engagement, 
rather than adherence or attendance, could facilitate increasingly relevant and meaningful 
findings. Similarly, service focus on therapeutic engagement, as opposed to solely 
attendance/attrition rates, would be more helpful for understanding how they, as a service, 
can work to increase engagement rates.  
Conclusion 
The findings of this study highlight the importance of trait psychological reactance, 
control beliefs and perceived autonomy in predicting therapeutic engagement in psychosis, 
together significantly predicting 46.2% of the variance in engagement. Measuring client 
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perceptions of autonomy in relation to mental healthcare in psychosis is clearly important. 
Findings highlight the importance of considering psychological variables in predicting 
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Tables 







Length of time 





































































Ethnicity White British/Irish 
White Other 
Mixed Multiple (any other mixed ethnic background) 
Mixed Race – White and Black African/Caribbean 
Asian 
Black African/Caribbean 
Mixed Race – White and Asian 
Other 




















Occupational status Working 


















Partnership status Single 
Married/Civil Partnership 
Living together 
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in total.  
Psychosis 
First Episode Psychosis 








Post-Traumatic Stress Disorder 
Personality Disorder (any type) 
Obsessive Compulsive Disorder 
Other 
Other - Psychotic Depression 
Other - Cannabis Induced Psychosis  
Other – Psychotic Disorder NOS 
Other – Dissociative Identity Disorder 
Other – Other Specified Dissociative Disorder 
Other – Complex Post Traumatic Stress Disorder 
Other - Anorexia 
Other - ADHD 































































Type of mental health 
service 
currently/previously 
involved with  
 
NB: 119 participants 
identified as 
being/having been 
involved with 267 
mental health services 
in total 
Community Mental Health Team 
Crisis Team / Home Based Treatment Team 
Early Intervention for Psychosis Service 
Assertive Outreach Team 
Rehab Team 
Prefer not to say 
Other 
Other – ‘Inpatient mental health service’ 
Other – ‘Therapy’ 
Other - ‘Psychiatrist’ / ‘Psychologist’ / ‘Therapist’ 
Other – ‘A&E crisis liaison’ 
Other – ‘Charity mental health service’ 
Other ‘Substance Misuse Service’ / ‘Mental health 































hospitalised due to 
mental health 
One previous admission 
More than one previous admission 
No previous admissions 
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Previous instances of 
disengagement from 
mental health services 
Yes 
No  
Prefer not to say 
 
No. of times if yes (N=56 responses):     1-5 
                                                                 6-10 
                                                                 10-40 















Who participant lives 
with 
Partner / Family 
Parent(s) 
Alone 
Friend / Roommates 
Carers 
















most supports them 


























spending with this 
person per week 
 (N=113) 
 Mean = 35.92 
SD = 37.51 
Range = 153 
Minimum - Maximum = 0 - 153 
 










1 2 3 4 5 6 7 
1. I feel in control 
of what the mental 
health service 
provides for me 
.879 - .421*** .409*** .538*** .606*** .650*** .643*** 
2.  I decide what 
treatments to take, 
not other people 
.858 - - .426*** .528*** .443*** .584*** .540*** 
3.  Other people 
tell me what to do 
about my mental 
health 
.824 - - - .607*** .488*** .443*** .487*** 
4.  Other people 
make decisions 
about my mental 
health without my 
input 
.808 - - - - .745*** .646*** .667*** 
5.  People ignore 
what I want to do 
about my mental 
health 
.713 - - - - - .646*** .702*** 





.626 - - - - - - 
 
.844*** 
7.  I feel supported 
to make my own 
informed treatment 
decisions 
.604 - - - - - - - 
 
*** = p<.001 
a Eigenvalue = 4.486; percent of variance = 58.67%. 
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Table 3 
Means, standard deviations, ranges, and Pearson’s correlation coefficients among variables 
 1 2 3 4 5 6 7 8 9 10 11 













p = .019 
N=115 
.663*** 
p < .001 
N=117 
.406*** 











2. Age - - .453*** 


























3. Length of time 
involved with mental 
health team 
(months) 
























4. Number of times 
previously 
disengaged 
- - - - .386** 




















5. Time spent with 
closest person per 
week (hours) 
























p = .004 
N=115 
.222* 

































9. BDSEE Critical - - - - - - - - - 
 
-.380*** 
p < .001 
.756*** 
p < .001 





Hierarchical regression of engagement on psychological reactance, mastery and autonomy variables 
 


























































































10. BDSEE Warm - - - - - - - - - - 
 
-.328*** 
p < .001 
N=113 
11. BDSEE Emotional 
over involvement 






































* p < .05 
** p < .01 
*** p < .001 
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The reference style used by the journal will be applied to the accepted article by Elsevier at 
the proof stage. Note that missing data will be highlighted at proof stage for the author to 
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your manuscript is submitted with double spacing applied. There are no other strict 
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Provide the full postal address of each affiliation, including the country name and, if 
available, the e-mail address of each author. 
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systems. Please use a concise and informative title (avoiding abbreviations where possible). 
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Highlights are optional yet highly encouraged for this journal, as they increase the 
discoverability of your article via search engines. They consist of a short collection of bullet 
points that capture the novel results of your research as well as new methods that were used 
during the study (if any).  
Highlights should be submitted in a separate editable file in the online submission system. 
Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 
characters, including spaces, per bullet point). 
Abstract 
An abstract of up to 300 words must be included in the submitted manuscript. An abstract is 
often presented separately from the article, so it must be able to stand alone. It should state 
briefly and clearly the purpose and setting of the research, the principal findings and major 
conclusions, and the paper's contribution to knowledge. For empirical papers the 
country/countries/locations of the study should be clearly stated, as should the methods and 
nature of the sample, the dates, and a summary of the findings/conclusion. Please note that 
excessive statistical details should be avoided, abbreviations/acronyms used only if essential 
or firmly established, and that the abstract should not be structured into subsections. Any 
references cited in the abstract must be given in full at the end of the abstract. 
Keywords 
Up to 8 keywords are entered separately into the online editorial system during submission, 
and should accurately reflect the content of the article. Again abbreviations/acronyms should be 
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Authors of empirical papers are expected to provide full details of the research methods used, 
including study location(s), sampling procedures, the date(s) when data were collected, 
research instruments, and techniques of data analysis. Specific guidance on the reporting of 
qualitative studies are provided here. 
Systematic reviews and meta-analyses must be reported according to PRISMA guidelines. 
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relevant text in the article, or on separate page(s) at the end. Number tables consecutively in 
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reference management software products. These include all products that support Citation 
Style Language styles, such as Mendeley. Using citation plug-ins from these products, 
authors only need to select the appropriate journal template when preparing their article, after 
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template is yet available for this journal, please follow the format of the sample references 
and citations as shown in this Guide. If you use reference management software, please 
ensure that you remove all field codes before submitting the electronic manuscript. More 
information on how to remove field codes from different reference management software. 
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any style or format as long as the style is consistent. Where applicable, author(s) name(s), 
journal title/ book title, chapter title/article title, year of publication, volume number/book 
chapter and the article number or pagination must be present. Use of DOI is highly encouraged. 
The reference style used by the journal will be applied to the accepted article by Elsevier at the 
proof stage. Note that missing data will be highlighted at proof stage for the author to correct. 
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Reference style 
Text: All citations in the text should refer to: 
Single author: the author's name (without initials, unless there is ambiguity) and the year of 
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Two authors: both authors' names and the year of publication; 
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Issues surrounding the conceptualisation and measurement of engagement, autonomy 
and psychological reactance constructs. 
This thesis has considered the predictive value of psychological factors to healthcare 
engagement, with a key focus upon psychological reactance and autonomy. Throughout the 
completion of both papers, consideration of issues associated with conceptualising, 
operationalising and measuring these complex, multidimensional constructs has been 
important. Issues regarding defining and measuring psychological constructs are frequently 
important and necessary to consider, where the phenomena under investigation often do not 
permit direct observation. Whilst the practice of measuring and quantifying complex, 
unobservable psychological constructs and processes is ubiquitous in psychological sciences, 
the validity and appropriateness of such practice is often questioned and criticised (Maree, 
2019; Maul et al., 2016). This is based on various philosophical and scientific issues, but a 
common remark is often around lack of agreement amongst researchers concerning the 
meaning and measurement of psychological concepts. For example, there remains 
controversy and disagreement around even very high-profile constructs such as “intelligence” 
and “depression” (Maul et al., 2016). Furthermore, despite the foundational role that 
measurement plays in the ability to draw conclusions from research, important information 
regarding measurement is often absent from manuscripts, sometimes without even a 
description of what the measure included (e.g. questionnaire items not reported). These issues 
have resulted in increased emphasis on the importance of researchers avoiding questionable 
measurement practices and increasing transparency (Flake & Fried, 2019). In light of this, 
and given the multidimensional and complex nature of engagement, autonomy and 
psychological reactance constructs, this paper aims to further discuss and reflect on the 





 A key discussion point in both papers was around the conceptualisation and 
measurement of “engagement”, with previous research having acknowledged that there is no 
one gold-standard (or even generally accepted) definition or measurement of engagement 
(Reynolds et al., 2019). As has been discussed, this is reflective of the complexity of 
engagement as a construct. Throughout this thesis, the term engagement has been used 
broadly, like an “umbrella-term”, to encapsulate all factors that have previously been 
associated with healthcare engagement. The term engagement has therefore been used to 
refer to adherence (to medication and physician recommendations), attendance, drop-out and 
therapeutic engagement. Indeed, this was necessary for the literature review, where included 
papers were required to have measured at least one of these aspects of engagement. In 
contrast, the empirical paper attempted to measure therapeutic engagement via a self-report 
questionnaire – the Singh O’Brien Level of Engagement Scale (SOLES; O’Brien et al., 
2009).  
Adherence, attendance and drop-out are discrete constructs that lend themselves to 
being measured objectively and categorically (attends vs does not attend, adherent vs non-
adherent). Self-report measures of adherence are also commonly utilised (e.g. Morisky 
Medication Adherence Scale; Morisky et al., 2008).Whilst there are some questions as to the 
validity of such scales, the wide utilisation of these at least provides some consistency, 
allowing stronger conclusions to be drawn (Basu et al., 2019; Tan et al., 2014). Categorical 
conceptualisations of engagement via attendance and adherence are perhaps more relevant 
and meaningful in physical healthcare research, and especially in the context of acute 
illnesses or where healthcare provision primarily involves periodically required attendance at 
appointments. For example, the literature review included papers measuring engagement via 
adherence to antibiotic treatment/recommendations (Fogarty & Youngs, 2000; Smith et al., 
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2018) and attendance at colposcopy clinic appointments (Orbell & Hagger, 2006); for these, 
and similar study designs, it is clearly not necessary (or perhaps even appropriate) to 
consider/measure therapeutic engagement. 
The issue becomes more complex in relation to mental healthcare (and chronic 
physical health illnesses). Within mental healthcare literature, with good reason, many 
researchers are only interested in investigating engagement via the discrete constructs of 
adherence and/or attendance. Indeed, these are individually important constructs for many 
reasons, and it is certainly important to understand factors that predict and improve 
psychiatric medication adherence and appointment attendance in mental healthcare (Karpov 
et al., 2018). However, as discussed in Sections One and Two, the concept of engagement in 
mental healthcare is more complex than just attendance or adherence. Within psychosis 
literature, engagement being a relational process, rather than an outcome, is frequently 
acknowledged within papers’ discussions of the concept and of why understanding 
(dis)engagement is important – although, a recent review found that, despite this, psychosis 
studies tend to measure engagement via categorical, binary methods (Reynolds et al., 2019).  
Unique to mental healthcare is a legal framework by which service users can be given 
compulsory treatment, and the nature of illnesses often means service users’ 
clinical/cognitive insight and capacity to make treatment-related decisions is reduced (Owen 
et al., 2016). Thus, issues and impacts of control, coercion and power asymmetry in mental 
healthcare are widely recognised in both research and clinical practice (McKeown et al., 
2019). This context is therefore unique in that service users may feel they have to attend 
appointments and/or adhere to medication (which frequently also entails attendance at clinics 
e.g. for antipsychotic depot injections). As such, categorical measurement methods may not 
reflect that some service users attend reluctantly, or are passive recipients of, rather than 
active participants in, their healthcare. Indeed, it has been suggested that coercive/compulsory 
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treatment may increase medication adherence, but reduce therapeutic engagement (Hotzy & 
Jaeger, 2016; James & Quirk, 2017). Alternatively, service users may actively participate in 
some aspects of treatment (e.g. group therapy), but not others (e.g. pharmacological 
treatment).   
This is important, because within models of service delivery, it is acknowledged that 
not only medication adherence and/or appointment attendance alone lead to “recovery”. For 
example, Early Intervention for Psychosis Services (EIS) involve pharmacological, 
psychological, social, occupational and educational interventions, with a key focus upon 
service user engagement, to enable recovery (Singh, 2010). Whilst it is often clear what the 
interventions themselves entail, what is meant by a focus upon engagement is not. Are EIS 
focused upon service users attending appointments, adhering to medication, participating in 
treatment discussions/decisions, being committed to working towards goals/recovery? Are 
some of these domains of engagement deemed more important than others within EIS? 
Certainly with regards to psychological therapy interventions, literature recognises engaging 
involves various factors, including attendance, therapeutic alliance, emotional involvement 
during sessions, completion of between-session tasks, self-disclosure of thoughts, emotions 
and difficulties, as well as clients’ confidence in the intervention being effective and 
commitment to treatment (Yoskowitz, 2018). This highlights the necessity of a therapeutic 
understanding of engagement, if research is to effectively identify ways engagement can be 
improved.  
Clearly, therapeutic engagement is a complex construct and one which is difficult to 
conceptualise. Whilst it is widely acknowledged that service users being therapeutically 
engaged with mental health services is different to attending appointments/adhering to 
medication, the additional factors that are involved in being therapeutically engaged are less 
clear. O’Brien et al. (2009) suggest therapeutic engagement is often conflated with 
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therapeutic alliance; and note that therapeutic engagement is related to individuals’ 
relationships with/attitudes towards a service, rather than individual professionals. O’Brien et 
al. (2009) go on to suggest therapeutic engagement (additionally to adherence/attendance) 
encompasses “the acceptance of a need for help, the formation of a therapeutic alliance with 
professionals, satisfaction with the help already received and a mutual acceptance of and 
working towards shared goals”. Indeed, this is in line with qualitative research findings of 
what the “essential ingredients” of engagement in First Episode Psychosis (FEP) are – 
treatment meeting the service user’s perceptions of their own needs, reduced control and 
coercion in treatment provision and promoting empowerment, and therapeutic alliance 
(Tindall et al., 2018). However, it is noteworthy that in qualitative research findings, there is 
often not a distinction between what therapeutic engagement is, and the factors that promote 
service users being therapeutically engaged, with a seemingly implicit assumption that what 
facilitates therapeutic engagement is therapeutic engagement (e.g. therapeutic relationships). 
Perhaps this overlap is what makes therapeutic engagement so difficult to conceptualise. 
Moreover, such relational phenomena will vary widely between individuals. Thus, the 
conceptualisation of therapeutic engagement remains ambiguous, and differs across studies 
(Bright et al., 2015). However, across studies there is agreement that therapeutic engagement 
is a relational process, rather than static behaviour(s), and common themes have been 
identified, including: therapeutic relationships, treatment satisfaction, adherence, attendance, 
perceived need for treatment, patient availability/collaboration, and help-seeking (Bright et 
al., 2015).  
Despite researchers not yet having agreed upon a definition of therapeutic engagement in 
mental healthcare, quantitative measures have been devised; most notably, the SOLES 
(O'Brien et al., 2009) and the Service Engagement Scale (Tait et al., 2002). The self-report 
SOLES was designed to measure engagement with services for people who experience 
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psychosis. Items were developed representing concepts related to engagement: attendance, 
satisfaction, therapeutic alliance, insight and adherence. The original paper showed that the 
SOLES had good predictive validity in terms of longitudinal disengagement, cross-sectional 
disengagement and appointment attendance. However, this was a relatively small sample for 
scale development (N = 184), and there appear to have been no further studies 
investigating/validating the psychometric properties of the SOLES. Our research paper did 
find significantly higher SOLES scores in participants who reported being currently involved 
with a mental health service, and significantly lower scores in participants who identified as 
having previously disengaged from services, providing a small amount of reassurance as to 
the validity of the SOLES. Moreover, the SOLES has not been widely utilised. Google 
Scholar states that the original paper has been cited 31 times, and only two previous studies 
employing the SOLES within psychosis research were identified - in one study investigating 
treatment beliefs and engagement in FEP (Perry et al., 2019), and in another investigating 
predictors of engagement with EIS (Casey et al., 2016).  
When originally designing the research study, it was planned that the Service 
Engagement Scale (Tait et al., 2002) would be utilised. However, this scale is clinician-rated, 
and upon further discussion with clinicians, it seemed this would perhaps significantly impact 
recruitment; care coordinators have extremely high workloads, and time/motivation to 
complete this scale would have likely not been often available. Thus, I opted to utilise the 
SOLES due to it being self-report. Another advantage of using the SOLES is that it provides 
an opportunity to measure engagement from the service user perspective; arguably the most 
important perspective, and one which is lacking within engagement literature (Bright et al., 
2015). Although the SOLES has not been extensively validated, given the advantages of 
being self-report and therefore relatively easy to administer/incorporate in study designs, and 
gaining service user ratings of engagement, it is somewhat surprising it has not been 
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employed more widely. This is perhaps reflective of engagement in psychosis research still 
being a relatively new area of literature, and with many studies focusing on disengagement 
using prospective designs, where data have previously been routinely collected. 
In contrast, the clinician-rated Service Engagement Scale (Tait et al., 2002) has been 
employed more widely, with 207 citations on Google Scholar. This scale was designed to 
measure engagement with Community Mental Health Services, and was originally validated 
on a sample of five community psychiatric nurses completing the scale for 66 service users of 
Assertive Outreach Teams, all of whom had received schizophrenia-spectrum diagnoses. The 
Service Engagement Scale measures provider reports of client availability, collaboration, help 
seeking, and adherence. The authors demonstrated that the scale had good internal 
consistency, test re-test reliability and construct validity (via the criterion group method, 
showing the scale was capable of distinguishing between groups of clients based on their 
level of engagement with services). Whilst this has been employed more widely than other 
scales, its psychometric properties do not seem to have been investigated further in 
subsequent studies.  
More recently, Kline et al. (2018) conducted a pilot study to validate a new measure of 
engagement with EIS; the Client Engagement and Service Use Scale (CENSUS). The authors 
state that whilst the Service Engagement Scale has been employed widely, it is narrow in 
focus and is limited due to not considering the service user perspective; thus, they state the 
Service Engagement Scale is poorly suited to the purpose of assessing engagement within 
EIS models of care (integrated, multi-component models), and acknowledge that clients may 
be “engaged” in some aspects of a service (e.g. psychological therapy) and poorly engaged 
with others (e.g. medication). The authors attempted to create a scale that could account for 
differences in engagement across various treatment components, conceptualise engagement 
as a process rather than a binary construct, and be used clinically to address both client and 
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provider perspectives of engagement in speciality care for FEP. The CENSUS is a 
questionnaire to be completed in a semi-structured interview with a client, with the aim that 
the measure would also facilitate an open conversation with clients about their specific needs 
and concerns, thus encouraging better engagement. Scores are obtained for engagement with 
different domains of treatment, based on scoring guidelines anchored in behavioural 
observations. This pilot study suggested strong inter-rater reliability and construct validity 
when considered in relation to appointment attendance and Service Engagement Scale scores. 
However, the sample was extremely small, with only six participants. This paper does not 
seem to have yet been cited in subsequent research; indeed, whilst it is reported it is suitable 
for research use, it seems it may be more useful clinically. Nonetheless, this scale is useful in 
providing new considerations of how to approach measurement of therapeutic engagement 
with EIS. Moreover, if it became utilised more widely in a clinical capacity, this would 
perhaps allow for results to be used in research, too.  
Other scales have been developed to measure therapeutic engagement in mental 
healthcare. Hall (2001) developed a clinician-rated measure of engagement, assessing 
domains of appointment keeping, client-keyworker relationship, communication/openness 
with keyworker, usefulness of treatment, involvement with treatment and medication 
adherence. The scale was validated on a sample of 44 keyworker-client dyads from 
community psychiatric rehabilitation services, and the authors stated it had good test re-test 
reliability and discriminant capacity. Gillespie et al. (2004) adapted Hall’s (2001) measure to 
be client-rated, measuring the same engagement domains. Gillespie (2004) validated the 
client-rated scale with 25 assertive outreach clients; they found good test re-test reliability, 
but found the client-rated version did not correlate with the clinician-rated version (this 
provides further evidence for the likely importance of capturing service user perspectives). 
Meaden et al. (2012) developed the clinician-rated Residential Rehabilitation Engagement 
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Scale as a measure of engagement in inpatient mental health rehabilitation services. The scale 
measured quality of relationships, patient communication and openness, goal-setting, 
perceived usefulness of rehabilitation, collaboration with rehabilitation, appointment keeping 
and adherence. The scale development sample consisted of 92 service users; the authors 
reported good internal consistency and test re-test reliability. These three scales have not been 
widely employed or cited, and little evidence for their validity has been reported. However, 
they do show similarities in the approach to therapeutic engagement scale development with 
the SOLES, Service Engagement Scale and CENSUS.  
Whilst therapeutic engagement research within psychosis is still at an early stage, it is 
clear that conceptualising, and attempting to measure, engagement in this way is important. 
Continuing to attempt to understand how engagement can be improved via only measuring 
adherence/attendance will significantly limit the clinical utility of research. Qualitative 
research that focuses on understanding the experiences and perspectives of service users, 
families and service providers in relation to service engagement has been, and will continue 
to be, important in furthering understanding. Hopefully, there will be continued future 
research focus on developing an operational and patient-oriented definition of engagement, as 
well as reliable and valid measures of therapeutic engagement – with the aim of developing 
understanding of how engagement can be increased, and therefore outcomes improved.  
Autonomy 
 As discussed in Section Two, perceptions of autonomy are important to consider in 
relation to engagement with services in psychosis. Researchers have distinguished between 
different types of perceptions of autonomy (Arrieta-Valero, 2019), but in relation to 
perceptions of autonomy in mental healthcare, perceptions of decisional autonomy and 
autonomy-support seem most pertinent. Decisional autonomy refers to service users’ freedom 
to deliberate and choose a course of action/treatment from among a suitable range of options. 
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For mental health service users, decisional autonomy is dependent, at least in part, upon 
experiences of autonomy-support. Autonomy-support refers to the extent to which 
individuals feel empowered and supported to make informed choices based on their own 
values and preferences; Arrieta-Valero, 2019; Hagger & Protogerou, 2020). Within mental 
healthcare literature, autonomy is generally implicitly considered in relation to treatment-
related empowerment (e.g. shared decision making) or experiences of control and coercion, 
and is rarely considered or measured as an individual construct. Thus, it seems to be assumed 
that experiences of autonomy-support (via approaches such as shared decision making) 
increase perceptions of autonomy (a dimension of treatment-related empowerment), and 
therefore improve outcomes (including increased engagement) – although this does not 
appear to have been measured previously (De las Cuevas, Peñate, & de Rivera, 2014; Fiorillo 
et al., 2020). Moreover, only one previous psychosis study has actually measured perceptions 
of autonomy-support (Browne et al., 2017), and none were identified that considered 
decisional autonomy.  
 In physical healthcare literature, perceptions of autonomy-support are generally 
measured via the Health Care Climate Questionnaire (HCCQ; Williams et al., 2000). The 
HCCQ measures patients’ perceptions concerning the extent of autonomy support provided 
by their health care providers. According to Williams et al. (2000), autonomy-support in 
health care settings “refers to providers’ interacting with patients by taking full account of 
their perspectives, affording choice, offering information, encouraging self-initiation, 
providing a rationale for recommended actions, and accepting the patients’ decisions”. The 
HCCQ was designed to assess these specific aspects of autonomy-support in healthcare 
environments. The full version includes 14 items, but the brief six-item version is used 
widely. This includes items: “I feel that my physician has provided me choices and options”; 
“I feel understood by my physician”; “My physician conveys confidence in my ability to 
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make changes”; “My physician encourages me to ask questions”; “My physician listens to 
how I would like to do things”; and “My physician tries to understand how I see things before 
suggesting a new way to do things”. It has good validity and reliability with respect to 
internal consistency, structural validity and construct validity, as well as acceptable test re-
test reliability (Czajkowska et al., 2017).  
 Whilst this seems a good measure, the present research study focussed on perceptions 
of autonomy in relation to services, not one physician - although, it would have perhaps been 
feasible to amend questions to begin with “Mental health professionals”. Importantly, I 
wanted to capture participants’ perceptions of decisional autonomy, as well as autonomy-
support. As can be seen in the HCCQ’s items, none capture respondents’ perceptions of 
whether they feel able to make their own treatment decisions. Thus, after consideration of the 
literature, we devised a scale with inclusion of items aimed to measure decisional autonomy, 
as well as items designed to measure perceptions of autonomy-support. Due to the cross-
sectional nature of the study, it was not possible to measure the validity or test-retest 
reliability of this scale. However, preliminary Exploratory Factor Analysis indicated a 
unidimensional structure, accounting for 58.6% of the variance. Moreover, this scale 
significantly predicted 28.2% of the variance in engagement (SOLES) alone. Thus, whilst the 
psychometric properties of this scale are indeed both unclear and questionable, the research 
findings (and a review of the literature) highlight that considering and measuring autonomy is 
important – and perhaps justifies a move away from implicitly assuming its role in relation to 
various outcomes, including engagement. By only implicitly acknowledging it, we may be 
conflating other variables with autonomy. For example, control beliefs are likely highly 
related to autonomy (as was evidenced by finding a significant correlation between autonomy 
and control beliefs, r = .494, p < .001); indeed, the first item on the autonomy scale is, “I feel 
in control of what the mental health service provides for me”. Further conceptualisation of 
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autonomy, in relation to other important factors in psychosis research, would be useful; as 
would further consideration of the appropriateness of measuring autonomy in psychosis 
research, and how best to undertake this. 
Psychological Reactance 
It has been argued that research into trait psychological reactance is understudied and 
underutilised; and that one reason for this may be confusion regarding its measurement (Yost 
& Finney, 2018). The measurement of trait psychological reactance is inherently complex 
due its multidimensional nature (Rosenberg & Siegel, 2018). Thus, the factor structure and 
validity of reactance scales has been queried, as has the validity of trait reactance as a 
construct in itself (as discussed in Section One). It has been suggested that future research 
acknowledging and potentially addressing these queries could improve the validity of both 
the construct and its measurement (Rosenberg & Siegel, 2018). However, the psychometric 
properties of trait psychological reactance measures are rarely adequately considered in 
clinical and health psychology research studies. Thus, here I will briefly outline the current 
state of evidence regarding the measurement of trait reactance.   
 A scale used in early studies, the Questionnaire for the Assessment of Psychological 
Reactance (QMPR; Merz, 1983) was deemed psychometrically unstable. The now most 
widely used scales of trait psychological reactance are the Hong Psychological Reactance 
Scale (HPRS; Hong & Page, 1989) and the Therapeutic Reactance Scale (TRS; Dowd, Milne 
& Wise, 1991); both developed in response to the limitations of the QMPR (Rosenberg & 
Siegel, 2018) - although the TRS was designed with intent for use within psychotherapy 
settings, it measures trait reactance generally. Only two studies (since scale development) 
have investigated the validity and factor structure of the TRS; Buboltz Jr et al. (2002) 
concluded that psychological reactance is a multidimensional construct and cannot be 
adequately assessed by a single dimension (TRS-total score), nor by the two originally 
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proposed TRS Verbal and Behavioural subscales. Buboltz Jr et al. (2002) advise caution 
utilising the TRS, and propose that, if used, a four factor solution is most appropriate, with 
subscales: Resentment of authority, Susceptibility to influence; Avoidance of conflict; and 
preservation of freedom. Inman et al. (2019) replicated these findings.  
The HPRS was originally proposed as having four factors (emotional response toward 
restricted choice, reactance toward compliance, resisting influence from others, and reactance 
toward advice and recommendations), although researchers often report a total HPRS score 
(Yost & Finney, 2018). Recently, numerous studies have demonstrated that a bifactor model 
is the best fit for the HPRS, but that a total HPRS score is appropriate as an overall index of 
trait reactance (Brown & Finney, 2011; Brown et al., 2011; Moreira et al., 2020; Waris et al., 
2020; Yost & Finney, 2018). Moreover, studies have also found strong correlations between 
the HPRS and TRS (Inman et al., 2019; Moreira et al., 2020; Waris et al., 2020). Yost and 
Finney (2018) report that trait reactance is a broad unidimensional construct that becomes 
multidimensional when operationalised in the HPRS, with multiple factors emerging in past 
research because the HPRS items, worded purposefully to be heterogeneous, converged into 
artefact factors based on similar wording, content, or both. However, it is noteworthy that in a 
large sample of psychiatric patients, De las Cuevas, Peñate, Betancort, et al. (2014) found 
evidence for a two factor solution to the HPRS, comprising of cognitive and affective factors, 
with the one-factor solution being unverifiable. The authors suggest the nature of their 
sample, with mostly “affective disorders”, may have influenced results – with an emotional 
method of processing information (as opposed to cognitive) being “over-represented” in the 






This thesis has investigated and measured constructs that are complex and 
multidimensional in nature; a practice that inherently presents methodological issues to 
consider. This paper has attempted to address these methodological concerns further, through 
further discussions around the conceptualisation and measurement of engagement, autonomy 
and reactance constructs; alongside some reflections of how these issues related to the 
research conducted and subsequent findings. Overall, despite methodological issues and the 
complexity of constructs measured, this thesis has provided unique contributions to the 
healthcare engagement research literature, and has been successful in gaining further insights 
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Introduction 
People experiencing psychosis benefit from long-term, recovery-oriented support 
from multi-disciplinary services to achieve improvements in mental health and quality of life 
(Kreyenbuhl, Nossel, & Dixon, 2009). To provide this support, it is important for services to 
be able to fully engage a person in the service being offered (Tibbo, 2015). However, it is 
recognised that many clients choose to disengage from services (or aspects of it), and this 
presents an important clinical challenge for services and researchers to consider (O'brien, 
White, Fahmy, & Singh, 2009) 
Disengagement from mental health services for people experiencing psychosis has 
been the focus of much research (Doyle et al., 2014; Kreyenbuhl et al., 2009). This research 
recognises the challenges inherent in measuring and researching (dis)engagement due to it 
being a complex and multifaceted concept (Doyle et al., 2014). Following discussion of 
differences in operationalizing and measuring engagement, Doyle et al. (2014) commented on 
the distinction between engagement in the literal sense of appointment attendance or 
recommended intervention, and the more intangible concept of therapeutic engagement. In a 
systematic review, O'brien et al. (2009) concluded that engagement should be seen as a more 
“complex phenomenon” encompassing factors that include “acceptance of a need for help, 
the formation of a therapeutic alliance with professionals, satisfaction with the help already 
received, and a mutual acceptance and working towards shared goals".  
The research on engagement in psychosis is focused primarily upon first-episode 
psychosis (FEP) and early intervention for psychosis services (EIS). This is based on the 
rationale that the initial stages of support received when experiencing psychosis are crucial in 
terms of longer-term outcomes, making facilitating engagement a priority for EIS (Fusar‐
Poli, McGorry, & Kane, 2017). Despite the difficulties in researching disengagement, the 
general consensus is that clients are at high risk of disengagement, with disengagement rates 
ETHICS PROPOSAL      4-13 
around one in three for EIS (E. Brown et al., 2019; Doyle et al., 2014).  In contrast to the 
benefits shown to be associated with engagement, disengagement from EIS has been 
associated with poorer clinical outcomes, including increased levels of perceived distress, 
increased risk of relapse and persistent psychotic symptoms (Doyle et al., 2014; Turner, 
Boden, Smith‐Hamel, & Mulder, 2009). Disengagement is associated with substance use, low 
severity of illness at baseline, past forensic history, unemployment, duration of untreated 
psychosis and lack of family support during treatment (see Doyle et al., 2014 for a review).  
The above findings emphasise the importance of the issue of engagement in EIS. 
However, the literature’s predominant focus upon EIS and prevention (Fusar-Poli, 2017) 
seems to have been at the cost of sufficient attention being paid to the issue of engagement in 
longer-term psychosis. An underlying assumption of mental health services is that people 
experiencing serious mental health difficulties require services’ help to achieve improvements 
in their mental health. However, it has been recognised that community mental health teams 
(CMHTs) experience difficulties in engaging people who have received psychosis-related 
diagnoses (Edwards, Macpherson, Commander, Meaden, & Kalidindi, 2016). Thus, 
understanding factors that impact engagement at all stages of psychosis is important.  
Generally, research on the correlates of service engagement in people with psychosis 
has largely focused on demographic (e.g. age, gender) or clinical correlates (e.g. symptoms, 
insight) (Nose, Barbui, & Tansella, 2003). However, more recently, significant associations 
have been found between service engagement and explanatory psychological concepts. 
Interestingly, these studies tend to include people experiencing longer-term psychosis as well 
as individuals in the early stages – thus, research into psychological factors recognises the 
importance of these at all stages of illness. Studies have investigated associations between 
engagement and recovery style (Tait, Birchwood, & Trower, 2003); illness perceptions 
(Casey et al., 2016; Williams & Steer, 2011); stigma (Clement et al., 2015; Hack, 
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Muralidharan, Brown, Drapalski, & Lucksted, 2019; Tsang, Fung, & Chung, 2010); 
attachment (MacBeth, Gumley, Schwannauer, & Fisher, 2011); and experiences of childhood 
abuse (Lecomte et al., 2008; Spidel, Lecomte, Greaves, Sahlstrom, & Yuille, 2010). These are 
all important clinical variables, but general social psychological principles of why people 
generally engage or disengage from adaptive behaviours have largely been ignored.  
Two potential psychological variables of interest are perceptions of autonomy and 
psychological reactance. Psychological reactance is a motivational state that can develop 
when a person perceives there is a threat to their personal freedom/autonomy (Brehm, 1966; 
Miron & Brehm, 2006). Reactance functions to reinstate an individual’s perceptions of 
autonomy, often through restoring the behaviour that is being threatened (Shen & Dillard, 
2005). Sense of autonomy is therefore closely linked to reactance, in that when sense of 
autonomy reduces, reactance is likely to increase. Client autonomy is an important concept; 
people who experience psychosis have identified empowerment and autonomy as key factors 
in their recovery (Perkins, 2001; Ramon, Healy, & Renouf, 2007). Moreover, increasing 
patient choice can help engagement and trust with services (De las Cuevas, Peñate, & de 
Rivera, 2014; Dixon, Holoshitz, & Nossel, 2016; Laugharne, Priebe, McCabe, Garland, & 
Clifford, 2012; Lobban, 2012). However, it is acknowledged that within the delivery of 
mental health services, there are often significant power differentials between clinicians and 
clients, with clients sometimes feeling they are being coerced into treatment (Grinter, 2012; 
Laugharne et al., 2012). In a qualitative study, Grinter (2012) found clients experiencing 
psychosis reported difficulties with constraints of medication prescribing, diagnostic labelling 
and stigma. In response to these difficulties, clients often rejected clinician advice or refused 
treatment. Grinter (2012) explained these responses as acts of reactance that aimed to 
challenge clinicians’ power and authority, and reinstate client autonomy. Whilst there are 
measures available to quantitatively measure reactance, these have not been used in relation 
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to engagement. However, they have been used to demonstrate reactance as a significant 
predictor of medication non-adherence in both psychosis and depression (De las Cuevas, de 
Leon, Peñate, & Betancort, 2017; De las Cuevas, Peñate, Betancort, & de Rivera, 2014; 
Fogarty & Youngs Jr, 2000; Madsen, McQuaid, & Craighead, 2009; Moore, Sellwood, & 
Stirling, 2000).  
Reactance was originally investigated as a state phenomenon, although it is now 
evident that individuals are likely to vary in their trait propensity to experience reactance; this 
is based on the assumption that people vary in the strength of their needs for autonomy and 
self-determination (Shen & Dillard, 2005). Although psychological reactance has been 
understood for over fifty years, this potentially useful construct has received little attention in 
the clinical psychology literature, and is rarely used consciously in clinical practice (De las 
Cuevas, Peñate, Betancort, et al., 2014). However, it makes theoretical sense that the (often 
intensive) support provided by mental health services may, at times, be perceived by clients 
as reducing their sense of autonomy, which may evoke reactance and lead clients to 
disengaging from (aspects of) the service. In a time where engagement is increasingly being 
recognised as important, as well as the impact of collaborative care on this (Dixon et al., 
2016), the impacts of autonomy and reactance are worth exploring further.  
Patterns of family interactions are another area of potential importance related to 
autonomy, psychological reactance and engagement. Crucially, the manner in which family 
members respond to the person’s experience of psychosis has considerable influence on client 
wellbeing and long-term outcomes (Claxton, Onwumere, & Fornells-Ambrojo, 2017). High 
levels of critical comments, hostility and/or emotional over-involvement in family members 
(commonly known as high expressed emotion [EE]) are associated with poorer service user 
outcomes, including more frequent relapse and hospital admissions (Cechnicki, Bielańska, 
Hanuszkiewicz, & Daren, 2013). High-EE relatives of people experiencing psychosis act in 
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more controlling ways in comparison to low-EE relatives (e Sa, Wearden, & Barrowclough, 
2013; Hooley & Campbell, 2002; Peterson & Docherty, 2004; Wuerker, Long, Haas, & 
Bellack, 2002). Such findings suggest that EE will be negatively associated with autonomy, 
and perhaps therefore positively associated with psychological reactance. Indeed, Sellwood, 
Tarrier, Quinn, and Barrowclough (2003) found that family EE was related to non-adherence 
with medication. EE may also impact client engagement.  
Aims 
This study aims to investigate factors potentially influencing engagement with 
services for people experiencing psychosis. These factors are: perception of autonomy, 
psychological reactance and familial expressed emotion.  
First, correlational analyses will be used to understand the relationships between 
individual variables before employing regression analyses to determine predictors of 
engagement. The study also aims to investigate whether psychological reactance mediates the 
relationship between autonomy and engagement. Finally, if participant numbers allow, the 
study will aim to investigate whether EE moderates the relationship between psychological 
reactance and engagement. 
Research questions  
1. Are any demographic variables associated with any of the variables measured? 
(collecting demographic information will aid in analysis and understanding of results 
as well as allowing a full description of the sample). 
2. What is / is there a relationship between autonomy and psychological reactance? 
3. What is / is there a relationship between autonomy and engagement? 
4. What is / is there a relationship between psychological reactance and engagement? 
5. What is / is there a relationship between EE and engagement? 
6. What is / is there a relationship between EE and autonomy? 
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7. What is / is there a relationship between EE and psychological reactance? 
8. Does autonomy, reactance or expressed emotion predict engagement? 
9. Does psychological reactance mediate the relationship between autonomy and 
engagement? 




For the regression analyses, an a priori power analysis using G*power using a 
multiple regression with five predictors at an alpha level of 0.05 (p < .05) and a power of 0.80 
is predicted to require a sample size of N = 92 in order to identify a medium effect size (f 2 = 
0.15).  
Sample sizes necessary for mediation analyses were calculated using MacKinnon, 
Fairchild, and Fritz (2007) guidance which is based on effect sizes. A literature search 
indicated that there are no existing studies investigating the relationship between autonomy 
and reactance which could be used to estimate an effect size (it seems that, in the literature, 
these two variables are assumed to be very closely related as they are so theoretically 
intertwined – reactance occurs when autonomy decreases). Thus, for the power analysis, here 
it seems feasible to assume that there will be at least a medium effect size found between 
these two variables.  
For the relationship between psychological reactance and engagement, a literature 
search found only one study investigating the relationship between reactance and engagement 
in a child welfare sample (Mirick, 2014). It was found that the correlation coefficient for the 
relationship between reactance and engagement was r = -0.277, which can be converted to a 
Cohen’s D effect size of -0.576. For medication adherence (a phenomenon related to 
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engagement), Fogarty and Youngs Jr (2000) found a correlation co-efficient of r = -0.32, 
which can be converted into a Cohen’s D effect size of -0.676. These can both be assumed to 
be medium effect sizes (Cohen, 2013). 
Based on Fritz and MacKinnon (2007) guidance, conservatively assuming both 
relationships would be in the region of 0.26 and with a plan to utilise a bias-corrected 
bootstrap method of mediation, a sample size of 148 would be required. If the relationship 
between autonomy and reactance had an effect size of approximately 0.26, but reactance and 
engagement had effect size of 0.39, a sample size of 115 would needed. If, as seems possible, 
both relationships had a medium effect size, the required sample size would be 71.  
With regards to moderation analyses, there are again no existing studies that can be 
utilised to gauge effect sizes for a power calculation. Thus, once data are collected, 
moderation will be investigated if data allow. As moderation often needs larger sample sizes, 
it is possible to conduct conditional process analyses using the Hayes PROCESS tool 
utilizing bootstrapping methodology to reduce sample sizes required to perform moderation 
analyses (Hayes, 2012). This will be considered when assessing whether data are suitable to 
perform moderation on.  
 Inclusion criteria 
Inclusion criteria are participants who self-report: being 18 years of age or over; 
experience psychosis/have received a psychosis-related diagnosis; and are service users or 
have been service users of a mental health service.  
In the online survey, participants are asked to confirm their eligibility to participate 
(Appendix D) by checking online boxes within the online survey prior to answering any 
questions. Participants who do not check the box confirming their eligibility will be directed 
to a page explaining why they do not currently meet eligibility criteria for this study, thanking 
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them for their time and interest, and providing appropriate resources for if they should feel 
upset (Appendix E). 
Exclusion criteria 
Participants who are not able to read, understand and complete the measures in 
English will not be able to participate.  
Design 
Data Collection 
This is an online questionnaire study. This is a single group, cross-sectional design 
utilising quantitative outcome measures.  
Measures 
There are 67 items within the survey in total. Please see Appendix G for full survey 
and all questions included. There are an additional three items asking participants to: provide 
consent; confirm eligibility; and an optional item at the end to enter a prize draw / request a 
summary of the study’s findings upon study completion.  
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1. Demographic Questions (11 items) 
Demographic information will be collected to allow for a full description of the 
sample and to aid in analysis and interpretation of results. Information will be 
collected on: country residing in, age, gender, partnership status, occupational 
status, ethnicity, mental health diagnoses/condition the person identifies as 
experiencing, whether the person is currently involved with a mental health 
service, type(s) of mental health team the participant is a service user of, length of 
time the participant has been a service user of this service and whether they have 
ever been in hospital due to their mental health. Every demographic question has a 
“prefer not to say” option.  
2. Engagement (17 items) 
The Singh O’Brien Level of Engagement Scale (SOLES; O’Brien et al., 2009)  
This is a 16-item self-report measure of engagement with services for people 
experiencing psychosis. The SOLES has good predictive validity and has been 
found to predict longitudinal disengagement, cross-sectional disengagement and 
attendance at appointments (O’Brien et al., 2009). O’Brien et al.’s (2009) analysis 
revealed that the scale had good internal consistency (Cronbach's alpha = 0.843). 
When scoring, item 13 is reverse scored. The SOLES is scored by calculating the 
mean of all non-missing items. The authors report that three items can be missed 
if person does not have a key-worker/care coordinator. In this study, participants 
are told to leave any questions that are not relevant blank. This is because other 
questions that are not only about key workers/care coordinators may also not be 
relevant. For example, some questions ask about psychiatric medication or 
hospital admissions, which may not be relevant for all participants. Higher scores 
indicate better engagement.  
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The SOLES has recently been used in one study investigating treatment beliefs 
and engagement in FEP (Perry et al., 2019), and in another investigating 
predictors of engagement with EIS (Casey et al., 2016).  
An additional supplementary question is asked on whether the person feels there 
have been times in the past they have disengaged from mental health services. 
This is to gather information on whether people who score lower on the SOLES 
identify as having previously disengaged from services.  
3. Autonomy (12 items) 
Mastery Scale – short version (Clench-Aas, Nes, & Aarø, 2017; Pearlin & 
Schooler, 1978) 
The full version of the mastery scale contains seven items including two positively 
phrased items constituting the mastery facet of the scale and five negatively 
framed questions constituting the perceived constraints facet (Lachman & Weaver, 
1998). The short version of the scale contains only the negatively framed 
questions. The short version of the scale is used here as it has been shown to have 
better psychometric properties in comparison to the longer version, with 
Cronbach’s alpha generally reported at approximately 0.8 (Clench-Aas et al., 
2017; Gadalla, 2009). 
This is therefore a five-item scale which aims to measure an individual’s control 
over things that happen in their life. The individuals answer on a five-point scale 
whether they strongly agree, agree, agree as much as disagree, disagree or 
strongly disagree with the statements that they have little control over things that 
happen to them; are unable to solve problems they have; cannot change important 
things in their life; feel helpless when dealing with problems in life; and 
sometimes feel they are being pushed around in life. The total scores are summed 
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with higher scores indicating higher sense of mastery. The mastery scale has been 
used in psychosis research (Eklund, Erlandsson, & Hagell, 2012; Hsiung et al., 
2010). 
Supplementary Questions 
As the Mastery scale is not specifically related to a person’s perceived autonomy 
over their mental health or relationship(s) with mental health services, seven 
supplementary autonomy questions are included in the survey. These will be rated 
on a four-point scale ranging from not at all (1) to all of the time (4). Items four 
and seven will be reverse scored. This raises issues relating to validity, reliability 
etc. These issues will be addressed as much as possible through the analysis. It 
will unfortunately not be possible to assess test-re-test reliability due to the 
surveys being anonymous.   
These supplementary questions (and the concept of measuring autonomy) were 
taken to a service user group and to a meeting with LSCFT’s EIS participation 
consultant. I received positive feedback on the questions and the concept, with 
service users feeding back they felt the questions “made sense” and were “easy to 
understand and answer”. I changed the wording of question six in response to 
service user feedback from “other people allow me to develop my own treatment 
plan” to “my views are considered important when developing my treatment 
plan”, as it was felt the word “allow” insinuated the other person is still in control 
and therefore the care being receiving isn’t person centred.   
4. Reactance (14 items) 
Hong Psychological Reactance Scale (HPRS; Hong & Page, 1989) 
This is a 14-item scale measuring trait psychological reactance proneness. This 
scale has been used in many studies measuring psychological reactance, and in 
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studies measuring psychological reactance in relation to medication compliance 
(De las Cuevas, Peñate, Betancort, et al., 2014; Moore et al., 2000). Participants 
rate how much they agree with each item on a five-point Likert scale ranging from 
strongly disagree (1) to strongly agree (5). Total item scores are summed to 
provide a total score, with higher scores indicating higher reactance proneness.  
The scale has been shown to have adequate psychometric properties, most 
recently in a thorough validity study conducted by Brown, Finney and France 
(2011). They reported that items of the HPRS are factorially complex, and 
therefore it is misleading to estimate reliability using Cronbach’s alpha. Thus, they 
recommend that only the variance due to the factor of interest be treated as 
systematic variance, as done when computing wH (Zinbarg, Revelle, & Yovel, 
2007). wH can be used to estimate how well the observed total score represents 
the latent factor score, as it is equivalent to the squared correlation between the 
HPRS total score and the general reactance factor score. Brown, Finney and 
France (2011) report wH was .78, meaning that 78% of the variance in HPRS total 
scores is attributable to trait reactance. 
5. Expressed Emotion (17 items) 
Brief Dyadic Scale of Expressed Emotion (BDSEE; Medina-Pradas et al., 
2011). 
This is a 14-item scale measuring patients’ perceptions of expressed emotion. It is 
composed of three subscales: perceived criticism, perceived emotional 
overinvolvement and perceived warmth. Items are scored on a 10-point Likert 
scale ranging from 1 (not at all/never) – 10 (very/always). Sum scores are 
calculated, with higher scores indicating more perceived criticism, emotional 
overinvolvement, or warmth.  
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Medina-Pradas et al. (2011) conducted factor analysis of the BDSEE and 
identified three separate factors which accounted for 73.1% of the variance (the 
three factors related to the criticism, emotional overinvolvement and warmth 
subscales). The criticism factor consists of four items and accounted for 19.6% of 
the variance with a Cronbach’s alpha of 0.90. The emotional overinvolvement 
factor consists of six items and accounted for 27% of the variance with a 
Cronbach’s alpha of 0.82. The warmth factor consists of four items and accounted 
for 26.5% of the variance with a Cronbach’s alpha of 0.92. Thus, Medina-Pradas 
el al. (2011) demonstrated the scale to have an adequate structure and high 
internal consistency.  
Medina-Pradas et al. (2011) also investigated the BDSEE’s construct validity. 
They found correlations between the BDSEE and three other family instruments 
were significant and in the expected directions. The BDSEE was also compared 
with the Camberwell Family Interview – the gold standard for investigating EE. 
They found participants’ perceptions and the “objective” ratings derived from the 
CFI were significantly correlated for criticism and emotional overinvolvement, 
and a positive but non-significant relationship was observed between the BDSEE 
and CFI’s measure of warmth. Thus, their findings suggest the BDSEE’s construct 
validity is good. This validation study was conducted with a sample of people who 
had received eating disorder diagnoses. The scale was originally validated by 
Keefe et al. (2006 – as cited in Medina-Pradas et al., 2011) on a sample of people 
who had received schizophrenia diagnoses. Whilst this study was never published, 
Medina-Pradas et al. (2011) do report on some of the findings from the original 
study. Cronbach’s alpha from the sample of patients with schizophrenia was 0.67 
to 0.79.  
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Before participants complete the BDSEE, three supplementary questions are asked 
about who the participant lives with, whom the closest person in their life is, and 
how much time per week the participant spends with this person. This information 
is necessary to fully understand the impacts of expressed emotion on engagement. 
Expressed emotion is impacted upon depending on who the person lives with and 
the amount of face-to-face contact time the person has with the person closest to 
them in their life.   
Analysis plan 
Initially, demographic statistics will be analysed (frequencies, descriptives, explore 
and crosstabs) to understand characteristics of the sample. The nature of the relationships 
between variables will then be explored using correlational analysis to answer research 
questions 1-7.  
Following this, assumptions of parametric data and collinearity will be explored. A 
hierarchical multiple linear regression analysis will be used to determine the predictors of 
engagement. Any demographic variables that significantly correlate with engagement will be 
entered first (e.g. age, gender). It is likely that some of the independent variables will be 
significantly correlated (potentially violating assumption of no multicollinearity), e.g. 
reactance and autonomy. Thus, when calculating power/sample size necessary, it was 
calculated with five predictors entered into the model –e.g. potential demographic variable, 
reactance, criticism, emotional overinvolvement, warmth. Final regression models will be 
tested to confirm that the assumptions of a multiple regression are met by assessing 
multicollinearity, linearity, homoscedasticity and independence of residuals.  
I will then explore the viability of a mediation analysis, and if underlying assumptions 
are met I will conduct mediation analysis to investigate whether psychological reactance 
mediates the relationship between autonomy and engagement.  
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Finally, viability of moderation analysis will be explored. If underlying assumptions 
are met, a moderation analysis will be conducted to investigate whether EE moderates the 
relationship between psychological reactance and engagement. 
If in any case the data are non-parametric / assumptions are not met, transformations 
may be applied if appropriate. If not appropriate, alternative non-parametric methods of 
analysis will be explored.  
Procedure 
Recruitment 
Participants will be recruited online using principally, but not exclusively, the Twitter, 
Facebook and Instagram social media platforms. The study poster (Appendix A) will be used 
as a picture in social media posts to advertise the study. Hashtags will be used to accompany 
the post; at time of recruitment, the researcher will conduct an optimisation analysis to 
determine trending hashtags / which hashtags are most used relating to mental health / 
psychosis and utilise these. All online posts will be posted from a Twitter/social media 
account set up specifically for the purposes of disseminating recruitment materials for this 
study. No pre-existing personal social media accounts belonging to the researcher will be 
used for the initial posting of any materials relating to this study.  
Advocacy groups and charities for people experiencing psychosis will be approached 
directly to seek assistance in recruitment, in the form of asking them to reshare the link to the 
online survey on their social media platforms or advertise the poster in appropriate online 
places e.g. websites. These approaches will principally, but not exclusively, be done via email 
to a publicly available email address. These contacts will be focussed on resharing 
recruitment materials (posters, Tweets) and will not take the form of direct recruitment.  
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Online survey 
Once the participants click the link embedded in the recruitment posts / type in the 
link copied from the poster, they will be directed to the online survey, designed and powered 
using the Qualtrics software. The full online survey can be viewed online at 
bit.ly/psychosisresearch; the survey is currently password protected and will remain this way 
until ethical approval is gained. The password for the survey is Lancaster2 
Here, participants are provided with all relevant information (information sheet, 
Appendix B) and asked to consent to participate (Appendix C) and confirm their eligibility to 
participate (Appendix D) by checking online boxes within the online survey prior to 
answering any questions. Participants who do not check the box confirming their eligibility 
will be directed to a page explaining why they do not currently meet eligibility criteria for 
this study, thanking them for their time and interest, and providing appropriate resources for 
if they should feel upset (Appendix E). Eligible participants will then be shown a pre-survey 
message (Appendix F) before being guided through the outcome measures described above 
(Appendix G). Participants will then be directed to the debrief information (Appendix H). 
Here, participants are thanked for their time, provided with appropriate resources if they feel 
upset and given contact details for if they have any queries. Here, participants are also given 
the link to follow should they wish to opt into the prize draw or receive a summary of the 
study’s findings upon research completion. If participants do not wish to opt in, they can click 
“next” to end the survey.  If participants click the link, they will be directed to the secondary 
survey where they can indicate whether they would like to enter the prize draw and/or receive 
a summary of the study’s results, and can provide the email address they wish to receive these 
to (Appendix I). More information about this can be found under the “Prize draw” heading. 
When participants have indicated their option preferences and typed an email address, they 
can click the “next” button which will re-direct them back to the debrief section in the 
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primary survey. Respondents can click the “next” button again which will end the survey and 
show them a short end of survey message (Appendix J). 
Prize Draw 
In order to aid recruitment, participants will be given the option to enter a prize draw 
to win one of five £30 Amazon vouchers. Participants who choose to opt into the prize draw 
will be redirected at the end of the primary survey to a secondary survey (Appendix I). The 
secondary survey will ask participants to indicate they are choosing to opt-in to the prize 
draw, and will ask participants to provide the email address they would like an Amazon 
voucher to be forwarded to should they win the prize draw. Participants will also be asked if 
they would like to receive a summary of the study’s findings to this email address upon study 
completion. Following completion of this, participants are re-directed back to the primary 
survey. The data collected in the secondary survey will not be linked to the primary 
anonymised survey, and this is made clear to participants within both surveys and within the 
information sheet (Appendix B). Participants are asked to email or telephone the student if 
they have any difficulties with or questions regarding the secondary survey.  
In order to choose winners, each entrant will be allocated a unique identifier ranging 
from ‘1’ up to the total number of entrants. A random number generator drawing from the 
same range of numbers will be used to determine winners. The Student (A. Nickson) will 
forward winning participants an electronic £30 Amazon voucher via email.  
Data storage 
During the project 
All anonymised survey data will be analysed and stored electronically under password 
protection on the student’s secure storage space on Lancaster University secure servers or 
Lancaster OneDrive. Only the student and research supervisors will have access to the data. 
The student will have guardianship of the data whilst completing the current research.  
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The prize draw/study summary preferences and email addresses provided by 
participants will be downloaded from Qualtrics in the form of a Microsoft Excel file upon 
completion of data collection. This file will be password protected and stored on Lancaster 
University’s secure server. Only the Student (A. Nickson) and Research Supervisor (B. 
Sellwood) will have access to this. As soon as data collection is finished, the prize draw will 
be drawn and vouchers sent out. Following this, only data pertaining to people who have 
opted to receive a summary of the study’s results will be kept, with everything else being 
deleted from the Excel file. Once the study is completed, the summary of study results will be 
sent out. Following this, the whole Excel file will be permanently deleted.  
Upon completion of final examination of the project 
Raw survey data will be saved as an SPSS file and stored by the DClinPsy Research 
Coordinator who will store the files in password-protected file space on the university server 
for 10 years. Once this time has elapsed all data will be destroyed. This will be overseen by 
the project supervisor/data custodian (Professor Bill Sellwood).  
There is potential for this study to be published in a peer reviewed journal. This may 
require data being made available to other researchers upon request. Although all data are 
anonymous, access to data will only be granted on a case-by-case basis by Professor Bill 
Sellwood (research supervisor).  
Ethical concerns 
Anonymity 
In the survey data, no identifiable information will be collected from participants. 
Participants will not be required to provide their name or any contact information in order to 
take part. Age data will only be collected in the form of “years”, i.e. no date of birth. 
Participants will provide their responses to the survey questions in a wholly anonymous way. 
This is outlined to participants in the information sheet (Appendices B).  
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Participants who wish to enter the prize draw or wish to receive information on the 
study’s findings will be asked to provide an email address they would like to receive the 
findings / voucher to (should they win). Participants will be made aware in the information 
sheet that this is provided in a separate survey and is not stored in connection to their survey 
responses. This maintains the anonymity of the data they provide. Once transferring this 
information from Qualtrics to Excel, data will be stored securely on the University’s secure 
server and will be password protected. These data will be permanently deleted from the 
University’s secure server following the prize draw and dissemination of study summaries (as 
mentioned above).  
There is the small potential for de-anonymisation of responses as, although survey 
responses and email addresses are stored separately, the researcher will have access to both 
prior to formal analysis. If there is a low or slow response rate, it may be possible that the 
researcher will be able to identify which email addresses are associated with which survey 
responses. To address this, the researcher will not access content until data collection is 
complete. 
 
Participants are encouraged to contact the student if they have any queries or 
questions about the study. The information sheets make it clear that any emails/email 
addresses/telephone numbers are not stored anywhere and are deleted as soon as the query is 
resolved / phone call has ended.  
Informed consent 
Consent will be obtained via a consent form (Appendix C) and a forced choice 
question at the beginning of the online survey. Participants will be required to check a box to 
confirm: that they have read and understood the “participant information sheets”; that they 
understand they can stop completing the survey at any time and for any reason; that they 
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understand once they have submitted/returned their anonymous survey responses it will not 
be possible to remove/withdraw them; that they understand their responses may be published 
as part of an anonymous dataset; and that they consent to Lancaster University keeping the 
anonymous data from the study for 10 years post-study completion. Participants will not be 
able to undertake the outcome measures section of the survey, or submit their responses, if 
they do not first indicate informed consent to participate.  
As it will not be possible to identify participants from the data they submit, 
participants will be informed that they will not be able to withdraw their data once they have 
started the survey (information sheets, Appendix B). However, participants are informed they 
can stop the survey at any point.  
Participant well-being 
The student is a trainee clinical psychologist and is supervised by two qualified 
clinical psychologists who are experienced in conducting psychological research. Thus, the 
study has been designed with an aim to minimise the potential psychological distress for 
participants and any time burden due to the questionnaires chosen.  
Whilst it is not anticipated that completing the survey will cause distress, it is outlined 
in the consent form (Appendix C) that participants may be answering questions about topics 
they find emotional and that they may find these upsetting at times. This is because it cannot 
be anticipated that, for some participants, answering questions about their mental health may 
sometimes be upsetting. Moreover, information relating to appropriate sources of support if a 
person is experiencing distress are provided in both the participant information (Appendix B) 
and debrief materials presented at the end of the survey (Appendix H).  
Service User Involvement 
Anonymous focus group feedback was collected from experts by experience who are 
members of a service user involvement group that is linked with Lancaster University’s 
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Public Involvement Network. This group was contacted via Lancaster DClinPsy’s staff 
representative of the group. An NHS EIS participation consultant also provided expert by 
experience feedback. None of the experts by experience are currently under the care of any 
individual involved in this study. Their feedback was used to refine the accessibility of the 
information provided to participants, to understand the potential time burden of completing 
the survey, and to re-word some of the demographic and supplementary autonomy questions.  
Dissemination Strategy 
The results of this study will be published in the thesis of the student. Attempts to 
publish the research in a relevant academic journal and relevant professional/scientific 
conferences will also be undertaken. The student will also provide an oral presentation of the 
results at the Lancaster DClinPsy thesis presentation day. Once the study is completed, the 
findings will be shared, using lay language, on the social media accounts used for 
recruitment, so that participants have the opportunity to see the results. Participants who 
request a summary of the study’s findings will also receive this once the research is complete.  
 
Timescale (2020)  
Ethical review  April ethical review  
Data collection  Estimated start date May 2020 – Estimated end date July 2020. 
Begin write up February 2020 
Analysis  August 2020 
Complete write up  September-October 2020 
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Appendix A: Recruitment poster version 0.1
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Appendix B: Participant Information Sheet version 0.2 
 
Participant Information Sheet  
 
Investigating factors that may influence whether people with experiences of 
psychosis engage with mental health services. 
 
For further information about how Lancaster University processes personal data for research 
purposes and your data rights please visit our webpage: www.lancaster.ac.uk/research/data-
protection 
  
My name is Amy Nickson and I am conducting this research as part of my training as a clinical 
psychologist at Lancaster University. You are being invited to take part in my research study. It 
involves completing a survey that should take no longer than 25 minutes. Please read the 
information below about the study before deciding to take part. It is important for you to 
understand why this research is being undertaken and what taking part will involve. Feel free to talk 
to others about the study or contact me by email at a.nickson@lancaster.ac.uk or by telephone on 
07508406276 if you would like to ask any questions. 
  
What is the study about? 
We are trying to find out what influences whether people experiencing psychosis decide to use 
mental health services or not. 
Psychosis might be seeing or hearing things (voices) that other people cannot, or having strong 
beliefs that others think are very unusual. Experiencing psychosis is sometimes linked with diagnoses 
like "schizophrenia", "schizoaffective disorder" or "delusional disorder" but not necessarily. 
 
Examples of mental health services include:  
- Early Intervention for Psychosis Teams 
- Community Mental Health Teams 
- Home Based Treatment Teams / Crisis Teams 
- Assertive Outreach Teams 
- Increasing Access to Psychological Therapies services (IAPT - these are sometimes called 
things like Mindsmatter or First Step) 
 
I am interested in whether the way these services provide support and care for people experiencing 
psychosis can impact upon whether people engage with them. One factor I am investigating is 
people experiencing psychosis’ sense of control and decision making in their treatment. I’m also 
interested in the way that families provide support might be involved. 
  
Who can take part? 
The study requires information from people aged 18 years and older, who experience psychosis, and 
are involved or have been involved with a mental health service (e.g. Early Intervention Team; 
Community Mental Health Team; Home Based Treatment Team; Crisis Team; Assertive Outreach 
Team; Rehab Team; IAPT). 
  
Do I have to take part? 
No.  It’s completely up to you to decide whether or not you decide to take part after reading this 
information. If you would like to ask any questions, please email me at a.nickson@lancaster.ac.uk or 
telephone me on 07508406276. 
Deciding not to take part in the study is completely fine and it will not affect your rights or access to 
services in any way. If you decide you do want to take part, but then later change your mind, you can 
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do that simply by closing the survey window. However, any data collected up until the point you exit 
the survey may be included in the overall study results as the data collected will be anonymous and 
so it will not be possible for me to identify and remove your data after you exit the survey.  
 
What will I be asked to do if I take part? 
If you decide you would like to take part, you will be asked to give your consent electronically on the 
next page, after which the online survey will begin. This will ask some questions about you (e.g. age, 
gender), your decision making, and how you feel the person closest to you acts towards you. The 
survey will NOT ask for any personal identifiable information such as name, address or date of birth.  
 
It will take approximately 20-25 minutes to complete the survey. 
 
Will my data be identifiable? 
No one will know the information you provide is yours, as the information you provide will be 
anonymous. 
There is an option to be entered into a prize draw for a chance to win one of five £30 Amazon 
vouchers. In order to enter the prize draw, you will be required to provide your email address at the 
end of the survey. Email addresses are collected and stored securely and separately to your survey 
responses, and so cannot be linked to the answers you give within the survey. 
 
If you email me at a.nickson@lancaster.ac.uk or telephone me on 07508406276 to ask questions 
about the study, it will NOT be possible for me to link your details (such as name, telephone number 
and/or email address) to any survey responses you may provide. This is a university email address 
and telephone number. Any email correspondence will be confidential, and emails will be securely 
stored until no longer needed (i.e. once you receive a satisfactory response to your questions), after 
which they will be permanently deleted. Telephone numbers will be deleted as soon as a phone call 
is over.  
 
At the end of the study, data will be kept securely on the university’s secure server for ten years. At 
the end of this period, data will be destroyed.  
 
A synthesis of the data may be published. The full data set will not be publicly available; however, it 
may be provided to other researchers upon request on a case by case basis. At all times all data will 
be anonymous, and no identifiable elements will be included.  
 
What will happen to the results? 
The results will be submitted for publication as a thesis as part of the Lancaster University Doctorate 
in Clinical Psychology programme. Following this, the report may be submitted for publication in an 
academic journal. I will also be sharing a summary of the results in oral presentations to other 
healthcare professionals and at conferences. There is also an option at the end of the survey to 
indicate whether you would like to receive a summary of the study's findings via email. The summary 
will never have specific information about you or any other individual participant. 
  
Are there any risks? 
There are no risks anticipated with participating in this study.  However, if you experience any 
distress whilst completing the questionnaire please stop immediately. You can also contact the 
organisations included in the resources provided at the end of this sheet. In addition, please contact 
these organisations if you experience distress following participating in this study. 
  
Are there any benefits to taking part? 
If you choose to enter the optional prize draw, you may win one of five £30 Amazon vouchers 
ETHICS PROPOSAL  4-43 
 
 
Moreover, some people like taking part in research due to its potential to help others in future. 
However, there are no other direct benefits to taking part in this research.  
  
Who has reviewed the project? 
This study has been reviewed and approved by Lancaster University’s Ethics Committee. 
 
Where can I obtain further information about the study if I need it? 
Researcher & Trainee Clinical Psychologist                            
Name: Amy Nickson        
Lancaster Doctorate in Clinical Psychology,                           
Lancaster University, Lancaster,                                                 
LA1 4YG 
Email: a.nickson@lancaster.ac.uk 
Telephone: 07508406276  
  
Alternatively, you can speak to my Research Supervisor from the Lancaster Clinical Psychology 
training programme on: 
  
Name: Professor Bill Sellwood                                    
Email: b.sellwood@lancaster.ac.uk                         
Contact Number: 01524 593998                 
  
Postal Address: C34 Furness College, Lancaster University, Lancaster, LA1 4YG 
  
Complaints 
If you wish to make a complaint or raise concerns about any aspect of this study and do not want to 
speak to the researcher, you can contact: 
Dr Ian Smith 
Email: I.smith@lancaster.ac.uk 
Research Director 
Doctorate in Clinical Psychology, 
Lancaster University, Lancaster 
LA1 4YG 
  
If you wish to speak to someone outside of the DClinPsy Doctorate Programme, you may also 
contact the Associate Dean for Research: 
  
Professor Roger Pickup Tel: +44 (0)1524 593746 
Email: r.pickup@lancaster.ac.uk 
Faculty of Health and Medicine  
Lancaster University, Lancaster 
LA1 4YG 
If you are feeling upset 
Should you feel distressed either as a result of taking part, or in the future, please contact your GP 
for support. In addition, the following resources may be of assistance: 
 
Mind for better mental health Website: mind.org.uk 
Hearing Voices Network Website: hearing-voices.org 
 
Rethink mental illness Website: rethink.org 




Appendix C: Consent Form version 0.1 
Consent Form 
We are asking if you would like to take part in a research project that explores psychological 
factors impacting whether people experiencing psychosis choose to engage with mental 
health services. Before you consent to participating in the study please read the information 
provided. If you have any questions or queries before taking part, please contact the 
student, Amy Nickson, by email at a.nickson@lancaster.ac.uk, or by telephone on 
07508406276.  
Please read the following statements and click on the option below to indicate that 
you 
are happy to take part in the study.  
1. I confirm that I have read the participant information sheet and fully understand 
what is expected of me. 
 
2. I understand that the questionnaire will include questions about emotional topics 
and that although every care has been taken for these questions to be asked in a 
sensitive manner, they may be upsetting at times. I understand that I do not have 
to complete the questionnaire and that I am free to stop at any time, for any 
reason. 
 
3. I understand that once I have submitted my anonymous responses it will not be 
possible to remove them. 
 
4. I understand that my anonymous responses will be added to other participants' 
responses and may be published as part of an anonymous data set and written 
up as a research report, which may be published. 
 
 
5. I consent to Lancaster University keeping the anonymous data from the study for 
10 years after the study has finished. 
 I consent to all five statements above and wish to take part in the current study 
 
 I do not consent to all five statements above and do not wish to take part in the 
current study (selecting this option will end the survey now). 
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Appendix D: Eligibility version 0.1 
(NB : selecting all statements here then clicking the red arrow “next page” button takes the 
participant to the pre-survey message - Appendix F -, whereas selecting none or only one or 
two of the statements and clicking the “next page” button takes the participant to the “not 
eligible” message – Appendix E) 
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Appendix E: Not Eligible message version 0.2 
 (NB : clicking the red arrow “next page” button here takes the participant to the “end of 
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Appendix G: Outcome measures 
Please note: each of the questions in this section has a ‘prefer not to say’ option. Please use 
this option if for any reason you do not wish to answer a question.  
What country do you live in? (please leave blank if you prefer not to say) 
___________________ 
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 Prefer not to say 
 
How would you describe your partnership status? 
 Married 
 Civil partnership 
 Divorced 
 Widowed 
 Living together but not married 
 Single 
 Other 
 Prefer not to say 
 
How would you describe your occupational status?  
 Employed full-time 
 Employed part-time 




 Caring for children/others 
 Volunteering 
 Other 
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What is your ethnicity? (categories from Office of National Statistics) 
 WHITE – English / Welsh / Northern Irish / Scottish / British 
 WHITE – Irish 
 WHITE – Gypsy or Irish Traveller 
 WHITE – Any other white background 
 MIXED / MULTIPLE – White and Black Caribbean 
 MIXED / MULTIPLE – White and Black African 
 MIXED / MULTIPLE – White and Asian 
 MIXED / MULTIPLE – Any other mixed / multiple ethnic background 
 ASIAN / ASIAN BRITISH – Indian 
 ASIAN / ASIAN BRITISH – Pakistani 
 ASIAN / ASIAN BRITISH – Bangladeshi 
 ASIAN / ASIAN BRITISH – Chinese 
 ASIAN / ASIAN BRITISH – Any other Asian background 
 BLACK / AFRICAN / CARIBBEAN / BLACK BRITISH – African 
 BLACK / AFRICAN / CARIBBEAN / BLACK BRITISH – Caribbean 
 BLACK / AFRICAN / CARIBBEAN / BLACK BRITISH – Any other Black/African/Caribbean 
background 
 OTHER ETHNIC GROUP – Arab 
 OTHER ETHNIC GROUP – Any other ethnic group 
 Prefer not to say  
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Which of the following conditions do you identify as experiencing / Have you been given 
any of the following diagnoses? Please select all you feel apply to you. 
 Psychosis 
 At risk of developing psychosis 
 First episode psychosis  
 Schizophrenia 
 Schizoaffective disorder 
 Schizophreniform Disorder 
 Delusional Disorder 
 
 Bipolar Disorder 
 Depression 
 Anxiety  
 Post-Traumatic Stress Disorder 
 Personality Disorder (any) 




 Prefer not to say 
 
 
Are you currently involved with a mental health service? 
 Yes 
 No 
 Prefer not to say 
Which type(s) of mental health service are you or have you been involved with? 
 Early Intervention for Psychosis Service 
 Community Mental Health Team  
 Assertive Outreach Team 
 Rehab Team 
 Crisis Team 
 Home Based Treatment Team 
 Increasing Access to Psychological Therapies (IAPT) service 
 Other (please specify) 
____________________________________________ 
 Prefer not to say 
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How long have you been / were you involved with this service? Please describe in months 
or years. Please enter “0” if you prefer not to say.  
_________________________________ 
 
Have you ever been in hospital due to your mental health? 
 Yes, once 
 Yes, more than once 
 No 


















ETHICS PROPOSAL  4-52 
 
 
Please rate from 0 (not at all) to 10 (entirely) your agreement with the 
following statements. Please circle or tick your answer.  
  
Questions can be left blank if they aren't relevant to you, i.e. if the question asks about 
medication but you aren't prescribed any.  
If you are no longer involved with a mental health team, please answer based on how you 






Please continue on the following page. 
 
 





Have there been any times in the past when you have disengaged from mental health 
services (e.g. stopped attending appointments or not wanting mental health services' help 
anymore)? 
 Yes (if so, please specify how many times) 
________________________________________________________________ 
 No 









To what extent do you agree with the following statements about 
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To what extent do you agree with the following statements about 
yourself? Please circle or tick your answer.  
If you are no longer involved with a mental health team, please answer based on how you 
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Please rate how much you agree with the following statements. Please 
circle or tick your answer.  
 
Please continue on the following page. 
 








Who do you live with? 
__________________________________________ 
 
Who is the closest person in your life whom helps support you with your 
mental health? This might be a parent, sibling, relative, partner or friend, 
for example.  
 
________________________________________ 




Approximately how much time do you spend per week with the closest 
person in your life whom helps support you with your mental health?  
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Please answer the following questions about the person you are closest to, 
whom you spend the most time with through the week and whom helps 
support you with your mental health.  
Please continue on the following page. 
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Please continue on the following page. 
 









Please continue on the following page. 
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Appendix H: Debrief section version 0.2 
Investigating factors that may influence whether people with experiences of 
psychosis engage with mental health services. 
  
Thank you for your time! 
Thank you for participating in this study.  
  
Please click here for details about how to enter the prize draw for the 
chance to win one of five £30 Amazon vouchers and/or how to obtain a 
summary of study results. 
  
If you opt-in to either of these, please note that your email address cannot be linked to 
your survey responses; it will remain confidential and it will be permanently deleted 
following the prize draw / dissemination of study results summary. 
  
If you have any questions or difficulties regarding entering the prize draw / requesting a summary of 
study results, please email Amy Nickson on a.nickson@lancaster.ac.uk, or by telephone on 
07508406276. 
  
If you do NOT wish to enter either of these, just click the “Next” button at the bottom and the survey 
will end. 
  
If you are feeling upset 
Should you feel distressed either as a result of taking part, or in the future, please contact your GP 
for support. In addition, the following resources may be of assistance: 
 
Mind for better mental health 
Website: mind.org.uk 
 
Hearing Voices Network 
Website: hearing-voices.org 
 
Rethink mental illness                                           
Website: rethink.org 
  
If you wish to discuss an aspect of the study 
Please contact: 
Amy Nickson 
Lancaster Doctorate in Clinical Psychology,                           
Lancaster University, Lancaster,                                                 
LA1 4YG 
Email: a.nickson@lancaster.ac.uk             
Phone: 07508406276  
  
If you have a complaint 
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If you wish to make a complaint or raise concerns about any aspect of this study and do not want to 
speak to the researcher, you can contact: 
Dr Ian Smith 
Email: I.smith@lancaster.ac.uk 
Research Director 
Doctorate in Clinical Psychology, 
Lancaster University, Lancaster 
LA1 4YG 
  
If you wish to speak to someone outside of the dclinpsy Doctorate Programme, you may also contact 
the Associate Dean for Research: 
Professor Roger Pickup Tel: +44 (0)1524 593746 
Email: r.pickup@lancaster.ac.uk 
Faculty of Health and Medicine  
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Appendix J: End of Survey message version 0.1 
 
 
 
 
